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ABSTRACT
The discovery of* insulin was a mile stone in the treatmait 
of diabetes. For most diabetics however , the development of the 
secondary complications of the • disease are often fatal and the 
cause and prevention of these secondary lesions remains the 
outstanding problem in the treatment of the disease «
islet cell transplantation as a total cure for the disease 
was proposed over 80 years ago . Islet implantation in rodents is 
now a safe and reliable method of reversing the metabolic 
derangements and preventing diabetic lesions in experimental 
animals . The problem of isolating sufficient islets from the 
human pancreas and in avoiding the immune tissue rejection 
phenomena have so far precluded its successful application in 
man.
Enzymes of defined . activity were used to achieve 
dissaggregation of the human pancreas . A periperfusion system 
was developed for evaluating the dynamic aspects of insulin 
release both from normal and dispersed pancreatic tissue • This 
allowed critical aspects in the technique of tissue 
disaggregation to be examined and improved ,such that in excess 
of 60% of the initial islet function could be recovered following 
disaggregation.
Implantion of this crude pancreatic disaggregate in the 
canine model resulted in uncontrolled fluctuations in blood 
glucose levels , a massive bleeding diathesis and hepatic trauma, 
indicating the need for purer islet preparations .
Attachment of islets to a collagen substrate was found to 
allow recovery of islets as an essentially pure preparation. 
Tissue culture techniques were used to confirm the viability of 
pancreatic islets isolated in this way .
Finally the problem of abrogating the immune tissue 
rejection phenomena was investigated across a discordant xenoge­
neic histocorapatability barrier . The imraunogenicity of human 
islets was shown to be altered following tissue culture of 28 
days such that survival of 3 months was achieved ih an immunocora- 
petant host .
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INTRODUCTION
I can think of no more appropriate introduction to this 
dissertation than the rather tragic case notes of Prof. Dr. 
Kussmaul written exactly 110 years ago .
' As I came to this patient about 11 o* clock in the morning 
I found her. lying in bed in the greatest unease . She was in 
great pain and oppression , throwing herself here and tiiere and 
begging for help , in great fear of death ».
He goes on to describe how extensive treatment produced
not the slightest improvement in her condition and how the
unfortunate woman eventually died in great distress.
This serves to remind us of what a terrible disease 
diabetes was before the discovery of insulin . It also perhaps 
explains why in the long history of the disease countless 
physicians and scientists have directed liieir endeavours and 
often their lives in trying to provide an understanding of the 
cause and treatment of diabetes .
There, are literally thousands of names ttiat could and 
perhaps should be mentioned in a comprehensive review of this 
subject . Obviously this is impossible within the confines of the 
limited number of pages allotted to this thesis . Instead an 
attempt will be made to selectively retrace some of the
historical developments which have led to our present
understanding of the disease , our endeavours to treat the 
disease , and the problems which remain unresolved .
CHAPTER ONE
1.1 HISTORY OF DIABETES
Possibly the first recorded reference to diabetes is con­
tained in the Ebers Papyrus purchased by Georg Ebers in Luxor in 
1872. This papyrus is one of the oldest known medical documents 
and- is thought to date from around 1,500 years B.C., although 
Dawson (1965) suggests that it may have been copied from an 
earlier document dating from around 3,400 B.C.. A complete tran­
slation by Joachim appeared in 1890 in which the following men­
tion is made of ' a medicine to drive away the passing of too 
much urine ’;
Branches qadet plant Honey
Grapes Sweet beer
Berries of uan tree
cook, filter and take for two days' ( Major 1965 ).
According to Ajgaonkar ( 1972 ) many of the symptoms of
diabetes i.e. polyuria , glycosuria and the foul breath of
the untreated diabetic were known to the Hindu physicians
before 400 B.C.
A more definitive description was provided by Aretaeus the 
Cappadocian ( 81—138 A.D.). He noted the excessive thirst and
urination ,general langour and fatal end point of the disease. He 
believed that the large fluid intake did not remain in the body 
but that it ' flowed through and that many parts of the flesh pass 
out with the urine'. For this reason he likened the effects of 
the disease to a syphon , the ionic term from which is derived 
the word diabetes.
Paracelsus ( circa. 496-541 A.D.) thought that diabetes was
due to the presence of abnormal salts in the urine and recorded
that death resulted when üiis * essence settles in the kidneys
and salts them • ( Major 1965 ).
In the 11th Century , diabetes was extensively described
by the Arabian physician Avicenna (980-1037) who noted the 
abnormal appetite , sweetness of urine , gangrene , and the 
muscular , mental and sexual impotence ( Wellman 1977 ). He
prescribed fenugree , seman contra and hops as a cure . It is 
interesting that this reme^r was repeated by Professor Bobin in 
Paris in 1913 with some degree of success (Garrison 1966).
Little further was recorded concerning the disease until the 
Royal Physician Thomas Willis ( 1621-1675 ) rediscoveMd the 
sweetness of diabetic wine by tasting it , and suggested Idiat 
the disorder arose first in the blood and then in the urine 
(Willis 1679).
It is clear from the writings of Dobson (1776) that this 
finding was still not accepted by many physicians , anri it was 
not until 1787 that William Cullen coined the adjectives 
'mellitus* and * insipidus* to distinguish between üie two forms 
of "diabetes" , ( the latter lacking glycosuria ).
Dobson (1776) , evaporated Hie urine of diabetic patients 
and obtained a brown substance which by appearance and taste was 
' indistinguishable from sugar '. He noted ( again by taste ) the 
presence of sugar in both the urine and serum of diabetic 
patients.
Chevruel (1815) the French chemist identified this sugar as 
glucose. Trommer (1841) introduced a test for glucose in 
the urine which was followed by the discovery that smai 1
amounts of sugar in urine and blood could be measured by the
reduction of copper in an alkali solution ( Fehling 1848). This
opened the way for a quantitative study of the nature of the
disease. Pavy (1862) first recognized that the extent of the
glycosuria was related to the level of hyperglycaemia.
Other metabolic defects of the disease were noted i.e.
acetone ( Petters 1857) , aceto-acetic acid ( Gerhardt 1865) and 
oxybutyric acid ( Stadelmann 1883) were identified in the urine 
of diabetic patients.
It is known that diabetes was being diagnosed in 1872 by a
’ chemical analysis of the urine ' by Prof. Adolf Kussmaul
sfter whom is named the acidosis induced ' air hunger ' often
present in the terminal stages of this disease ( Kussmaul 1874)
It is of considerable interest that the first indication 
that the pancreas could be associated with the development of
diabetes came when Johann Brunner ( 1653-1727) succeeded in
removing the pancreas from a dog and noted the ensuing polyuria 
and polydypsia. Despite assertions to the contrary (Wellmann
1977) , it appears from the writings of de Sauvages (1752) that
Brunner clearly recognized the * artificial production of 
diabetes'.It seems that like many experiments in science , these 
findings associating diabetes with the pancreas were too
premature and were not pursued.
Nearly 150 years later Bouchardat ( 1851) pointed out that 
diabetics dying from the disease often had a small atrophic 
pancreas. However these findings were not conclusive for many
diabetics had macroscopically normal pancreases.
On March 19th 1853 Claude Bernard presented his zoology 
dissertation in which he introduced the perhaps then heretic view 
that animals like plants could synthesize glucose ( Unger 
1979).He identified the liver as the main site of glycogen depo­
sition and also as the site of glucogenesis , an excess of which 
was released into the circulation and excreted via the kidneys in 
diabetic patients.He believed however that this mechanism was 
under the control of the central nervous system .
In 1883 the experimental work of Amozan ( 1884 ) again
implicated the pancreas with diabetes. He showed that pancreatic 
duct ligation was followed by pancreatic atrophy and subsequent 
diabetes.
Von Meering and Minkowski ( 1892,1893 ) established without 
doubt ,that the pancreas was related to diabetes. Minkowski after 
a disagreement with Von Meering ( Naunyn 1906 ) succeeded in
removing the pancreas from dogs and showed that , if the dog 
survived the operation , its urine would contain increasing 
amounts of sugar and the dog would become severely diabetic. 
This could be reversed in the short term by reimplanting the 
pancreas. They went on to show that diabetes did not occur if Hie 
pancreas had an intact blood supply and that a neural element was 
not essential for blood sugar control. In the same year Hedon 
(1892) noted that in experimental conditions in which the vascular 
supply to the pancreas remained patent, but in which the external 
secretion was curtailed ,diabetes did not develop.
Attention was drawn to the possibility that an * external 
secretion ' might be instrumental in regulating blood sugar
8
levels.
In his doctoral Hiesis Paul Langerhans ( 1869 ) hgd des­
cribed anatomically isolated clusters of cells scattered throug­
hout the rabbit pancreas , however it was not until 1889 that 
these structures became known as the • Islands of Langerhans • .
Laguesse (1893) suggested that these islands provided the 
internal secretion instrumental in controlling blood sugar 
levels.
In 1883 Hoppe-Seyler had drawn attention to Hie micro- 
vasculat lesions within the pancreas of diabetic patients. Hanse- 
mann (1894) reported atrophy of the pancreatic parenchyma and 
Opie (1901) suggested that progressive fibrosis may damage the 
islets within the pancreas of diabetic patients. Opie further 
noted hyalinization and sclerosis of the islands in diabetics 
(fying from Hie disease. Weichselbaum (1901) described hydropic 
degeneration or vacuolization and Cecil (1908) noted the hyper­
trophy and inflamatory lesions ( renamed insulinitis by Von 
Meyenburg in 1940 ).
Weichselbaum (1901) reported a reduction in both Hie number 
and size of islets in diabetic patients . Ssobelew (1902) confir­
med these findings and noted the complete absence of islets in 4 
out of 13 diabetic pancreases. He fïirHier showed that pancreatic 
duct ligation destoyed adl bf the pancreas without causing dia­
betes but that diabetes resulred immediately following the remo­
ved. of the islets.
Ssobelew concluded that the pencreatic islets produced a 
substance which played an important if not an exclusive role in 
the aetiolo of diabetes •
Bayliss and Starling (1904) had introduced the concept of 
chemical messengers for which Hiey proposed the name 
'hormone', and De Meyer (1909) concluded from Hie available 
evidence that islets produced such a hormone and suggested that 
it should be called ' insuline ' • This hypothesis was independently 
proposed by Sharpey-Shaffer (1913) who prophetically suggested 
that it may derive from a substance with a larger molecular 
wei^t . The scene was therefore set for attempts to isolate this 
hormone.
Minkowski (1893), Ssobelew (1902), De Witt (1906),McCallim 
(1909), Kirkbridge (1912) and Allen (1913) among others are 
known to have prepared pancreatic extracts. However, the 
inactivation of any extracted insuline , or the febrile and toxic 
effects of these preparations precluded their clinical use 
(Macleod 1920 ) .Zeulzers method (1908) was so encouraging that he 
signed a contract with Hoechst Pharmaceuticals but no ccxnmercial 
product ever appeared.
The technique of making alcoholic extracts was improved by 
Scott (1912) and Murlin (1913) vdiose valuable work was 
unfortunately interrupted by war service ( Garrison 1966 ).
The Roumanian physiologist Paulesco was probably the first 
to prepare a suitable extract from duct ligated pancreatic 
tissue. He showed in 1916 that this extract , if given 
intravenously , could lower the blood sugar from 140 mg/ 100ml tc 
26 mg/ 100ml in one hour. Paulesco further noted that this hormone 
which he named ' pancreine ' would also reduce the glycosuria and 
ketonuria in pancreatectomised animals.However these findings
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were not published until July 23rd 1921 ( Paulesco 1921 ).
On Hie 20th November 1921 , four months after Paulesco *s 
work was published , Banting and Best presented their experimen­
tal findings in which they showed that extracts prepared from the 
pancreatic tissue of glands ligated 10 weeks earlier could reduce 
the blood sugar if given intravenously or subcutaneously. In May 
1922 they published their findings ( Banting & Best 1922 )on its 
use in controlling hyperglycaemia in dogs. The alcoholic extrac­
tion technique developed by Collip (1923) considerably purified 
this extract enabling the evaluation of its use in treating the 
diabetic patient.
There was little doubt that this hormone which Banting and 
Best christened 'isletine* but which at McCloud's insistance they 
renamed ' insulin ' ( Papaspyros 1964) was the prime agent in
reducing hyperglycaemia.
Banting's Nobel Lecture in Stockholm (1925) reported Hie 
progress with insulin replacement therapy in the clinical field.
The assumption that the underlying cause of the disease 
resided solely in a hormone deficiency of the pancreatic islets 
was however too parsimonious to expladn many of the experimental 
findings. A number of studies indicated that the pathological 
aü.terations to the pancreas were neither a constant nor specific 
finding in diabetes.Hydropic changes and hyalination (Ohlmacher 
1904) and vacuolization (Suaerbeck 1904) were demonstrated in the 
pancresis of non-diabetic individuals. Of more serious concern was 
the inability to demonstrate any pathological alterations in the 
pancreases from many known diabetic patients (Sauerbeck 1904), 
and in many other diabetic subjects doubts were raised sis to
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whether the observed changes were paHiognomic of Hie diabetic 
state.
Hence attention became focused upon the actions of several 
other factors which are now known to induce hyperglyc^ m^mi a by 
initiating hepatic glycogenolysis or gluconeogenesis (Bloom
1978).
Hormones of the chromaffin system ( thyroid, pituitary and 
adrenal glands ) emerged as real contenders as factors Tn-î-h-ia-h-îng 
the disense ( Falta 1913 ). Pierre Marie (1886) first described 
diabetes associated with acromegaly and Minkowski ( 1887 )
recorded the presence of eosinophilic adenomas in the disease. 
Blum (1901) and Zuelzer (1908) both observed hyperglycaemia 
caused by epiphrine.lt is now knovm that diabetes will occur in 
about 25% of cases in which hypersecretion of these hormones 
occur i.e.acromegaly, Cushing's syndrome and phaeochzxwaocytoma . 
Bloom (1978) , however argues Hiat no evidence has emerged to 
suggest that these hormones induce carbohydrate intolerance unless 
hypersecretion exists or insulinopoenia is already established
An alternative pathogenic Hieory of the disease was 
suggested when Allen (1913) managed to prepare a pancreatic ext­
ract which when injected into dogs resulted in hyperglycaemia. A 
similar initial hyperglycaemic effect was observed following 
insulin replacement therapy by Murlin (1923) who named this as yet 
unknown hormone glucagon. Glucagon was isolated by Staud (1955) 
and its presence was identified in the A cells of the pancreas by 
Baum (1962).
From the work of Diamare (1899) and Mankovski (1902) two
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types of pancreatic islet cells ( Hie A and B cells ) were known, 
Since then three other cell types , the C , D and PP cells have 
been demonstrated ( for a review of islet cells see the Lausanne 
Classification 1977 ).These cells share certain characteristics 
and togeHier with certain gut secretory cells are recognized as 
the APUD ( amine precurser uptake and decarboxylation ) cells and 
it is now fashionable in such terms as the gastro—entero—pancrea­
tic ( GEP ) endocrine system (Orci 1975 ) or entero—insular axis 
( Brown 1978 ).
The work of Muller (1971) and Gerich (1975) indicated that 
abnormal glucagon secretion in response to both glucose induced 
hyperglycaemia and insulin induced hypoglycaemia may be a preci­
pitating factor in the disease. This led Unger (1975) to propose 
his so called ' double trouble theory ' and to suggest that 
deranged glucagon secretion was a prerequisite for many aspects 
of the disease i.e. the development of ketoacidosis , however 
this finding has been strongly argued against by Bames (1976). 
In addition evidence has been presented by Sherwin (1976) and 
Shichiri (1982) that glucagon secretion may be apparently normal 
in diabetics if strict blood glucose control was established with 
appropriate intravenous insulin infusion systems . This suggests 
that glucagon is of secondary importance and may exert its effect 
only during times of insulin deficiency .
A fu' her possibility for the underlying cause of the 
disease emerged when Feyrter (1966) suggested that cellular 
secretions may influence adjacent cells i.e. a paracrine rela­
tionship existed . Orci (1976 ) demonstrated the existance of 
gap junctions between the A and B cells and suggested that
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interactions between some cells of the entero-insular axis may 
play an important part in glucose homeostasis . The increased 
insulin secretion in response to an oral glucose stimulus as 
opposed to when it is given intravenously is almost certainly 
due to pareital cell secretion influencing insulin response 
(Bloom 1978) • It remains possible that a disorder in gut
secretions of the GEP endocrine system may play an important part 
in the pathogenesis or treatment of the disease ( Schmidt 1977 )
but as yet this remains unproven.( for a comprehensive review of 
this subject see Cruetzfeldt 1980 )
The theories of the pathogenesis of the disease presented 
above emphasize a single causal factor in the development of 
diabetes , however a major contribution to our understanding of 
the disease came with the realization that diabetes might be a 
heterogenous disease with multi-factorial origins.
In 1908 Naunyn had desribed three types of diabetes . He 
distinguished between the 'pure diabetes' i.e. the young diabetic 
with onset mostly before the 30th year,the 'mild diabetes' 
usually occurring in older patients and the 'organic diabetes' 
which was associated with other conditions.
The extensive works of Dr.Joslyn (1921) identified obesity 
as the greatest risk factor in the 'mild' diabetic .He showed 
that diabetes was at least 6 times more common in the obese and 
in certain age groups was 40 times more frequent .
A difference between young and mature diabetics in genetic 
susceptability to the disease was reported by Cammidge ( 1928 ) 
and led geneticists to expect that more than one genetic 
mechanism was concerned in the development of the disease.
14
However, interest agsdn became focused upon the pancreatic 
islets when Gellhom (1941) established the existence of insulin 
like activity in normal human serum. Groen (1952) developed the 
rat diaphragm, and Martin (1958) the adipose tissue, in vitro 
assays for insulin. However Leonard (1959) reported that the 
insulin like activity measured in human serum was not suppressed 
by anti-insulin serum raised in guinea pigs ,( a serum which 
completely blocked the biological activity of crystalline 
insulin ). Moreover , insulin like activity persisted in the 
serum of totally pancreatectomized dogs indicating a non-pancrea- 
tic origin for this non-suppressable insulin. It is now known 
that this hormone is more active in vitro and does not appear to 
be involved in blood sugar homeostasis ( Zapf 1978 ).
Nevertheless it did lead to the realization that nozmial serum 
insulin levels were present in many adult onset diabetics 
(Bomstein 1950 ). Hence interest became focused upon mechanisms 
which might inactivate or antagonize the action of insulin in 
serum. Enzymatic degradation by insulinase ( Brohn-Kahn 1949 ),
lipid metabolites ( Bornstein 1953 ) and circulating antagonists 
i.e. synalbumin ( Antoniades 1962 ) were suggested , however 
there was no clear evidence to support their importance ( Deckert 
1965 ).
Hartcroft (1955) confirmed both normal B cell granula­
tion and extractable insulin from the pancreas of maturity onset 
diabetics . In contradistinction McClean ( 1959 ) indicated that 
B cells were either absent or their number was severely reduced 
in the juvenile onset diabetic .
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The specific immunological reactive insulin assay developed 
by Yarlow and Berson (1960) provided an accurate and reproducible 
technique for the measurement of circulating pancreatic insulin. 
This method brought about the realization that in the keto- 
acidotic juvenile onset diabetic , insulin secretion is either 
totally deficient or severely impaired ( Antoniades 1962 ). 
These findings were complimented by the extensive studies of 
Gepts (1965) who showed extensive degranulation ,hypertrophy , 
insulinitis and vacuolization resulting in the almost total 
disappearance of insulin secreting cells in the pancreas of 
young diabetics.
In contrast , non destructive islet pathology were often , 
but not always attendent in the diabetic who developed- the di­
sease later in life. The development of diabetes in the face of 
an apparently adequate insulin reserve was difficult to explain . 
It has been suggested by Ceraisi (1963) that the islets display a 
delayed or impoverished insulin response to a glucose stimulus . 
Archer (1975) found that in obese maturily cnset diabetes , 
elevated insulin levels were associated with decreased receptor 
sites on the cell surfaces in peripheral tissues and Seltzer 
( 1974 ) showed that the elevated insu lin levels were more
apparent than real , and were in effect less than those measured 
in non-diabetic subjects with a corresponding level of 
hyperglycaemia.
It was clear that real differences existed between juve­
nile and maturity onset dibetes and that these differences did 
not reflect solely quantitative gradations of insulinopoenia.
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indeed diabetes may only be demonstratable under clinical 
testing conditions or in times of* stress i.e.during puberty or 
pregnancy . In addition other 'types' of* diabetes were proposed 
i.e. the non—ketotic prone *J' diabetes of* malnourished young 
people ( Hugh—Jones 1955 ) and the inappropriately named maturity 
onset like diabetes of the young (Tattersall 1974 ).
Many attempts were made to classify the disease in terms 
of the degree of glucose intolerance and the age at onset and the 
diagnostic criteria used to define the disease ,none of which 
were entirely successful ( for a review of classification systems 
see West 1979 ).
It was established by Singal ( 1973 ) that insulin depen­
dant diabetes was clearly associated with certain haplotypes 
coded for by the major histocompatabilty complex on the 6th 
chromosome . In particular the presence of HLA-Dr3 and / or the 
HLA-Dr4 antigens were shown to be common and it was estimated 
that 93% of insulin dependant diabetics below the aige of 20 were 
either HLA—Dr3 or HLA—DR4 positive ( Platz 1981 ).Immunologiocail
factors were further implicated in the disease when Lendrum 
(1976) established the presence of antibodies to cytoplasmic and 
membrane components of pancreatic B cells in newly diagnosed 
juvenile onset diabetics.
The realization that a separate genetic susceptability and 
the suggestive evidence that immunological factors may be present 
in insulin dependant diabetes provided the impetus which resulted 
in a new classification system and diagnostic criteria being 
proposed by the National Diabetes Data Group (1979). This classi­
fication system was adopted by the World Health Organization
17
CLASSIFICATION OF DIABETES MELLITUS AND OTHER 
CATEGORIES OF GLUCOSE INTOLERANCE
CLASS A. Diabetes Mellitus.
I. Type I . Insulin - dependent type ( IDDM ).
II. Type II . Non - insulin dependent 'types ( NIDDM ).
a. NIDDM in non-obese.
b. NIDDM in obese ( includes families with 
autosomal dominant inheritance).
III. Other types , including diabetes mellitus associated 
with certain conditions and syndromes .
1. Pancreatic disease.
2. Hormonal.
3. Drug or chemical induced.
4. Certain genetic syndromes.
5. Insulin receptor abnormalities.
6. Other types.
CLASS B Impaired Glucose Tolerance ( IGT )
a. IGT in non - obese .
b. IGT in obese.
c. IGT in association with certain conditions and 
syndromes .
1. Pancreatic disease , 2. Hormonal 3. Drug
induced , 4. Insulin receptor abnormalities , 5.
Certain genetic syndromes.
CLASS C. Gestational Diabetes ( GDM ).
CLASS D. Previous Abnormality of Glucose Tolerance
( Pre. AGT ).
Potential Abnormality of Glucose Tolerance 
( Pot. AGT ).
Table 1
( Tuomilento 1982 ) and is reproduced in table 1.
This attempt at a historical review of diabetes hopefully 
demonstrates the important advances which have been made in the 
understanding of many aspects of the disease however in the vast 
majority of cases we remain unaware of the underlying cause of the 
disease process. Thus diabetes remains an 'idiopathic' disease .
It has been suggested that many factors i.e. viral infec­
tions ( Craighead 1977 ) , immunological interactions ( Cudworth 
1978 ) and toxicity ( Prosser 1978 ) may be instrumental in the
onset of the disease but the evidence (except in a few isolated 
cases ) is not persuasive .
If our knowledge of the disease and of factors causing 
it are incomplete ,what of the disease itself ? . As mentioned
earlier , death rapidly ensues in the untreated diabetic , but 
what is the incidence of the disease , and how effectively does 
insulin ' cure ' it ? .
NATURAL HISTORY 
The size or importance of a disease is commonly determined 
by the number of people who die of it , the number of people who 
acquire it each year , the number of people who have the disease 
or the number of people who become disabled because of it.
As Drury (1980) has argued , each of these factors interact 
and result in imprecise estimates of the size of the problem 
For instance , if the mortality from the disease decreases ( as 
has happened ) then the number of people with the disease may 
increase dramatically , indeed the prevalence of diabetes below 
the age of 40 in America increased 12 fold over the 35 years 
prior to 1976 ( Heurris 1982 ).Similarly , diabetics who live
18
longer will exhibit a far greater morbidity . In addition West 
(1975) has reported that the incidence and prevailance of dia­
betes may vary 4 fold depending upon our definition of the di­
sease. This is illustrated by the study carried out in Birmin­
gham where 0.6% of the subjects were known diabetics but glycosu­
ria was demonstrated in 2.7% of the sample (Malins 1974 ). One
additional factor is that in many studies there are as many 
subjects who exhibit a 'diabetic* glucose tolerance test but 
who are nevertheless asymptomatic , as the number of known 
diabetics in the sample . The significance of this finding awaits 
greater clarification ( Keen 1982 ).
Despite these reservations there is little doubt that 
diabetes is an extremely common disease with in excess of 30 
million sufferers worldwide ( W.H.O. 1980 ) . Its prevalence is 
known to vary greatly between countries , populations and sub­
populations ranging from an estimated 0.02% of the eskimo 
population in Alaska (Mouratoff 1967 ) to in excess of 40% among 
adult Pima indians ( Bennett 1971 , Zimmet 1976 ). Indeed West 
(1974) hsis indicated that if present trends continue a majority 
of the population in some countries can soon expect to become 
diabetic .
The W.H.O. Statistics (1980) emphasizes the tremendous 
health problem which this disease continues to pose. In many 
countries diabetes is a major cause of mortality and morbidity 
and in many less affluent societies where insulin is not readily 
available and health resources are scarce diabetes remains a 
dreadful and deadly disease.It is erroneous however to think that
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nthis is only a problem of developing countries , ( see later ).
TREATMENT
Prior to 1922 the only available treatment for diabetes was 
by starvation therapy or by certain dietary measures.
Dobson (1776) suggested limewater, Rollo (1797) prescribed a 
meat-only diet and Bouchardet (1875) advised a diet of fat and 
alcohol.Bouchardet further noted that many diabetics fared better 
under the prevailing conditions of malnutrition.
Starvation therapy was first proposed by Areteus (81-138 
A.D.)and was somewhat successful in increasing the lifespan of 
the diabetic patient. We know from the extensive data of the 
Joslyn Clinic that between the years 1897 and 1914 death usually 
occurred within two years of the onset of the disease. However, 
during the period 1914 to 1922 when starvation therapy was pres­
cribed the average survivsd of the diabetic was increased to 
nearly six years.
While these measures undoubtedly reduced the osmotic 
diuresis and delayed the onset of other symptoms of the disease , 
the occurrence of keto-acidosis inevitably proved fatal.
The isolation of Insulin by Banting and Best (1922) and the 
purification procedure developed by Collip(1923) are now well 
known and the speed with which this preparation became available 
is remarkable.
In November 1921 Banting and Best presented their 
experimental work in dogs from which they concluded that 'the 
results did not at present justify the therapeutic administration 
of degenerated gland extracts to patients with diabetes 
mellitus.'.By the time this paper appeared in print,insulin had
20
been used 7 months previously on a 14 year old boy in Toronto and 
was being used by a few 'approved specialists'(Sonksen,1977).
Early experience with insulin was extremely encouraging and 
on the 19th August 1922 the Times Newspaper of London carried the 
heading 'Canadian cure for diabetes' and reported that the 15 
year old daughter of the United States Secretary for State was in 
hospital in Toronto undergoing treatment for the disease.
It soon became apparent that the acute metabolic com­
plications of the disease could be prevented by frequent injec­
tions of insulin. In addition , the acute medical emergency i.e. 
diabetic coma ( or more accurately , uncontrolled hyperglycaemia, 
hyperosmolality and keto-acidosis ( Alberti 1977 ) ) could , in 
many cases , be corrected.
Keto-acidotic coma ,which was the cause of death in nearly 
66% of diabetic patients prior to 1922 ( Marble 1971 ) ,
decreased to 15% by 1930 and declined to present day levels by 
1940 (Sonkson 1977), being now the cause of death in approximate­
ly 1% of the diabetic population ( Marks 1971). Nevertheless, it 
is well to remember that diabetic coma remains a serious condi­
tion with a case mortality of between 5 & 15% (Alberti 1977) . It 
may prove fatal in as many as 50% of elderly patients or when 
medical assistance is delayed ( Gale 1976 ).
The prolongation of the life of the diabetic being treated 
with insulin soon became apparent. The mean life 
expectancy of all diabetic patients at the Joslyn Clinic steadily 
increased from 4.9 years in 1922 to 18 years in 1970 . This
longevity was most marked in those who developed the disease
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before the age of 20 , increasing from less than 2 years in 1922 
to 27.8 years by 1970 and continues to rise. However, early 
experience with insulin wsis not without some problems.
Until 1937 the only commercially available insulin was an 
amorphous short acting preparation called regular or plain 
insulin necessitating frequent ( sometimes 5 daily ) subcutaneous 
injections to maintain blood sugar levels within acceptable 
limits..
Frequent localized reactions and lipoatrophy occurred at the 
injection site ( Marble 1971 ) which are now thought to be mainly 
due to the unwanted contaminants in these insulin preparations 
(Teuscher 1974 ). Impaired growth was common and many children 
displayed symptoms of Mauriacs syndrome ( White 1938 ) which is 
now a well recognized complication of poorly controlled 
diabetes ( Guest 1953 ). These adverse effects almost disappeared 
following the development of longer acting insulin prepara­
tions ( Scott 1934 ) and ( Hagedom 1936 ) and the availability 
of purer single peak and mono-component insulins (Gallaway 1971 ) 
and the less immunogenic mono-species porcine insulin prepara­
tions ( Wentworth 1976 ) .
Montgomery (1979) in a review of insulins and insulin 
therapy argued that it was possible to select an optimal insulin 
replacement regime to sustain the diabetic and prevent the acute 
metabolic effects of the diseeise. The recent introduction of 
biosynthetic human insulin produced by recombinant DNA technology 
provided a useful addition to the wide range of insulins availab­
le and is particularly useful in cases of persistant insulin 
allergy or resistance ( Glynne 1982 ).
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Watanabe ( 1918 ) first discovered the hypoglycaeraic effect 
of certain guanidine compounds and although their toxicity 
precluded their general use a similar effect was noted in Sulpho- 
nylurea derivitives ( Loubatieres 1942 ) . The introduction of 
safer forms of sulphonylureas ( Franke 1955 ) and biguanide 
preparations ( Pomeranze 1957 ) provided a major breakthrough in 
adult diabetic management. Prior to 1955 it was usual to initiate 
insulin therapy in all diabetics the effect of which tended to 
increase obesity and insulin resistance in many already obese 
diabetic patients ( Sonksen 1977). The introduction of these oral 
hypoglycaemic agents enabled many patients to adequately control 
their diabetes without insulin and it became apparent that in 
the mild usually obese diabetic , diet or oreüL hypoglycaemic 
agents were usually the best course of treatment (Sherwin 1978 ).
Thus treatment regimes have evolved to provide adequate 
control of carbohydrate intolerance and prolong the life of the 
diabetic . However , this longevity hsus brought about the 
realisation of the extent to which major pathological disorders 
often accompany this disease.
Avicenna ( 980—1037 A.D. ) first noted the susceptability 
of diabetics to gangrene of the extremeties , Jaeger (1855) 
descibed diabetic retinopathy and Rollo ( 1798 ) reported
peripheral neuropathy but it was not until the 1930's that diabe- 
tologists became aware of the magnitude of the prevalence of 
coronaury heart disease , renal failure , blindness , neuropathy 
and skin disorders in the diabetic patient .
It has been estimated that over 75% of insulin dependant
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diabetics will exhibit pathological alterations to the eye within
20 years of the onset of the disease ( Caird 1969 ) . Diabetic
retinopathy is now the most common cause of blindness 
between the ages of 30 and 64 in England and Wales (Kohner 
1982).Pirart ( 1978 ) in an extensive study reported that 45% of 
diabetics will develop neuropathy , 55% retinopathy and 15%
nephropathy within 20 to 25 years duration of the disease.
Gangrene of the leg or foot has been estimated to be between 50
and 70 times more common in age matched diabetics ( Bell 1957 ) , 
heart disease 20 times more common in adult diabetics ( Burton 
1980 ) , perinatal mortality increased 5 times ( Larsson 1974 )
and the risk of dying from cerebro-vascular disease was shown to 
be almost 4 times greater in the diabetic ( Lavy 1973 ).It is now 
generally accepted that the occurrence of these major complica 
tions are responsible for the early morbidity and mortality 
associated with the diseeise.
Marks (1971) has reported that the life expectancy among 
diabetics of all ages is only 2/3 that of the general population. 
The mortality statistics of the Joslyn Clinic attribute this 
increased mortality mostly to large vessel and renal disease and 
show that this increased risk is most marked in those people who 
develop the disease early in life. Of the 1,260 diabetics 
between the ages of 20 and 35 who died between 1956 and 1968 ,
78% of the deaths were the result of cardiovascular or renal 
complications associated with the disease.For the young diabetic 
retinopathy ,coronary heart and renal disease go hand in hand 
( Balodimos 1971 ) and there remains a desperate need for
treatment which will not only treat the metabolic abnormalities
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of diabetes but prevent the dreadful sequalae of complications
secondary to the disease.
Despite nearly 50 years of investigation and debate the 
cause of these secondary complications remains enigmatic and 
their treatment or prevention constitute the outstanding problem 
in diabetic research and management today.
Many causes have been proposed . Hypersecretion of growth 
hormone appears to play at least a permissive role in the 
development of retinopathy ( Lundbaek 1976 ) and genetic
susceptability to this complication has been proposed on the 
grounds of a positive chlorpropamide alcohol flush reaction 
(Leslie 1979 ) and familial studies ( Creutzfeldt 1976 ). Glucose 
metabolites i.e. sorbital ( Gabbay 1975 ) have been implicated 
while it has been suggested that control of hypertension may 
influence the onset of some lesions ( Mogensen 1980 ). Ristelle 
( 1976 ) suggests that abnormal collagen synthesis may be
influencial in renal damage while Brownlee ( 1979 ) argues that 
coronary atheroma may be linked to elevated circulating free 
fatty acids in the less well controlled diabetic.
Pirart ( 1978 ) however argues that the only positive
correlate with the development of these secondary lesions is the 
severity and duration of the disordered blood sugar levels . Not 
all diabetologists accept this view and consider that the 
evidence is insufficient to warrant the increased risk of iatro­
genic hypoglycaemia arising from more rigid control of blood 
sugar levels.
Over the past 40 years innumerable clinical studies have
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failed to resolve this vital issue. Knowles (1964 ) after review­
ing 300 clinical studies concluded that insufficient evidence 
existed to prove a mitigating effect of greater control of blood 
sugar levels on the development of these secondary lesions. The 
findings of the University Group Diabetes Programme (1970) indi­
cated that neither conventional insulin therapy or treatment with 
oral hypoglycaemic agents offered any potential in reducing mor­
tality or vascular complications in diabetic patients, indeed 
they suggested that cardiovascular mortality may even be in­
creased in subjects receiving sulphonylurea and biguanidine com­
pounds. These conclusions have however been severely criticised 
( Kilo 1979 ) .
Kaplan ( 1973 ) argued that clinical trials comparing
varying degrees of often assumed metabolic dysfunction have not 
and will not provide an answer to this vital question.
There is a wealth of data that similar renal ( Federlin 
1976), vascular ( Engerman 1977 ) and ocular ( Orloff 1978 )
diabetic lesions can be prevented in experimentally induced dia­
betic animals following complete restoration of blood sugar con­
trol by pacreatic islet cell transplantation. The studies of 
Mauer ( 1975 ) and Federlin (1976 ) further suggest that regres­
sion of existing lesions may occur . Perhaps the most convincing 
evidence derives from the elegant experiments of Lee ( 1974 ) who 
demonstrated regression of existing diabetic renal lesions follo­
wing kidney transplantation into isogeneic normoglycaemic rats.
For this reason alone it would appesir prudent to strive to 
achieve the best hormonal suid biochemical control possible .
It is now well recognized that conventional insulin therapy
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is unable to fully restore the carbohydrate intolerance and 
metabolic disorders of the disease ( Crofford 1975 ) . In order 
to achieve this aim insulin infusion systems have been adapted 
which attempt to mimic normal insulin release in response to 
changing physiological requirements i.e. during exercise and 
postprandial and to be responsive to alterations in insulin 
secretagogues.
Kadish (1965) first described a servoregulated infusion 
device which delivered insulin in response to changes in measured 
blood sugar levels ( the so called artificial pancreas or closed 
loop system ).Since then improved glucose sensors (Clemens 1977) 
and algorithms which deliver projected insulin requirements 
(Kemer 1976 ) have improved the degree of blood sugar control 
Near normauL metabolic profiles aure now possible ( Buckle 1977 )
at leaist in the short term . However , these devices are complex 
and expensive and sufficiently smadl implantable glucose sensors 
and miniturized monitoring systems have proved difficult to deve­
lop . Shichiri (1982 ) has reported short term control with impla­
ntable glucose sensors in dogs but considerable innovative work 
is still needed before long term control becomes a reality.One 
interesting finding of Mirouze ( 1979 ) was that extended remis­
sion ( enabling the complete withdrawl from insulin therapy for 
periods in excess of four years ) occurred in some patients when 
closed loop systems were used to treat newly diagnosed juvenile 
diabetics and confirmation of these findings would have important 
implications in the treatment of diabetes.
More pertinent to the treatment of insulin dependent diabe­
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tics have been the portable infusion systems based upon pre­
programmed diurnal insulin release models ( Irsigler 1979 ) and 
long term subcutaneous insulin delivery with postprandial bolus 
injections ( Pickup 1978 ).
Impressive improvements to a wide range of abnormalities
i.e. decreased levels of catecholamines and growth hormones 
(Tamborlane 1979 ),ketone bodies ( Buckle 1977 ) and glucagon
( Raskin 1979 ) have been reported. Alberti ( 1981 ) , however, 
reported increased lactate levels in diabetics even when treated 
with closed loop infusion systems and questions whether metabo­
lism in the diabetic can ever be completely normalized by insulin 
delivery into the peripheral circulation.In addition it has been 
shown that diurnal variations in blood sugar levels may be far 
greater than in non-diabetics although mean blood sugar levels 
were normal.
The long term effect of these reported improvements in 
metabolic control remains uncertain and we must wait to see if 
these improvements are sufficient to abrogate the secondary com­
plications of the disease.
An alternative strategy has been to attempt total pancreatic 
endocrine replacement by transplantation of the vascularized 
pancreas or isolated islets of Langerhans.
Early attempts at whole gland tranplantation ( Kelly 1965 )
demonstrated that insulin could be withdrawn for a time in all 
recipients and that normal carbohydrate control could be achieved 
however mortality was high with less than 20% of patients survi­
ving one year ( Lillihei 1970 ).
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Despite improvements in techniques the outcome of whole or 
segmental grafts remains depressing with an 18% mortality within 
3 months and 30% within a year ( Sutherland 1983 )•
To the end of June 1982 there had been 223 whole or segmental 
grafts reported to the transplant registry. Of the grafts which 
had been undertaken since 1977 only 10% were still functioning at 
1 year with the longest graft surviving 49 months, when unfortu­
nately the patient died from pre-existing diabetic lesions.
It is difficult to draw conclusions from these figures . Most 
pancreatic tranplantation has been carried out in conjunction 
with simultaneous renal transplantation in patients already expe­
riencing the end stage of the sequalae of diabetic complications. 
To this must be added the increased risk associated with chronic 
3nti—rejection therapy . Therefore whole or segmental pancreatic 
tranplantation has , inevitably ,been justified only in those 
cases where the prognosis is more severe than the risks attendant 
following transplantation.
At present it would appear that improvements in technique 
and avoidance of rejection are necessary if whole gland transpla­
ntation is to become other than a last final effort in treating 
the end stages of the disease.
In contrast the initial early attempts at islet tranplanta- 
ton ( Sutherland 1978 ) showed that islet transplantion was safe 
but ineffective.
To June 1982 there had been 76 cases of allogeneic islet 
tissue implantation reported to the transplant registry of which 
only 4 were able to survive without exogenous insulin (Sutherland 
1983 ).However two of these cases (Chasten 1979 and Valante 1980)
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were in non-immunosupressed patients and provide hope that a safe 
technique for islet cell transplantation is feasible.
The potential benefit of successful islet cell transplanta­
tion are clear however its application awaits breakthroughs in
the isolation of sufficient islets to fully correct or cure the 
disease and in controlling the rejection problem.
In conclusion diabetes is a disease of multi-factorial
origins . Each new c^e needs careful appraisal as to the
underlying cause and clinical expertise in providing long term 
treatment and support.
For some , perhaps 20% of insulin dependent diabetics
( Colon 1974 ) and a larger proportion of non-insulin dependent
diabetics conventional insulin treatment is capable of providing 
adequate support to maintain active and useful life into old age 
but for most insulin-dependent diabetics there has to be a better 
alternative than the gradusü. progression towards the debilitating 
and life threatening sequalae of the disease.
THE CLINICAL PROBLEM
In the United States of America , diabetes is now the 
4th.leading cause of death (W.H.O.1980) . The National Diabetes 
Data Group (1978) has indicated that there are in excess of 5.2 
diagnosed diabetics ( 2.5% of the population ) and that
this figure is steadily increasing. The actual figure may be more
as Madows (1973) indicated that the survey methods used 
uderestimate by 15% the actual number of diabetics.
There is little doubt that for many of these unfortunate
30
people the future is depressingly bleak. At least 1.3 million are 
being treated for coronary heart disease ( Rpt. of Nat. Comm, on 
Diabetes 1975 ), however there is evidence that coronary heart 
disease which appears to exert the greatest toll in older NIDDM 
is declining in line with the decreasing coronary heart disease 
of the non—diabetic population ( Monthly vital stats, rpt.1979 ). 
This however is not true for the the ocular and renal lesions 
which appear to be more frequent in the usually young IDDM ,
( Knowles 1974 ) who comprise approximately 22% of the diabetic 
population ( H a m s  1982 ) . There are an estimated 5,000 
diabetics who are newly registered as blind each year ; a 25 
fold increase over the general population ( Rpt. natl. comm . on 
diabetes 1975 ) . In addition 3,000 diabetics with irreversible 
renal damage will either die or in most cases receive 
maintainance dialysis or renal transplantation ( Cameron 1983 ).
This accounts for between 1/4 and 1/3 of the patients accepted 
for treatment of chronic renal failure in the U.S.A.
( Avram 1982 ) .
I have been unable to find more than one estimate of the 
financial impact of providing adequate medical care for the 
diabetic population .Entmacher (1976) estimated that the direct 
cost of medical services totalled 2.5 billion dollars in 1976 in 
the U.S.A.To this must be added inflation , the costs of rehabi­
litation services for blindness and following amputations , the 
imputed loss of earnings arising from disability and early 
mortality . The true financial cost must by now be staggering .
The most important aspect of the disease , that is 
human suffering and the erosion of the quality of life is of
31
course not quantifiable.
Comparable figures for England and Wales suggest that 
the percentage of diabetics in the population is smaller than in 
the U.S.A. . About 600,000 diabetics are known , that is about 
1.1% of the population. . Perhaps a more accurate reflection of 
the size of the problem is that in 1979 , 2,700 hospital beds in 
England and Wales ( 1.64 %of the total ) were used solely for the 
treatment of diabetes ( D.H.S.S. report MB4 no.13, 1979 ). This
figure is only for those patients who are known to be in 
hospital for the treatment of diabetes. It does not include 
hospitalization for the secondary complications of the disease 
which provide an addditional demand upon the medical resources 
and heaü-th care personnel.
1^ is clear that fiscal policies are already 
lamentably inadequate to provide help for many of those people 
who are experiencing the sequalae of secondary complications of 
the disease.
There are at least 500 diabetics per year who require 
treatment for end stage renal failure , yet in 1981 only 80 
received treatment ( Cameron 1983 ) . Thus at legist 84% of 
diabetics who enter renal failure are allowed to die .
Thus it would appear that diabetes still presents a 
considerably problem , in terms of suffering and the far reaching 
social and psychological problems arising from the chronic 
debilitating effects of the disease.
Finally it is well to emphasize that the ultimate goal 
must be prevention of the disesise. As to when this will become a
32
is unknown • Recent advances in immunology and virology 
have provided possible avenues of research , however it is felt 
that prophesizing is best left to the prophets . In the meantime 
we must strive to provide the best treatment possible.
this country the aphorism coined by Aretaeus 
( 81-138 A.D. ) is particularly appropriate:
' It is impossible to make all of the sick well , for the 
physician in that case would be superior to the gods: but the
physician can secure respite from pain and intervals in disease 
and can render disease latent '.
This forms the basis for this thesis which attempts to 
resolve some of the problems in isolating sufficient islets from 
the human pancreas to restore normal glucose homeostasis , and to 
investigate manoeuvres which might abrogate the foreign tissue 
rejection phenomena.
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CHAPTER TWO 
REVIEW OF ISLET CELL IMPLANTATION
2.1 INTRODUCTION
The duct ligation studies of Ssobelew (1902) clearly 
deroons'brated tiiat it was only the endocrine portion of the 
pancreas which was necessary to prevent diabetes. He prophesized 
that islet cell transplantation might eventually provide a cure 
for the disease.
The idea of replacing only the endocrine portion of the 
gland and bierefore circumventing the problems associated with 
transplanting the zymogen and enzyme rich exocrine tissue was 
very appealing . However , the isolation of large numbers of 
islets dispersed throughout the gland has proved a practical 
hurdle.
Bensley (1911) was able to hand dissect islets from the 
guinea pig pancreas . Hellerstrom (1964) refined this micro­
dissection technique to isolate islets from the pancreas of 
the guinea pig and obese and normal mouse in increased numbers. 
Micro-dissection of islets from the human pancreas has been 
reported by Havu (1969) and Ferguson (1977). However , the yield 
( 30-40 islets per operator per 45 minutes ) has been insuffi­
cient for transplantation experiments.
Other approaches have been pursued. Improved islet yield 
has been reported following progressive exocrine atrophy induced 
by either duct ligation (Kramp 1975) or by donor pretreatment 
with an exocrine cell toxin such as DL-ethionine ( Payne 1979 ). 
Questions have been raised as to whether the induced fibrosis may
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also result in metabolic abnormalities of the islets ( Bergen, 
1977 ) • In addition it is difficult to see how the application 
of these or similar manoeuvres can have relevance to the 
treatment of the diabetic patient .
The question of how to provide the diabetic with a new 
complement of islet tissue has been approached from three 
directions ;
1. Implantation of exocrine-poor foetal or neonatal tissue.
2. Transplantation of the enzymatically digested but 
unseparated adult pancreatic tissue directly into a site 
which will tolerate the introduction of pancreatic 
zymogens and enzymes.
3. Transplantation of adult isolated islets freed from the 
tissue stroma following exposure to enzymatic digestion.
The vast majority of our present knowledge of non— 
vascularized pancreatic transplantation has been developed and 
verified in the rodent model. Rodents have proved particularly 
useful in that transplantation can be attempted using inbred 
strains and therefore the physiological effect can be evaluated 
in isograft situations where rejection factors do not play a 
role. In addition, one of the main problems in islet cell 
transplantation i.e. obtaining sufficient islets to reverse 
diabetes can be resolved by using multiple donors.
While it is probable that most of the findings gleaned 
from rodents can be applied to answering similar questions in man 
we must remain aware that certain physiological and anatomical 
differences exist between rodent and large animal models which
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may invalidate some of these assumptions.
For this reason it is perhaps prudent to review the 
experimental rodent work before discussing its application in 
larger animal models and clinical transplantation.
2.2 THE RODENT MODEL
In 1951 Browning and Resnick (1952) implanted foetal murine 
pancreatic tissue sub-cutaneously and into the anterior chamber 
of the eye in alloxan diabetic mice. Reduction of glycosuria and 
growth of the implants were noted in some animals, but there was 
no long term effect from tiie implanted tissue .
The propensi^ for growth of foetal tissue was emphasized 
when Chen (1954) noted growth and differentiation of rat 
pancreatic primordia maintained imi ng standard tissue culture 
techniques. Coupland (1960) confirmed that liie growth potential 
of foetal rat tissue continued to be esqiressed following 
intra-occular implantation into an acceptable host . He showed 
:^hat acinar tissue degenerated but that ductal epithelium and
endocrine tissue proliferated .
In a long series of experiments House ( 1958 , 1961 )
defined many of the factors which influence the outcome of 
successful foetal implantation. He went on to show biat implants 
grew better in diabetic than in normoglycaemic hosts , however
when severely diabetic hosts were used ( blood sugar levels in
excess of 20 mMol. ) no insulin containing cells persisted in the 
implanted tissue. House (1961) extended these findings and showed 
that the age of the donor pancreas was critical. The greatest 
growth occurred when foetal tissue was implanted . Neonatsd.
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tissue harvested 2 - 1 2  hours af %r birth showed slightly less 
growth , neonatal 5—6 day tissue showed negligable growth but 
persisted while adult tissue disappeared within three weeks.
Since then foetal pancreatic implantation has retained its 
promise however Moskalewski (1965) provided the main impetus to 
islet cell research when he showed that the adult guinea pig 
pancreea could be disaggregated following exposure to the enzyme 
cœxplex collagenase . Subsequent studies have used tiiis or 
similar enzyme preparations to obtain islets from the neonatal 
and adult rodent pancreas. Lacy (1967) showed that islets 
isolated in tiiis way would exibit a normal ingnlin secretory 
response to alterations in glucose concentrations in vitro. 
Continued insulin release during culture ( Andersson 1976 ) and 
the incorporation of radio-labelled amino acids into insulin and 
pro-insulin have confirmed the viability of islets isolated in 
this manner ( Lin 1973 ). Collagenase isolated islets now 
represent the standard preparation with which to investigate 
their physiological and metabolic function in vitro and their 
effect in reversing diabetes in transplanted animals.
2.2 a FOETAL AND NEONATAL ISO-IMPLANTATION OF ISLET TISSUE
Embryologically the mammalian pancreas develops frcxn two 
diverticuli which appeeur as buds on the primitive gut .. Formation 
of endocrine cells have been denonstrated in the epithelium of 
these buds and the endocrine cells gradually form into clusters 
which represent primitive islets.
In the rat , the dorsal lobe of the diverticulum appears 
midway through the 12th day of intra—uterine life and the ventral 
lobe appears approximately 12 hours later ( Richardson 1977 ) .The
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two lobes fuse and embryonic islet like structures appear around 
the 15i±L day of gestation. Granulated B cells have been
demonstrated after the 15th day of development ( Pictet 1972 ) ,
however Freie ( 1975 ) and Hard ( 1944 ) were unable to observe B 
cells before tiie 17th day. Insulin is first assayable during the 
nth day of gestation ( Pictet 1972 ) and it may be that B cells 
become functionally active before they attain their structurally 
recognizable characteristics •
The insulin content of the foetal pancreas increases 
dramatically between Idle 15th and 22nd day of ges"^  ation , showing 
an almost three fold increase each day during the last 4 to 6 
.days of intra-uterine life ( Freie 1975 , Hegre 1972 )• During
this period the number of islets more than doubles each day.
Acinar cells and recognizable acini with a few
eosinophillic zymogen granules are not recognizable until the 
17th day of gestation ( Murrell 1966 ) , after which they
increase dramatically during the last 6 days of intra-uterine 
life ( Pictet 1972). Thus foetal and neonatal tissue represents 
an absolute or relatdLve exocrine deficiency .
It would therefore appear that the age of foetal tissue is 
critical for successful implantation.Foetal tissue of less than 
16 days gestation was ineffective in reversing diabetes when 
implanted beneath the kidney capsule ( Brown 1980) althou^ 
Usadel (1980) reported growth and survival of both exocrine and 
endocrine elements in 14—16 day gestation foetal tissue into the 
dorsal sub-cutaneous space.
When undispersed foetal tissue of over 18 days gestational
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age has been used there have been reported cases of cyst 
formation and tissue erosion .presumed to be due to the 
developing acinar tissue, ( Mullen 1977 , Brown 1980 ) .
Brown (1974) was the first to demonstrate that 4 or 6 foetal 
. pancreases implanted under the kidney capsule could reverse 
the diabetic state in 66 % of streptozotocin diabetic rats. 
Normoglycaemia was restored after 22 days , circulating insulin 
levels were elevated , glycosuria and polyuria were abolished and 
a normal glucose tolerance test was obtained.
Hegre ( 1976 ) studied the quantitative aspects of 
implanting foetal pancreatic tissue in to renal sub-capsular 
sites . He showed that tissue from 4 pancreases would reverse 
diabetes in 19 weeks but that a similar effect was seen in 11 
weeks if 8 pancreases were used. Garvey (1979) and Mullen (1980) 
among others have subsequently reversed diabetes utilizing the 
renal sub-capsular site . Other sites which have been used 
including intra-muscular, intra- testicular and sub cutaneous 
implantation ( Spence 1979) have showed no evidence of graft 
function. This may be due to the need for early vascularization 
which Browning (1951) reported to be a prerequisite for survival 
and growth.
Mullen ( 1977 ) suggested that there may be a physiological 
advantage in diverting the secreted insulin after sub-capsular 
implantation directly into the portal circulation by performing a 
reno - portal vein shunt . Spence (1979) found the splenic pulp 
to be equally effective as a site for reimplantation , however 
Feldman (1980) was unsuccessful in implanting chopped foetal 
tissue directly into the portal vein , with only 12% of
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experimental rats becoming normoglycaemic and 16% of the 
animals died from portal hypertension and hepatic failure using 
tissue from 4 to 8 pancreases ..
It is apparent üiat considerable growth has to occur if 
amelioration of the diabetic state was to occur • The weight of 
tile pancreas on tiie 16tii day of development is only about l/600th 
that of the adult rat pancreas (Hegre 1972) and tiie insulin 
content is even more markedly reduced , 0.2ywU as against 3,750 
yW U ( Brown 1980 ) .
Brown (1980) went on to show üiat a single foetal pancreas 
implanted under the renal capsule of severely diabetic rats would 
eventually reverse the diabetic state if tiie rats were maintained 
on insulin until glycosuria declined. Insulin was then decresused 
until normoglycaemia %ras established at an average of 45 days. 
Brown measured an 800 fold increase in liie insulin content of the 
graft over the 45 day period , eventually reaching 25% of the 
normal adult value.
Garvey (1979) and Mullen (1980) have emphasized the need for 
insulin tiierapy during the period of growüi and development of 
the implanted tissue. However liie work of McEvoy (1978 ) and 
Mullen ( 1977) would suggest that a period or degree of
hyperglycaemia or insulin deficiency ( Halsted's so called 'law 
of deficiency ' 1909 ) may provide the greatest impetus to
sustained growth of the foetal tissue.
In contrast to foetal tissue , üie neonatal pancreas
has been shown to comprise approximately 80% acinar and ductal
elements and about 20% islet tissue ( Matas 1976 ) , this of
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course varies depending upon the age of the neonate .
The first successful reversal of diabetes by ni»onq-hai 
tissue followed intarai-peritoneal injection of f»ai i y
dispersed but unseparated disaggregate from 20 to 35 donor
pancreases (Leonard 1973). In the majority of experimental 
animals , normoglycaemia was restored within a few days.
Glycosuria and polyuria was abolished and the rats exibited a 
normal intravenous glucose tolerance test (IVGTT) two weeks
later.
Other sites of neonatal implantation which have been 
successfully employed include into “ttie lung ( Matas 1977 ) ,
abdominal muscle ( Axen “1981 ) and beneath the kidney capsule 
( Serie 1983 ).
Matas ( 1976 ) showed that Ihe recovery of islet tissue was 
improved following minimal collagenase digestion. He went on to 
show that one neonatal pancreas if infused directly into Ihe 
portal vein could reverse diabetes in 55% of experimental
animals. Although it has been suggested tiiat non—endocrine 
elements may be ttarombogenic within the liver only transient 
increases in transaminase were noted and no long term deleterious 
effects on liver function were seen ( Amamoo 1975 ) .
Islets become lodged wilhin the portal vein radicals and 
are rapidly endotheliarised within the vascular bed (Matas 1977). 
Revascularisation of the islets occurs after a mean of 8 days and 
either throu^ migration or recannalization , move into the 
hepatic lobules where surprisingly they have been shown to form 
intercellular junctional complexes with adjacent hépatocytes 
( Griffith.1977') .
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Studies have demonstrated the continued survival of all 
pancreatic islet cells (Lorenz 1977) within the islets. 
Mitotic figures have been reported (Leonard 1976) and both islets 
with normal morphology and chain like regenerating single islet 
•cell lines were observed (Hegre 1976).This would suggest some 
growth potential and would accord with the findings of Rumpf 
(1977) who indicated that the full potential of neonatal tissue 
may take many months to be fully expressed.
It would appear that in distinction to adult islets 
(Kemp 1973 ) intraportal implantation .of islets from 3 to 4
neonatal pancreases offers no advantage over other sites in 
terms of the number of animals which become normoglycaemic ( Axen 
1981 ) . However , direct comparisons between different studies 
are hazardous in terms of the induced diabetic state and 
differences between enzymatic dispersal techniques.
Whichever site is used both the number of animals becoming 
normoglycaemic and the time needed to restore normoglycaemia are 
directly related to the amount of islet tissue implanted 
( Leonard 1975 ).
Both sub—normal (Steff es 1974) and supra—normaLL (Weber 
1976) intta-venous glucose tolerance tests have been reported and 
appear to reflect the amount of islet tissue implanted. 
Indeed , when larger quantities of islet tissue has been 
implanted , decreased blood sugar levels, hyperinsulinaemia , 
hyperglucagonaemia and polyphagia have been reported ( Weber 
1976 ).
It is clear that if a sufficient quantity of dispersed 
neonatal tissue is implanted normoglycaemia occurs ( Matas 1976 )
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neonatal tissue is implanted normoglycaemia occurs ( Matas 1976 ) 
glycosuria is abolished ( Leonard 1975 ) weight gain is retttored 
and other deranged metabolic patinrays return to normal ( Mauer
1975 ) .
Concern has been expressed that transplanted rats fail to 
exhibit the early or 'cephalic* phase of insulin release in
response to an oral glucose load ( Siegel 1979 )• This is
thought to be due to the lack of islet innervation (Trimble 1980) 
and/or an increased sensitivity of th,e implanted ^let tissue to 
catecholamines (Pipeleers 1978) . The long tezmi studies of
( Vermitsky 1977 ) , however have shown that tiiis 'cephalic*
phase of insulin release although absent at 11 months had 
returned to normal by 13 monldis» It is clear that an i>apressive 
restoration of normal glucose homeostasis has been achieved in 
this model.
One important and as yet unexplained advantage to foetal 
and neonatal tissue implantation is the finding Idiat in contradi­
stinction to adult islet tissue *ttiere have been no reported
reversals to the diabetic state of apparently ' cured* animals , 
( see later )
In summary , tbs results of foetal and neonatal 
implantation in the rat model suggest tiiat both represent ideal 
sources of islet tisue. In liie case of foetal tissue it can be 
transplanted vdiole without recourse to enzymatic exposure. Acinar 
tissue is eitiier absent or poorly developed and fails to 
differentiate following implantaticxi while islet and possibly 
ductal elements exhibit substantial proliferation potential.
Neonatal tissue may be dispersed and the exocrine
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contaminants appear to cause no adverse localized tissue 
reaction.
In the rat model it,has been shown that there are at least 
four factors which directly influence the outcome of foetal and 
neonatal transplantation ;
1. The age of the donor tissue.
2. The severity of the animals diabetic state.
3. The amount of tissue implanted.
4. The site of implantation.
It has been shown that under appropriate conditions the 
endocrine components from one donor pancreas would appear capable 
of reversing the diabetic state of one adult recipient.
2*2 b ISOGENEIC IMPLANTATKW OF ADULT RODENT TRi VT TISSUE
In contrast to foetal and neonatal tissue tranplantation 
the implantation of either whole or dispersed but unseparated 
adult pancreatic tissue has proved unsuccessful ( Kostianovsky 
1972 ), and at times hazardous to the recipient. Although reports 
have appeared indicating that exocrine poor tissue derived from 
prior duct ligated , or DL-ethionine pre - treated rats may be 
successfully implanted and that a small degree of exocrine conta­
mination may be well tolerated ( Ziegler 1975 ) , no
physiological or morphological evidence of islet function or 
survival has been obtained following implantation of unseparated 
adult rodent pancreatic tissue.
For this reason purified or partially purified pancreatic 
islet preparations have proved most effective in attempts at
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iso-implantation in the rodent model.
Moskalewski (1965) showed that at least 70 morphologically 
intact islets in excess of 150yi/m diameter could be hand 
harvested from Idle rodent pancreas following collagenase
digestion. Kostianovski (1966) improved the yield of islets by
prior disruption of the gland using retrograde injection of fluid 
into the pancreatic duct. Lacy ( 1967) used ductal distension and 
collagenase digestion to isolate islets from the guinea pig, rat 
and monkey pancreas.
Since then numerous studies have indicated the yield of 
islets from the rat pancresis could be improved by varying the 
method of mechanical disaggregation ( Matas 1976 ) , the time of 
enzymatic digestion (Mallaise 1971 ) ,the type ( Moskalewski 
1967) or even batch of collagenase used ( Toledo-Pereyra 1977 ). 
Other enzymes have partially substituted for , but not as yet 
replaced collagenase ( Henriksson 1977 ) . Sequential
digestion procedures ( Scharp 1975 ) and screen filtration
( Shibata 1976 ) to r«nove the islets freed from the tissue
strcmia and the digestion solution have been advocated as factors 
improving the yield of islets. Discontinuous density 
centrifugation has been used to rapidly separate and harvest 
islets froB collagenase digested tissue, ( Scharp 1975 ).
Isolated islets now represent the standard preparation with 
which to investigate "üieir effect in reversing diabetes in 
transplanted animals.
Youneszan (1970) was the first to attempt adult islet 
implantation to reverse alloxan induced diabetes in allogeneic 
rats. Isolated islets frcxn 4 donors ( 60% of the normeüL adult
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rat islet tissue ) were implanted into the peritoneum , and 
although significant reductions in glycosuria and hyperglycaemia 
were noted in the short term , normalization of these parameters 
did not occur and the islets were almost certainly rejected.
Ballinger (1972) noted a partial although more sustained 
amelioration of the diabetic state following implantation of 
400-600 isologous islets into liie peritoneum and Reckard (1973) 
reported that transplantation of 600-1200 islets into 
streptozotocin diabetic rats restored the fasting blood sugar 
levels to normal limits.
Since then successful islet implantation has been reported 
S’ variety of sites. These include implantation into intra— 
muscular sites ( Helmke 1975 ) , implantation into the pancreatic 
mass and sub-mandibular gland ( Georgakakis 1977 ) ,the testis 
( Ferguson 1973 ) , the spleen ( Koncz 1976 ), the peritoneum 
(Barker 1974 ) , and beneath the kidney capsule (Reece-Smith 
1981 ) .
Provided a sufficient number of islets are implanted into 
each of these sites a rapid return to normoglycaemia can be 
achieved . Other sites such as sub—cutaneous implantation and 
injection of islets into the systemic circulation have been 
reported to be ineffective ( Barker 1974).
The most advantageous site in terms of the least number of 
islets needed to provide a curative effect would appear to be 
directly into the portal vein ( Reckard 1978 ) .
Many investigators have since applied intra—portal implan­
tation of isolated islets to reverse experimentally induced
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diabetes in the rat model •
Oakes ( 1978 ) was unable to demonstrate any long term
deleterious effects on liver function following inta-portal 
implantation , and although an increased incidence of hepatic
cysts ( Finch 1977 ) and tumours . ( Feldman 1977 ) has been noted 
it is most likely that these result from the use of streptozo­
tocin ( Lauder 1981 )•
Implantation of Cr^ | labelled islets have shown that these 
remain confined within the liver • Long term quantitative studies 
of the extractable insulin content of the liver have established 
that at least 50% ( Rabinovitch 1976 ) and as many as 90%
( Trimble 1980 ) of Qie islets can survive in this site.
One worrying aspect of adult islet implantation is that 
many apparently 'cured* animals spontaneously revert to the pre­
transplant diabetic state , sometimes after a period of many 
months. The studies of Rumpf ( 1977 ) who implanted large 
numbers of islets into ^e peritoneum and portal vein strongly 
suggest that the recurrence of diabetes resulted from implanting 
a minimal number of islets to restore the euglycaemic state. 
Leonard ( 1975 ) suggests that this failure was due to exhaustion 
of the islets by overstimulation •
Thus, isolated islet implantation can represent a safe , 
effective and reproducable technique for restoring full 
normoglycaemic control in the rat model . It is clear .however 
that the effectiveness of islet cell implantation depends upon 
the site of implantation, the severity of the diabetic state and 
the number of islets used.
Provided these conditions are met an impressive return to
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normal of 1die metabolic disorders associated witdi diabetes has 
been recorded ( Lorenz 1975 ) , ( Feldman 1977 ).
2.2 c AT.T.QGENEIC IMPLANTATION OF RODENT PANCREATIC TISSUE
The work of Medawar (1944) established that grafts between 
genetically different individuals of a species ( allografts )were 
destroyed by a mechanism which was immunological in nature.
It is now known that this allogeneic immune tissue response 
involves the recognition , proliferation and infiltration by
tl ose cells ( cytotoxic, helper and suppressor T lymphocytes , 5 
lymphocytes , K cells and macrophages etc. ) with specificities 
for the foreign antigens .
This rejection mechanism is invoked by antigens present on 
cell surfaces which are encoded for mainly by loci contained 
within the major histocompatability complex (MHC) , although less 
reactive non-MHC histocompatability loci have been described 
( Silvers 1977 ) .
In the rat model the MHC ( designated as RT-1 ) has so far
been shown to contain 5 loci • These loci have been further
distinguished as those expressing the class I antigens RT-IA 
and RT-IC , which are expressed on almost all nucleated cells , 
( Berah 1970 ) and the class two antigens of which RT-IB ( also 
designated la ) is the most characterized and. are expressed on 
the surface of only a limited range of cells including 
macrophages , lymphocytes , dendrytic cells ( Puri 1980 ) and in
some species on vascular endothelium ( Hancock 1982 ).
It is clear that vdien major differences exist in the RT-1 
between donor and recipient rat strains .rejection of the
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implanted tissue occurs very rapidly.
Slater (1976 ) and Franklin. ( 1979 ) have recorded lympho- 
reticular cell infiltration of the graft within two days 
followed by progressive lymphocyte and plasma cell involvement 
and destruction of the engrafted tissue . Similarly 
physiological evidence of graft survival ( defined as a return to 
the diabetic state following successful islet implantation ) has 
been reported as having a mean survival time of 3.2 ( Nash 1977), 
3.7 ( Reckard 1980 ) , 4.0 ( Morris 1980 ) and 5.2 ( Lacy 1979)
days •
It was initially believed that foetal tissue may be less 
immunogenic tiian adult pancreatic tissue ( Gonet 1965 ) . Most
studies however indicate that a rapid immune destruction of the 
graft occurs in the rodent model ( Garvey 1979 , Mullen 1980) .
Spence ( 1979 ) reported lymphocyte infiltration of the graft
within 4 days and the destruction of the foetal pancreatic 
allograft before they developed sufficiently to reverse the 
diabetic state. Mullen ( 1980 ) used morphological and
physiological criteria to investigate allogeneic foetal 
implantation between various strains of rats and reported that 
the longest mean survival time wets less than 10 days. One report 
exists however of long term allogeneic foetal islet survival in 
the dorsal sub-cutaneous space in non-immunosupressed outbred 
rats ( Obando 1975 ). It may be that this is an immunologically 
privileged site ( Barker 1977 ) for foetal pancreatic tissue.It 
is interesting that Shumakov ( 1980 ) reported survival of human 
foe*tal pancreas in this site in immune competent rats .
The work of Strautz ( 1970 ) and Gates ( 1972 ) suggested
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that aü.logeneic islet survival and function could be maintained 
by encasing the islets within a Millipore chamber of 0.45^ M pore 
size . Other investigators have however been unable to reproduce 
these results ( Helmke 1975 ) , ( Buscard 1975 ) , Tze ( 1979 )
and Garvey ( 1980 ) . A recent study ( Helmke 1982 ) suggests 
that these synthetic chambers , even allowing for islet survival, 
are insufficiently permeable to insulin diffusion to restore 
physiological carbohydrate control . In addition problems of 
fibrotic reactions around the capsule would appear to preclude 
their long term use .
Most attempts to prolong allogeneic islet cell survival 
have involved the use of non-specific immunosuppresion , i.e. 
immunosuppressive agents vhich are known to act by depressing the 
immune system • Pharmacological agents which have proved 
effective in averting rejection following clinical organ 
transplantation have however proved less successful in prolonging 
islet allograft survival in the rodent model .
Neither Azathioprine ( Finch 1976 ), ( Vialettes 1979 ) ,
or Prednisolone ( Nelken 1977 ) ) have prolonged the fate of 
allogeneic islets by more than a few days at the most .
Cyclophosphamide has been reported to prolong allogeneic 
islet survival in some studies ( Finch 1977 ), but other studies 
have reported this agent to be ineffective ( Bell 1980 ).
The relatively new immunosuppressive agent Cyclosporin A has 
also proved ineffective in prolonging graft survival when 
recommended levels of the drug have been administered ( Morris 
1980) , ( Rynasiewicz 1980 ) . Reports to the contrary exist ,
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(Vialettes 1979 ) , ( Reece-Smith 1983 ) and ( Squifflet 1983 ),
but in these cases ,%diat are now thought to be near to: tie levels 
of the drug were administered ( Cameron 1983 ) .
One immunosuppressive agent which has almost universally 
been shown to have a beneficial effect on allogeneic islet 
survival has been the use of anti-lymphocyte or anti-thymocyte 
serum or more accurately the gamma globulin component of that 
serum.The functional survival of islets transplanted across a 
strong histocompatability barrier has been prolonged from between 
4 to 7 days to in excess of 60 days in many studies ( Finch 
1977 ), ( Lacy 1979 ) , ( Reemstma 1981 ).
Two further regimes of non-speficic immunosuppression are 
of note. The use of intra-venous silica , a macrophage
immobilizing agent , has been used to prolong islet allograft 
survival to in excess of 100 days in 80% of recipients
( Nash 1980 ). Total lymphoid irradiation TLI has been carried 
out by some investigators • In these cases TLI prior to
engraftment in conjunction wilii other forms of immunosuppression 
has led to life long acceptance of allogeneic islet grafts .The 
reported high mortality and incidence of tumours ( mostly fibro­
sarcomas ) following eaqposure to the high levels of radiation
used ( Mullen 1983 ) suggests that this approach may prove
hazardous in man.
In general non-specific immunosuppression has proved 
ineffective in prolonging adult adlogeneic islet grafts . In 
addition the attendant risks of infection and neoplasms suggest
that this approach may be inappropriate in the clinical field .
Similar results have been obtained in the few studies
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attempting allogeneic foetal and neonatal transplantation 
( Mullen 1982 ), • To date only one non-specific immunosuppres­
sive regime has proved effective in prolonging allogeneic foetal 
grafts when Mullen ( 1980 ) reported life term immunological 
unresponsiveness following TLI and either donor bone marrow or 
foetal liver infusion.
The initial work by Murray ( 1935 ) , who implanted
pancreatic tissue following culture in the recipients serum 
introduced the first attempt at specific immunosuppression of 
islet tissue. This may be conveniently viewed as the selective 
suppression of the donor antigen presenting cells thought to be 
responsible for the induction of the allogeneic tissue rejection 
phenomena. Specific immunosuppression may be either antigen 
induced ( active enhancement ) by the introduction of 
preparations containing donor histocompatability antigens or 
antibody induced ( passive enhancement ) by treatment of the 
recipient with antibodies directed sigainst donor antigens .
The realization that not all antigens need to be 'covered' 
by enhancing antibodies ( Fabre 1974 ) , and that
incompatabilities within the RTl.A , RTl.B and RTl.C loci differ 
not only in the type of immune response they elicit ( Klempnauer 
1983 ) but also in their ability to invoke the cytotoxic T cell
response ( Klein 1977 ) have important implications in the field 
of pancreatic transplantation.
Although the mechanisms proposed differ , it has been 
suggested by Bach ( 1976 ) , Wagner ( 1976 ) and Lafferty ( 1977) 
that the allogeneic T cell response may be induced by
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costimulatory activity ( stimulator cells ) arising from
•recognition' of the RTl.B ( la ) antigens on ia,e surface of 
implanted cells .
Whatever the validity of this proposal , it has been shown 
that passive enhancement by antibodies directed against the donor 
RTl.B antigens results in the long term survival of islet 
allografts in the murine model ( Faustman 1981 ) .Recent studies 
using RTl.B antibodies in the rat model reported only modest 
prolongation of islet survival ( Reece-Smith 1983 ).The reason 
for this discrepancy remains unclear but it is possible that the 
differences may be due to the specificities of the antibodies
employed .
Active enhancement has been attempted by injecting donor
strain foetal liver ( Nelken 1977 ) or spleen cells ( Smith 1983)
prior to transplantation . The level of induced tolerance in
these experiments has been highly varied but surviving allografts
at 157 to 200 days was reported in 3 out of 14 rats ( Smith
1983 ).
An alternative ^proach , i.e. by altering the immunogenicity 
of the donor islets has been attempted by some investigators. It 
was first promulgated by Summerlin ( 1973 ) and shown by Boyles 
(1975) that pancreatic islets , following a critical period in 
culture , may be effective in achieving long term allogeneic 
islet survival in rats. Boyles ( 1975 ) reported that
implantation of allogeneic adult islets , cultured for 14 to 16
days in 95 % oxygen restored normoglycaemia for between 3 and 6 
months in 80 % of experimental animals . Two rats remained 
normoglycaemic for 11 and 12 months.
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It is believed that islet cells do not express RTl.B ( la ) 
antigens ( Baekkeskov 1981 )and that the adherent and lympho- 
reticular cells which are thought to initiate the immune response 
are either lost or lose their immunogenicity during the period of 
culture.
Bowen (1980 ) was able to prolong islet survival in non-
immunosupressed mice in excess of 3 months following culture 
for 7 days in high oxygen levels . Lacy ( 1979 ) reported
i«urvival in excess of 100 days following culture of hand picked 
islets for 7 days at 24 C combined with a single injection of 
ALS. Reetsma ( 1981 ) was unable to reproduce these results and 
suggested that a contributory factor may have been his inability 
to identify and exclude small lymph nodes from the islet 
preparation .
These findings provide convincing evidence that allogeneic 
implantation into a non-immunosupressed recipient may be 
possible. However , the optimal conditions for preservation of 
islet tissue and for the loss of tissue immunogenicity remain 
undefined . Lafferty ( 1983 ) indicates the necessity of high 
oxygen levels , however Yasunami ( 1983 ) reported rat to mouse 
xenogeneic islet survival following 7 days culture under 
atmospheric oxygen levels . Low temperature culture combined with 
ALS immunosupression (Lacy 1980 ) and culture of rat mega-islets 
in 95 % oxygen ( reported by Bowen ( 1980 ) to prevent islet
disintegration in high oxygen levels ), have been applied 
successfully in prolonging xenograft survival ( Lacy 1982 ).
Both Mandel (1979 ) and Garvey (1980 ) reported that they
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were unable to reduce the immunogenicity of foetal pancreatic 
tissue by in vitro culture techniques. Extended culture for 17 
days before even minimal prolongation of islet tissue survival 
was reported by Simeonovic ( 1981 ) , who recorded that the 
rodent foetal pancreas is grossly contaminated with lymphoid 
tissue which may explain this lack of success.
More encouraging results were recently reported by Collier 
( 1983 ) when following organ culture for 23 days , 7 out of 25 
allogeneic foetal pancreatic grafts survived at least 104 days, 
at which time 4 of these animals were normoglycaemic .
2.3 ISLET CELL IMPLANTATION IN LARGER ANIMALS
Early attempts to restore normoglycaemia by islet 
implantation in larger animals were unsuccessful .
Sutherland (1974) implanted a semi-purified islet 
preparation into the peritoneum and thi^ muscle in pigs with no 
evidence of graft function . Kemp (1973) reported immediate death 
in dogs following auto-implantation of islet tissue into the 
liver.Kumar ( 1973 ) reported progressive atrophy of implanted 
canine foetal tissue into the anterior chamber of the eye in 
dogs.
The first indication that implantation of islet tissue in 
larger animals might prove successful was provided by Scharp 
(1975) . Following 70% resection of the monkey pancreas and the 
administration of 50 mg/kg streptozotocin , followed by 
collagenase digestion and ficoll separation of the resected 
tissue ,the islets were implanted into the portal vein. Two of 
the four experimental animals were reported to be normoglycaemic
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at 3 weeks following implantation and one animal remained 
normoglycaemic for the 6 week term of this study. An IVGTT however 
showed only a marginal improvement over the diabetic state of 
the control animals .
Similar results were reported by Matas ( 1976 ) and Lorenz 
( 1979 ) in partially pancreatectomised and streptozotocin
induced diabetic dogs .However , the use of this experimental 
design must be questioned.
In these circumstances it is difficult to determine the 
relative contribution of the residual pancreas and implanted 
tissue in restoring carbohydrate control in this experimental 
design . This is particularly important in view of the finding 
(Trimble 1977 ) that implantation of islet tissue can result in 
the recovery or promote the growth of insulin containing cells 
within the residual pancreas. While the technical difficulties in 
ensuring the completeness of pancreatectomy and the high 
mortality resulting from this procedure in rats (Slepjevic 1975) 
justifies the use of a chemically induced diabetic but not insu— 
linpoenic state . In larger animals the completeness of surgical 
resection can be ensured and would appear to be more appropriate.
The most impressive studies so far of islet cell 
implantation were those carried out by Mirkovitch ( 1976 ) . He 
implanted unsepeurated collagensise digested pancreatic tissue from 
the horizontal portion of the gland directly into the splenic 
pulp of pancreatectomised dogs following cannulation through the 
splenic vein. All experimental animals became normoglycaemic 
within 10 days and no significant difference was noted in 
IVGTT's carried out in transplanted and normal animals during the
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ten week term of the experiment. Similar results have recently 
been reported by Madureira ( 1982 ) . In both studies
splenectomy resulted in diabetes and death confirming the role 
of the intra-splenic tissue in maintaining normoglycaemia.
The effectiveness of intra-splenic auto-implantation of 
digested tissue derived from a portion of the canine gland has 
been confirmed in other studies ( Kolb 1977 ) and ( Orsetti 
1981 ) . Normoglycaemia was established in these cases but an
IVGTT was reported as grossly abnormal .
In some studies the entire canine pancresis has been 
enzymatically disaggregated and implanted into the splenic pulp 
Kretschmer ( 1977 ) , ( Mehigan 1980 ) , Horaguchi ( 1981 ) and
Long ( 1983 )• In these studies between 88 and 100 % of
transplanted animals became normoglycaemic . One study reported a 
normal IVGTT in 3 out of 4 dogs ( Long 1983) .
Several factors have been shown to directly influence the 
outcome in this model of intra-splenic canine implantation .
A critical time for esqposure to enzymatic digestion appears 
to exist ( Kretschmer 1979 ) .Dispersed tissue implanted before 
this time failed to restore normoglycaemia ( Kretschmer 1977) 
although the studies of Gray ( 1979 ) suggest that finely chopped 
but undigested pancreatic tissue may be well tolerated and 
showed evidence of continued insulin secretion . i'rolonged 
exposure to the enzymatic digestion leads to a progressive loss 
of insulin containing tissue ( Kretschmer 1979 ).
At this stage of digestion most investigators have reported 
that isolated islets are not readily seen , but remain entrapped
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within the non-endocrine tissue stroma ( Mirkovitch 1976 ).
The survival of both endocrine and exocrine tissue 
components have been reported within the spleen , however it 
would appear that exocrine tissue does not maintain its 
secretory function ( Hadji - Georgopoulos 1982 ) .It is clear 
that intra-splenic implantation can be effective and although 
increased serum transaminase levels have been reported ( Kolb 
1977 ) suggesting a deleterious effect upon liver function these
however .returned to normal within 4 weeks.
In contrast infusion of a portion ( Matas 1976 ) or the
total enzymatically dispersed canine gland ( Kretschmer 1977 ),
( Mehigan 1980 ) , ( Horaguchi 1981 ) and ( Dobroschke 1981 )
into the portal vein has been less successful , although Kolb 
( 1977 ) and Madureira ( 1982 ) reported no difference between
the two sites.
The development of portal hypertension following portal 
implantation in dogs ( Matas 1976 ) has been a consistent finding 
with the development of a fatal haematological dysfunction 
resembling disseminated intravenous coagulation occurring in all 
animsils in the studies of Mehigan (1980) and Dobroschke (1982).
Evidence of extensive thrombosis of the portal system and 
massive internal bleeding was seen at autopsy. It has been 
suggested that anticoagulation therapy could prevent these 
haematological changes . The study of Mehigan ( 1980 ) tends to 
support this view as anticoagulation decreased the severity of 
these disorders , but deaths have still occurred in fully 
heparinised animals ( Mehigan 1980 ) and ( Mamer 1982 ).
In those studies where intra-portal implantation has been
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successfully carried out most reporters have shown that the 
percentage of animals which become normoglycaemic is much less 
than when implantation is carried out into the splenic pulp 
( Horaguchi 1981 ).
Three attempts at auto- implantating islet tissue in larger 
species ( other than man )have been reported •
Hoverstein ( 1977 ) was unsuccessful in restoring
normoglycaemia in pancreatectomised monkeys by intra-splenic or 
Intra—peritoneal auto—implantation of dispersed pancreatic tissue 
Mieney ( 1979 ) reported success in autoimplanting dispersed
pancreatic tissue into the portal vein in baboons . In 2 out of 4 
experimental animals , blood sugar levels within the normal range 
were reported during the 6 week term of the experiment . Mamer 
( 1982 ) was unsuccessful in restoring normoglycaemia following
implantation into the portal vein in pigs . Islet cells were 
demonstrable at autopsy , however their function as measured by 
C peptide secretion was insufficient to reverse the diabetic 
state.
2.3 b ALLOGENEIC IMPLANTATION IN LARGER ANIMALS
The limited number of studies dealing with allogeneic 
implantation in the dog suggest that the findings are similar to 
those reported in the rodent model .
The immune destruction of implanted pancreatic tissue in 
non-immunosupressed canine recipients has been reported to occur 
within 3 ( Kolb 1979 ) , 5 ( Toledo-Pereyra 1982 ) and 8.5
( Zammit 1979 ) days. A limited number of immunosuppressive
regimes have been attempted . To date neither Azothioprine and
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Prednisilone ( Kolb 1979 ) , ( Kretschner 1979 ) , Cyclosporin
( Du Tpit 1982 ) __pr ALS ( Toledo-Pereyra 1982 ) have proved
unsuccessful in prolonging graft survival by more than 10 days.
Whether specific immunosuppresion or long term culture will 
be more effective remains unknown.
One further report exists of an unsuccessful study in 
implanting foetal into maternal and foetal into sibling 
pancreatic tissue in monkeys ( Jonasson 1977 ).
2.4 HUMAN PANCREATIC ISLET TISSUE IMPLANTATION
Several early attempts at implanting either foetal or 
neoplastic islet tissue in man have appeared in the literature. 
Intra-muscular and sub-cutaneous pockets were among the first 
sites chosen •
Cultured islet apudoma cells were implanted into the 
axillary tissue tissue of a diabetic patient by Murray (1935) and 
into two diabetic patients by Porter (1956) . Although a slight 
reduction in requirements was reported by Murray* he did not 
consider tiiis significant. Urea (1970) implanted an insulinoma 
beneath the fascia lata of a young insulin resistant diabetic . 
Insulin containing cells were shown to be present 3 months,.later 
but complete fibrosis of the graft had occurred at 9 months. No 
physiological evidence of graft function was obtained in this 
patient and his insulin requirements were not significantly 
aLLtered.
Implantation of foetal tissue was attempted by Craig in 1941 
( reported Craig 1968 ) into the axilla of three diabetic
patients , however all grafts failed . Brooks (1959) was also
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HUMAN ISLET CELL IMPLANTATION REPORTED IN THE 
LITERATURE UP TO DECEMBER 1983
Principle Reporter Allografts Autografts
and Centre Adult Infant Foetal
SUTHERLAND
(Minnesota)
' 12 6 0 10
LORENZ
(Berlin)
7 0 ,0 0
VALENTES
(Genova)
14 0 13 14 ■
TRAVERSO 
(Los Angeles)
0 0 0 4
CAMERON
(Baltimore)
0 0 0 8
DOBROSCHKE
(Geiasen)
0 1 0 4
REEMTSMA 
(New York)
0 0 0 1
NARDI
(Boston)
0 0 0 5
HINSHAW
(California)
0 0 0 5
CROTH
(Stockholm
0 9 9 0
LARGIADER
(Zurich)
6 1. 0 0
GRODINSKI
(Detroit)
0 0 0 3
WILSON
(Boston)
0 0 0 1
NARASIMHAM 
(Minniapolis)
0 0 1 0
CHASTAN
(Bordeaux)
0 0 1 0
USADEL
(Frankfurt)
0 0 1 . 0
TOLEDO-PEREYRA
(Detroit)
0 ' 0 0 6
Totals 32 3 25 68
Table 2
unsuccessftil in significantly reducing the insulin reqirements of
diabetic patients following foetal implantation into muscle 
pockets .
The main surge in studies involving islet implantation began 
in 1977 when Sutherland ( 1978 ) began a series experiments using 
allografts derived from adult and infant pancreatic tissue . 
Since then there have been 133 attempts at islet cell 
implantation either published or reported to the International 
Islet Transplant Registry ( Sutherland 1980) ,( table 2 ) .
To date, 40 attempts at allo-implantation of adult or infant 
derived pancreatic tissue have been carried out ( table 3 ). In 
addition , foetal tissue from either a single or multiple donors 
have been implanted in a further 25 patients ( table 4 ).
The techniques of tissue preparation have varied 
considerably. In most ,but not all cases .collagenase digestion 
has been used to disaggregate adult and infant pancreatic tissue. 
Some investigators have attempted a partial purification of the 
islets , while others have implanted unseparated tissue 
disaggregates. Mechanically disaggregated foel^ tissue has been 
implanted without recourse to enzymatic digestion.
2-4a ALLOIMPLANTATION OF PARTIALLY PURIFIED ISLET PREPARATIONS
Although there have been no studies in man comparable to 
isolated islet implantation in rodents , some investigators have 
attempted to purify islets but the final preparation still 
represents a grossly contaminated preparation
Sutherland (1978) attempted to purify islets by density 
centrifugation using the sucrose polymer Ficoll. He implanted
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partially purified collagenase digested adult pancreatic islet 
tissue into the peritoneum in 3 patients.One further patient 
received separated islet tissue into an intramuscular site . In 
each of the three intraperitoneal trials the amount of islet 
tissue recovered was extr«nely low ( less than 0.4% of the normal 
human islet mass ) and although a transient decrease in insulin 
requirements occurred in one patient no long term effects of the 
implanted tissue were noted. The intra-muscular recipient 
received a larger volume of tissue ( 14.5% of the adult islet 
mass ) but no metabolic effects were seen.
An alternative approach to islet purification was carried 
out by Valente ( 1982 ) . During short term culture techniques , 
it has been reported that islet tissue selectively survives while 
exocrine tissue becomes non-viable ( Matas 1976 ). Vailente 
cultured semi—purified islet preparations for several days and 
attempted to avoid the immune rejection phenomena by implanting 
these islets encapsulated in millipore chambers as allografts in 
a series of 14 diabetic patients. Between 5 and 90 thousand 
encapsulated islets were engrafted sub-cutaneously in 13 
recipients and into the peritoneal cavity in 1 patient. In 13 
patients insulin requirements were diminished in the 3 months 
following implantation , but as in animal studies ( Helmke 
1982 ) this was not maintained , presumsüaly due to fibrotic
reactions which Valente found to encircle the bio—artificial 
chambers. Nevertheless it was reported that two patients were 
able to be completely withdrawn from exogenous insulin therapy 
for 3 months and one patient remained insulin independent at 1 
year.
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In these studies the amount of islet tissue remaining 
following digestion , and more importantly the purification 
techniques used , was usually extremely low . In many cases one 
would not have expected the recipients metabolic state to be 
greatly influenced from this small volume of islet tissue.
The demonstration that digested but unseparated pancreatic 
tissue containing an increased quantity of islet tissue was 
apparently well tolerated in the canine model prompted its 
application in clinical trials.
2.4b ALLOIMPLANTATION OF UNSEPARATED DISPERSED PANCREATIC TISSUE
To date , dispersed pancreas implantation of allogeneic adult 
tissue has been performed in 14 cases and alloimplantation of 
dispersed infant tissue in 8 cases .
Sutherland ( 1980 ) implanted collagenase digested unsepa— 
rated pancreatic disaggregates into the portal vein of 7 diabetic 
patients ( one patient received two implants ). No adverse 
reaction to the implanted tissue was reported with the exception 
of the patient who underwent two implants and in whom transient 
but severe portal hypertension ( 60 cm water ) occurred. The 
islet yield following digestion , as estimated from the dispersed 
tissue insulin content , ranged from 20% to 60% of normal adult 
values.Two patients were temporarily withdrawn from insulin 
therapy between the 2nd and 4th and the 13th and 17th post­
operative days indicating that some early islet cell function may 
have resulted.Increases in urinary C—peptide levels were measured 
in two patients for one montdi following implantation . However , 
in the other five cases no evidence of graft function was
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obtained . No patient was permanently withdrawn from insulin 
therapy and no long term decrease in daily insulin requirements 
were apparent.
Largiader ( 1980 ) attempted allo-implantation of disper­
sed pancreatic tissue into the mesenteric vein in 4 patients and 
directly into the spleen in two patients . No evidence of graft 
function was noted.
2.4c ALLO-IMPLANTATION OF UNSEPARATED INFANT PANCREATIC TISSUE
Sutherland ( 1980 ) implanted collagenase digested
unseparated pancreatic tissue derived from a single infant donor
into 6 patients with diabetes of 9 - 35 years standing.In two
patients islet tissue eqivalent to 8.5% and 9 % of the normal
adult islet mass was implanted into the peritoneum.In one patient
the daily insulin requirements were temporarily reduced from 80
to 28 Units per day three to five weeks following implantation.
In four patients dispersed infant tissue containing between 0.4%
and 12 % of the adult islet mass was implanted into the portal
vein . In three cases diminished insulin requirements were noted 
e
betw^ the 2nd and 9th weeks following implantation, however all 
patients have subsequently returned to their pre-transplant 
insulin requirements • Paradoxically , the patient who received 
the least amount of islet tissue was able to decrease his daily 
insulin requirements from 72 to 32 Units after 7 weeks and 
continued to be adequately maintained on this reduced dose at 18 
months.
Largiader ( 1980 ) implanted dispersed pancreatic tissue 
containing about 200,000 islets from a 2 year old child into the 
spleen following sub-capsular puncture . The recipient was a 23
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year old female who developed IDDM 12 years previously.Daily 
insulin requirements decreased until insulin therapy could be 
discontinued completely 8 months following implantation.This 
patient remained insulin independent until for some unknown 
reason the graft failed after 19 months.
In the one other case of allo-implantation of infant tissue, 
Dobroschke (1982) implanted dispersed pancreas derived from a 
newborn child with congenital nesidioblastosis into the spleen of 
an immunosuppressed patient with IDDM of 32 years duration. A 
decreased insulin requirement was reported at 14 days post-op but 
no further details on this patient have as yet been reported.
2.4d ALLO-IMPLANTATION OF FOETAL TISSUE
Valente (1982 ) hsis reported on the implantation of foetal 
pancreatic tissue into 13 non—immunosuppressed patients with IDDM 
of between 9 and 13 years standing. Cultured foetal tissue from 4 
or 5 donors were implanted intra—muscularly in two patients and 
into the portal vein in two patients. No change in insulin 
requirements were noted in three of these patients , however in 
one patient receiving intra-portal foetal tissue the daily 
insulin requirements declined from 80 Units a day prior to 
implantation to 20 Units per day at 9 months . Nine patient's 
received minced foetal pancreases into the abdmninal rectus 
muscle . One to three foetal donors were used for each 
recipient. Six patients showed no change in insulin requirementr 
while two patients showed a slight reduction .One patient was 
able to be withdrawn from insulin at six months and remained so 
at one year.
66
Groth ( 1980 ) implanted a single foetal pancreas into the
abdominal rectus muscle of two immunosupressed and 4 non—
immunosupressed patients . No evidence of graft function was 
obtained in any of these patients. In a further three 
immuunosuppressed patients multiple donors were used. In two 
patients 15 foetal pancreas , following storage at 4*C for up to 
3 hours were implanted into the spleen in one case and intra- 
portally in the other recipient .There was no evidence of graft 
function at 2 and 5 months. In the remaining case 6 cultured
foetal pancreases were implanted into the portal vein. One month 
later urinary C-peptide levels were recorded and increased to 5% 
of normal adult values by 4 months ,but then ceased. It is
possible that immime reactions were involved in this graft
failure for islet cell surface antibodies were detected which 
coincided with the cessation of urinary C-peptide secretion.
Three other attempts at foetal implantation have been
reported .
Usadel (1982) implanted a single foetal pancreas following 8 
days in culture into the brachioradialis muscle of a 29 year old 
femade who had undergone total pancreatectomy. No evidence of 
grsift function was obtained.
The work of Narasimham ( 1977 ) is interesting in that he
attempted to reduce the imirunogenicity of a single 19 week foetal
pancreas by culturing a dispersed cell suspension from the gland 
in CO—culture wi1±i cells from the recipients bone marrow and 
lymph nodes . Skin sensization studies following injection of 100 
islet cells beneath the skin of the left forearm induced no signs 
of rejection i.e. erythema . The remaining tissue was implanted
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into the liver and intra-rauscularly and the patient was reported 
as being maintained on one third of his pre-transplant insulin 
requirements one month later .No further details on this 
interesting study have been reported however .
Chaston ( 1980 ) cryopreserved 30 relatively undifferen-
#
tiated foetal pancreas of 9 weeks gestational age . He implanted 
60 fragments of approximately 1 mm’ into the pectorialis muscle 
of a 25 year old diabetic diagnosed as insulin dependent 8 
months previously.This patient became insulin free 62 days later 
and remained so for the next 11 months . Blood sugar levels then 
became erratic and it became necessary to reintroduce insulin 
therapy 14 months after foetal implantation .
In summary , it is extremely difficult to evaluate the 
technical and immunological aspects of alloimplantation at this 
time . In most cases , graft function , at least sufficient to 
allow withdrawal from exogenous insulin therapy has not 
occurred. Moreover evaluation of the degree of restored 
pancreatic function is often obscured by differences in the pre­
existing tabetic state .For instance, in some patients with 
diabetes of long standing , C-peptide levels were demonstrable , 
indicating some measure of residual insulin secretion (Valente 
1982) ,( Chaston 1980 ). Nevertheless , there is indirect
evidence that human islet cell implantation has in msuiy cases 
provided islet cell function ( Valente 1982 ) and in one case at 
least been successful in restoring full metabolic control .
In those clinical studies where the implanted tissue has 
provided no evidence of or has ceased to function it is not
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possible to determine whether this failure arises from technical 
or immunological factors.
Although the results of Groth (1980) suggest that immune 
responses may have been involved in the cessation of function of 
foetal graft it is by no means clear that this represents 
allo-geneic tissue rejection mechanisms. Islet cell surface 
antibodies are a well recognized finding often at the onset of 
the disease and an equally plausable explanation is that 
recurrent disease may have occurred .
It is clear that foetal implantation has been successful in 
restoring normoglycaemia in non-immunosuppressed patients for in 
excess of one year which must raise the question of whether 
human islet foetal tissue is as immunogenic as evidence in the 
rodent model would suggest. The available evidence suggests that 
foetal tissue may prove a safe and efficient technique for 
reversing the metabolic disorders of diabetes but that currently 
very little information concerning the critical Eispects of 
successful foetal implantation is available.
The effect of rejection mechanisms on graft failure has been 
somewhat clarified by clinical experience with islet cell 
autoimplantation in patients undergoing partial or total 
pancreatectomy in cases of chronic pancreatitis ( see later).
Evidence from vascularized whole gland transplantation 
strongly suggests that the adult pancreas is subject to normal 
allogeneic immune tissue rejection mechanisms and it may be 
expected that many graft failures may have occurred for this 
reason.
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2*5 AUTO—IMPr«ANTATION OF THE ADULT HUMAN
Although there are many surgical procedures available 
for the treatment of chronic pancreatitis, partial resection 
{ Child 1969 ) and pancreatico-duodenectomy { Braasch 1978 ) are 
the two commonly employed. Both methods have their proponents . 
However, diabetes is a predictable outcome following total , and 
IS the usual but not inevitable outcome following major 
resection of the gland ( Mehigan 1980 ) .
There have been .68 attempts at implanting autologous 
dispersed pancreatic preparations following total or partial
resection of the pancreas of which 54 have been reported in 
detail ( table 5 ) .
2•5a AUTO-IMPLANTATION FOLLOWING TOTAL RESECTION
Dobroschke (1982) attempted to purify islets by repeated 
washing and centrifugation of the collagenase digested tissue.He 
estimated that between 70 and 100 thousand islets were implanted 
into the portal vein in 3 patients following total resection , 
and in 1 patient following partial resection of the gland . All 4 
patients rec^iired insulin and were adequately maintained on ^  
between 10 and 44 Units per day . In one patient who underwent 
total pancreatectomy endogenous C-peptide was demonstrated, 
possibly indicating that some islet function was restored.
Lorenz (1981) has reported on 4 of 7 autografts carried out 
following total resection of the gland . The collagenase disper­
sed pancreatic tissue containing between 15 and 25 % of the 
normal pancreatic insulin content was infused slowly into the 
portal vein. He recorded no significant increase in liver enzyme 
release or decrease in liver function following implantation ,
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but in one patient elevation of* portal vein pressure precluded
t
the implantation of more than 80 % of the dispersed tissue. Three 
patients were subsequently insulin dependent and are maintained 
on 8,10 and 12 Units of insulin per day . The remaining patient 
was insulin free with an essentially normal IVGTT two months 
later. In this patient serum C-peptide levels were 30 % of the 
pre- operative levels.
Traverse (1980) performed total pancreatectomy and intra- 
portal implantation of collagenase digested pancreatic tissue in 
four patients « In two cases only the portion of the pancreas to 
the left of the portal vein was used while in the other two cases 
the whole pancreas was processed . Portal hypertension and 
systemic hypotension developed in 3 of the recipients so that 
only 1/3 to 1/2 of the dispersed tissue could be implanted. Serum 
transaminase levels were 20 times the normal level following 
implantation suggesting some cellular damage within the liver. 
These returned to normal by the 7th post-operative day.All four 
patients have required insulin and were being adequately 
maintained on between 15 and 32 Units per day.
2.5c AUTO-IMPLANTATION FOLLOWING PARTIAL PANCREATECTOMY
Hinshaw ( 1981 ),disagregated the pancreas by
handprocessing the chopped ,partially digested ( 4 cases ) and 
non — digested tissue ( 1 case )through a metal sieve in a 
series of autografts following partial resection of the pancreas 
Following partial purification by sedimentation and 
centrifugation the final tissue volume implanted into the portal 
vein was approximately 10 cc . This contained between 500,000
71
and 2,000,000 islets and islet fragments . It is unclear what 
this represents ia terras of islet volume.Two-of— the patients 
remain normoglycaemic with normal glucose tolerance tests , one 
patient was insulin free for 20 months and then required insulin 
therapy and two patients have remadned insulin dependent.
Short term culture of dispersed pancreatic tissue in an 
attempt to purify pancreatic islets has been attempted by 
Reerastma ( 1980 ) , who implanted minced but not digested 
adult pancreatic tissue following 7 days in culture into a sub­
cutaneous space in the forearm of a patient who became diabetic 
following a partial pancreatectomy .No evidence of graft function 
was noted.
Valente (1982) reported implanting partially purified
pancreatic disaggregate as autografts following 93 % to 97 % 
resection of the gland for pancreatitis. Approximately 150,000 
islets , following 7 days in culture $ were implanted intra­
muscularly in one patient with no evidence of graft function.In 
three other patients 25 to 320 thousand islets , cultured for 
between 2 and 4 days ,were implanted into the peritoneal cavity. 
Two patients remained insulin independent while in the remaining 
patient , glucose control was being controlled with hypoglycaemic 
agents. IVGTT*s performed in these patients following 
implantation showed K values between 0.8 and 1.3 .
In a further series of ten patients Valente (1982) implanted 
collageneise digested , unseparated pancreatic tissue containing 
between 25 and 400 thousand islets into the portal vein following 
93 — 98 % resection of the pancreas .He reported that no adverse
reactions to the implanted tissue occurred but it was noted that
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portal vein pressures remained elevated from their pre- operative 
levels in all patients 7 days later.Nine patients became normo­
glycaemic by the end of the first week . The remaining patient 
was reported to require insulin 3 weeks following implantation 
(Valente 1980) but subsequently required no exogenous insulin
(Valente 1982) . In this series of patients IVGTT's performed
between 1 and 12 months following implantation were essentially 
normal with K values between 1.1 and 1.9 . Cannulation of the 
suprahepatic and portal vein showed a slight increase in blood 
insulin levels indicating intra-hepatic secretion from the
implanted tissue , but whether this increase was sufficient to 
fully account for the excellent control of glucose homeostasis 
must remain speculative.
Cameron ( 1981 ) reported on 8 patients who underwent 95% 
pancreatectomy and implantation into the portal vein of
unseparated disaggregate . Between 38 and 83 ml of sedimented 
tissue was implanted • Increased portal vein pressure of up to 
60 cm water occurred in all patients following 
implantation.Normoglycaemia was established in a mean of 28 days 
in 6 of these patients . Three of these patients reverted to the 
diabetic state at 3 , 6 and 8 months following implantation and
three remained insulin independent at 9 , 18 and 22 months. In
the three patients who remained normoglycaemic Cameron obtained 
evidence of markedly increased insulin and glucagon levels in 
blood samples withdrawn simultaneously from the portal and 
supra—hepatic vein. Of the remaining two patients one had a 
massive intra and post—operative bleeding diathesis accompanied
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by disseminated in-3-avascular coagulation , requiring multiple
transfusions of blood and blood products . This experience
prompted this group to infuse ^rotinin and heparin with the
disaggregated tissue , a procedure which was shown to modulate
haematological disorders following pancreatic implantation in the
canine model. Despite this measure one further patient developed
severe portal hypertension which at laparotomy 24 hours later was
found to compromise the venous drainage of the large and
bowel, and a meso-caval shunt was constructed . This patient died 
10 days later.
Toledo-Pereyra ( 1983 ) reported on 6 cases where islet
autoimplantation was carried out following 80 to 95 % resection 
of the pancreas. Two of these patients remain insulin independent 
one of which exhibited an essentially normal oral glucose test 
three weeks following implantation . Two patients were reported 
to be insulin free immediately following implantation are now 
being maintained on 20 and 83 Units of iraulin per day . The 
remaining two patients died . One case has been reported in 
detail by Mittal ( 1980 ) in which disseminated intravenous 
coagulation and massive bleeding followed the implantation of 
pancreatic digest . In the remaining patient massive bleeding 
also occured ( estimated to be in excess of 10 litres ) following 
implantation wi-üi pulmonary vascular conjestion securing after 
surgery . Problems associated with sepsis , internal bleeding and 
a perforated transverse colon necessitated further surgery and 
the patient died 3 months later from multiple causes .
Grodinski (1981) has performed intra-portal implantation of 
unseparated tissue in 3 patients following 90 % resection of the
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gland . In one patient portal hypertension from 15 to 45 cm water 
persisted for four hours following implantation . All three 
patients have required insulin therapy and catheterization of the 
suprahepatic veins demonstrated no significant portal insulin 
secretion.
Two other groups have carried out ( but not reported ) islet 
cell implantation. Wilson ( reported by Lorenz 1982 )
implanted cultured pancreatic tissue into the peritoneal
membranes . This patient remained insulin dependent. Nardi 
( reported by Sutherland 1980 ) implanted dispersed tissue
following 95 % resection of the gland into the portal vein in two 
and sub-cutaneously in one patient. All three patients require 
insulin. In a further two patients Nardi implanted dispersed 
tissue into the portal vein following 80 % resection of the 
gland. Both patients remain normoglycaemic.
2.6 CONCLUSIONS
In experiments in animals, techniques have emerged enabling 
the successful reversal of chemically induced diabetes following 
implantation of isolated islets and neonatal and foetal pancrea­
tic tissue . In addition in some ( but not all ) hands, 
implantation of dispersed pancreatic microfragments has been 
effective in larger animals.
In these animal models critical factors have been identified 
which directly influence the outcome of implantation . There is 
also evidence that under certain conditions long term survival of 
allogeneic and even xenogeneic islet grafts in non—immunosuppre— 
ssed recipients may be obtained.
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Whether these conditions apply in the human model remains
unclear. Alloimplantation of adult . infant and foetal pancreatic
tissue preparations into insulin dependent patients has in most
cases failed to ameliorate the diabetic state. Yet , allo-
implantation of foetal ( Chaston 1980 ), ( Valente 1982 ) and
infant pancreatic tissue ( Kolb 1980 ) have allowed insulin
therapy to be withdrawn for many months in three
dependent diabetics two of whom received no immunosuppressive
treatment.
Despite these encouraging findings and although experimen­
tal allo-implantation in animals remains an intense area of 
research , clinical attempts are now very infrequent and only 3 
have been attempted between 1980 and 1983 (Sutherland 1983 ).
Continuing experience with auto-implantation would suggest
that the main reason for this is the inability to reproduce in
man the effectiveness of techniques developed in experimental 
animals .
In discussing islet cell implantation in man , Largiader 
( 1977 ) described the procedures used as safe but ineffective.
Time has shown that these assertions may no longer be
tenable.
Total or partial resection of the pancreas is carried out in
an endeavour to cure intractable pain resulting from chronic
pancreatitis. The question of whether to perform total or partial 
resection must remain a matter of clinical judgement and
persuasion , however it is only following total pancreatectomy 
that unequivocal evaluation of the degree of restored islet cell
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function can be made.
There have been 12 cases of islet cell implantation 
following total resection of the pancreas . One patient remains 
normoglycaemic with an essentially normal IVGTT . Most of the 
remaining 11 patients are being maintained on fairly low daily 
insulin requirements , which provides suggestive evidence that 
some graft function may have been restored. Direct evidence that 
this is so has been provided in some of these patients.
Sufficient evidence has now emerged following implantation 
of both total and partially resected glands to indicate that 
the procedures used can involve considerable risk to the 
recipient . Four deaths have been reported following implantation 
of dispersed microfragments , of which three were directly 
attributable to the procedures used. In other cases portal 
hypertension have been common and cardiac dysrhythmia , 
disseminated intravascular coagulation and systemic hypotension 
have presented serious risks.
It is clear that a desperate need still exists for a 
technique of islet preparation which can be shown to be safe to 
apply and in addition to provide a reproducible treatment 
enabling total endocrine replacement therapy to be carried out as 
a cure for the many insulin dependent diabetic patients.
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CHAPTER THREE 
DETAILS OF PROPOSED RESEARCH
3.1 INTRODUCTION
This chapter describes the rationale behind the 
experimental work carried out over a 4 year period.
Where help has been provided this is gratefully
acknowledged at the end of this thesis , but essentially the
experimental rationale to be described and its practical 
application were designed and carried out solely by the author .
3.2 EXPERIMENTAL DESIGN
Our initial experience suggested that procedures which 
presented few problems with the rodent model were inappropriate 
when dealing with the pancreas of larger animals and man. The
human pancreas proved resistant to ductal distention , it was
extremely difficut to chop into small pieces with either scissors 
or scalpel blades ,and perhaps more importantly enzymatic 
disaggregation proved rapid and uncontrolled towards the end of 
the digestion period. Cell viability in these preparations was
invariably very low although small numbers of islets were
obtained . It was apparent that considerable improvements in 
these techniques were necessary if sufficient islets were to be 
available to ensure adequate carbohydrate control following 
implantation into an insulin dependent diabetic .
With this in mind it was decided to investigate aspects of
the 'rodent* technique of islet cell isolation in an attempt to
identify where the procedures could be specifically improved .
The initial steps necessary for rodent islet isolation are 
now fairly standard . They consist of prior disruption of the
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gland , mechanical or hand chopping of the tissue and enzymatic 
digestion. It is perhaps appropriate to briefly consider each in 
detail .
Prior Disruption
The purpose of distention of the gland is to initially 
disrupt the tissue permitting subsequent enzymatic digestion to 
release islets from the tissue stroma. In the rat , injection of 
fluid into the pancreatic duct provides distention and disruption 
of the tubulo-acinar endpieces and the desired acinar-endocrine 
separation. However, ductal distention of larger animals and the 
human pancreas is ineffective in this respect ( Scharp 1980 ).
It has been shown in dogs ( Downing 1979 ) that a more 
satisfactory way to initially disrupt the pancreatic parenchyma 
was by injection of fluid into the pancreatic vein.
In dogs , each islet receives arterial blood from a single 
afferent arteriole , and exits via multiple efferent arterioles 
into the acinar portal circulation ( Fujita 1976 ). It has been 
suggested that the afferent and efferent arterioles are separated 
by sphincters ( Wharton 1934 ) which Downing ( 1979 ) suggests 
allows tissue disruption while at the same time preserving the 
integrity of the pancreatic islets.
A similar islet-acinar portal circulation has been described 
in the pancreas of other animals ( Fujita 1976 ). Whether venous 
distention of the gland proves as effective in the human model 
however awaits clarification .
Mechanical Dissociation 
It is usual to cut the tissue sample into small pieces in 
order to aid enzymatic digestion and to prevent necrosis of the
79
central tissue during the period of digestion.
Because of the large volume and fibrous nature of the human 
pancreeis , it is extremely difficult to chop into sufficiently 
small pieces with either scissors or razor blades . Weber (1977) 
reported that even relatively small volumes of human pancreas
i.e. biopsy specimens required up to 30 minutes to chop.
A variety of mechanical chopping aids have been described 
which will reduce the entire gland into sufficiently small 
fragments within a few minutes. These chopping aids include rows 
of parallel razor blades set 1mm apart ( Gunnarsekaran 1979 ),
electrically driven counter rotating blades ( Gray 1977 ) ,
tissue homogenizers ( MacDonedd 1980 ) and modified kitchen 
implements ( Gordon 1981 ).
Mehigan ( 1981 ) has suggested that the method of
mechanical chopping is not important . Yet the few studies which 
have attempted to critically evaluate the effect of these devices 
upon cell recovery and survival would argue against this 
assumption. Matas (1976) estimated in rats that mechanical
chopping resulted in a 39 % loss , while Kretschmer (1977) 
using the canine pancreas showed a 45% loss in the insulin
content following mechanical chopping of the tissue .Chick (1979)
reported that a counter rotating blade , similar to that used by 
Gray ( 1977 ), resulted in unacceptably high cellular damage when 
used to process the pancreas from larger animals and man.
It would appear that if cellular damage is to be mimimized 
then considerable care is necessary in the choice and evaluation 
of a particular mechanical chopping aid .
Enzymatic Digestion
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Since the initial finding more than 60 years ago by
Rous (1916 ) that exposure to trypsin could disperse mammalian 
cells, enzymatic digestion is now the usual procedure in 
effecting tissue disaggregation.
Weymouth (1974) has provided an excellent review of the use 
of various enzymes and other agents which have proved effective 
in disaggregating a wide variety of tissues.
It is generally agreed that the choice of enzyme will depend 
upon the age and nature of the tissue to be dissociated . When
dealing with a relatively fibrous tissue such as the pancreas ,
intercellular adhesion can be most effectively reduced by 
enzymatic treatment of the fibrous tissue stroma . Thus , perhaps 
not surprisingly , collagenase or collagenase containing mixtures 
have proved the universal agent used in attempts to effect
primary tissue dissociation of the human pancreas.
Commercial preparations of collagenase are available from 
many sources and are obtained following the ammonium sulfate 
precipitation of extracellular filtrate of various strains of 
Clostridia histolyticum. In addition to pure collagenases i.e. 
enzymes capable of hydrolyzing collagen under physiological 
conditions of pH and temperature ,these preparations have been 
shown to contain a number of other enzymes with proteolytic 
activity (Mandl 1971) . Not all commercial enzyme preparations 
have proved equally effective in their ability to release viable 
islets or islet cells ( Moskalewski 1965 ).
Inconsistancies between batches of collagenase in their 
efficiency in isolating islets have been reported ( Toledo- 
Pereyra 1979 ) . Neilson (1980) has observed that a reduced
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insulin response of isolated islets could be traced to a specific 
batch of collagenase. Cytotoxic 'collagenase* preparations have 
even been described ( Moskedewski 1969 ) . There is little doubt 
that many of the reported deleterious effects of these enzymes 
can be traced to impurities within the commercial enzyme 
preparations . Enzyme contaminants of collagenase have been shown 
to have a deleterious effect upon cell survival (Moskalewski 
1974 ) , cell ultrastructure ( Amsterdam 1978 ) and upon membrane 
receptor sites ( Selawry 1978 , Gingerich 1979 ). In addition 
it has been reported that a low molecular weight contaminant of 
commercial collagenase may induce irreversible stimulation of the 
cellular adenylate cyclase system ( Lacombe 1979 ) , thus
resulting in permanent activation of cAMP activity .
It is felt tiiat the question of whether purer or alternative 
enzymes preparations can increeise islet recovery and viability 
deserves special consideration .
It remains unknown whether purified collagenase alone is 
capable of dissociating pancreatic tissue , or whether sis 
Sutherland (1981) implies , these contaminants play an essential 
role in tissue bresikup. If the former is true then there appeeu^ s 
to be little resuson for using a vsuriable enzyme complex , 
contaminants of which may have as yet unknown effects upon the 
islet yield and function ,
One further and to some extent related suspect of enzymatic 
disaggregation techniques is the need to establish the end point 
of the digestion process, i.e. the time when the greatest number 
of* islets can be isolated. Islets isolated after this time may be 
subjected to damage due to enzymatic overdigestion , while
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underdigestion results in islets remaining entrapped within the 
non-endocrine tissue stroma ( Scharp 1980 ). It is possible that 
the identification of this end point of digestion may prove less 
critical if a less cytotoxic enzyme preparation is used to effect 
tissue disaggregation .
Assessment of Islet Function
Finally , it is necessary to formulate the criteria to be 
applied in determining whether a peurticular procedure is truely 
effective in producing a sufficient quantity of viable islet 
tissue to restore normal carbohydrate metabolism.
It is clear from a review of ttie human clinical trials that 
two procedures have emerged for reporting the yield of recovered 
human islet tissue.
In many cases , the number of islets have been estimated by 
direct counting of islets in an aliquot of pancreatic digest 
( Valente 1982 ) It has been suggested that the number of 
islets may be related to the total number of islets in the human 
pancreas and thus provide a measure of islet recovery .however 
this is open to two sérious sources of error.
According to morphological studies in man ( Clark 1913 ),
direct counting methods following intra—vital staining have 
shown that the number of islets vary considerably between 
individuals .In addition , there is still no general agreement on 
the absolute number of islets in the normal adult human pancreas 
and most estimates range between 200,000 and 2,000,000 (for a 
review of islet numbers and volume see Volk 1977 ) .
There is aggreement however that the size of islets in the 
human pancreas is highly varied . Ogilvie (1937) estimated that
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the weight of individusd islets ranged from 0.48 to 2.74yy g . 
Tenj ings ( 1947 ) has provided a mathematical computation of the 
size classification . This accords with the studies of Heilman 
(1959) who reported that the number of islets increased as the 
diameter of islets decreased , indicating a preponderance of 
smaller size islets. The bulk of the insulin containing tissue 
was however contained within islets belonging to the medium size 
classification. Thus, determination of the number of islets 
recovered must be accompanied by the size classification or 
insulin content to provide a meaningful estimate of the recovered 
islet mass .
An alternative method used to estimate the islet yield has 
been to assay the insulin content of the dispersed pancreatic 
tissue . Providing that insulin granulation is complete , the 
extractable insulin content of the pancreas has been shown by 
Leonard (1973 ) to provide an approximation of the islet tissue 
volume . This technique has provided valuable information on the 
remaining insulin containing tissue following digestion and where 
islet loss may occur in the separation procedure.
Both approaches , namely islet numbers and insulin content , 
suffer from the disadvantage that they provide ,at best ,only a 
quantitative evaluation of the remaining islet tissue and tell us 
little of the tissue viability .
In some instances , dye exclusion tests of viability have 
been used , but the inaccuracy of this method has been long 
recognized ( Phillips 1973 ) . In addition it is clear that 
inaccuracies may be compounded when dye exclusion is used to 
estimate the viability of islets where the tissue fragments may
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be many cells deep.
It may be argued that , as in animal experiments , in vivo 
assessment of human islet function may be obtained following 
implantation . This is not entirely persuasive when dealing with 
human tissue for the risks of implantation cannot be quantified 
unless an adequate islet function can be assured. The development 
of an in vitro method of evaluating islet function is therefore 
an essential part of evaluating the separation technique .
In some studies , small numbers of human islets , have been 
tested by batch incubation ( Andersson 1976 ) and periperfusion 
procedures ( Ferguson 1977 ) . Periperfusion techniques provide 
the advantage that both quantitative and qualitative measures of 
the capacity of individual islets to release insulin in response 
to various secretagogues may be obtained. These have not yet 
been successfully applied to estimating the IRI release from 
human chopped pancreatic tissue or in evaluating the remaining 
endocrine function of the pancreatic disaggregate .
There is a desperate need for a system capable of providing 
reproducable estimates of the rate of insulin release both from 
normal and disaggregated pancreatic tissue over a given period of 
time and in response to insulin secretagogues. Only then will it 
be possible to critically evaluate and improve the procedures 
detailed above , and ensure that sufficient viable islets are 
available for implantation .
Implantation
Once the procedures are established and a sufficient 
quantity of dispersed islet tissue is available it remains to be 
shown whether (1) implantation of the unseparated i.e disaggre­
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gated pancreatic tissue or separated i.e. isolated islet 
preparations will restore normal carbohydrate control and (2) 
whether either can be safely infused without for example the 
development of portal hypertension or severe haemodynaraic changes 
( Cameron 1981 ).
Evaluation of the effect of implanting pancreatic tissue 
must of course be first carried out in an animal model .
Islet Separation
Even if implantation of unseparated dispersed pancreas is 
successful there are valid physiological ( Dobroschke 1982 ) and 
immunological ( Lacy 1982 ) reasons why the implantation of a 
relatively pure endocrine preparation is to be preferred .
To date , attempts to purify human islet tissue by either 
centrifugation or sedimentation have resulted in low yields of 
islet recovery ( Sutherland 1979 ) , ( Dobroschke 1982 ) . It is
intended to investigate alternative techniques for purifying 
islet preparations and evaluating their survival under tissue 
culture conditions .
Materials and Methods
The materials used have been presented in Appendix I 
Appendix II contains the methods used • Preparation of media and 
soluble collagen is presented in Appendix III. The periperfusion 
design is detailed in Appendix IV . Fractionation and 
purification of commercial collagenase has been published in 
abridged form ( Compton 1982 ) but is presented in full in 
Appendix V .
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CHAPTER FOUR 
RESULTS
Before assessment of the techniques used to effect islet 
isolation can be meaningful it is necessary to first establish 
control values of the various parameters to be measured using 
adult human pancreatic tissue .
It is unknown how the period of cold storage may influence 
these results and therefore we have excluded data on those glands 
with cold ischaemic times in excess of 4 hours .
4.1 ^STUDIES ON NORMAL ADULT HUMAN PANCREATIC TISSUE
The insulin , total protein and amylase content was esti­
mated on whole or near whole adult human pancreas , ( table 6 ).
These results indicate that there was a wide fluctuation in 
the total insulin content of individual pancreas , ranging from 
25,000 to 535,000 ng of insulin per g tissue • In one instance we 
measured the insulin content of the pancreas from a child who died 
following the onset of diabetic coma . In this case the insulin 
content was found to be 950 ng/g tissue or only 0.06 % of the 
average normal value .
One point of note is that the mean insulin content 
( 157,500 ng /g tissue ) differed greatly from the median 
( 82,500 ng/g tissue j suggesting that the di.itribution may not 
be normally distributed . Filliben's test for normality ( corr,.. 
coeff. 0.89 ) and Grubb’s test for outliers ( T= 0.87 and 2.49 ) 
indicated that the data was failing to fulfill the criteria for 
normality tor good reasons and not because of outlying extreme 
values .
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TISSUE COMPONENTS OF THE NORMAL HUMAN PANCREAS
Insulin 
ng g wet wt.
Total Protein 
mg g wet wt.
Amylase 
mg g wet wt.
31,280 208.9 10.67
360,460 173.1 2.3
120,380 147.6 2.62
54,190 149.1 2.78
84,440 167.6 4.56
52,780 157.2 4.35
513,820 110.6 2.09
83,030 161.7 3.23
175,830 172.3 10.66
241,152 90.9 11.13
535,300 108.3 7.28
400,040 148.7 5.05
25,800 98.9 7.79
91,538 114.6 4.64
240,360 106.9 5.39
91,080 182.6 4.67
73,905 198.2 4.53
121,340 110.7 3.42
69,380 142.1 4.35
25,990
223,740
81,350
57,308
25,382
124.3 11.2
mean 157,500 143.7 5.63
median 82,500
table 6
Because it has been reported ( Dickson 1977 ) that the
recovery of insulin from tissue extracts may be at times low and 
variable and to ensure that these differences did not arise 
from inaccuracies in the method of extracting and measuring 
tissue insulin a recovery experiment was carried out .
Duplicate samples of a known weight of pancreatic tissue 
from the same pancreas were taken to one of which a measured 
amount of insulin was added. It was assumed that any inaccui'acy 
in estimating tissue insulin content would be reflected by an
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RECOVERY OF ADDED INSULIN FROM SPIKED
SPLIT SAMPLES OF PANCREAS
Exp.
No.
Measured Insulin 
in Homogenate 
ng
Insulin
Added
ng
Expected
Recovery
ng
Actual
Recovery
ng
Percentage
Recovery
H02/80 14,550 32,000 46,550 39,050 83.9
H02/80 31,920 8,000 39,920 27,300 68.4
H02/80 11,700 8,000 19,700 33,600 170.6
H02/80 8,800 16,000 24,800 33,600 135.5
H03/80 11,100 8,000 19,100 22,000 115.2
H05/80 9,200 16,000 25,200 25,030 99.3
H06/80 23,340 320,000 340,000 132,800 39.1
H06/80 20,320 160,000 180,320 194,000 107.6
H06/80 37,120 160,000 197,120 63,700 32.3
H06/80 60,410 80,000 140,410 101,640 72.4
H05/80 48,190 80,000 128,190 127,020 99.1
H07/80 203,630 160,000 363,630 231.120 63.6
H07/80 194,400 80,000 274,400 330,240 120.4
H07/80 158,570 160,000 318,570 331,320 104.0
K07/80 192,860 320,000 512,860 483,360 94.3
H13/80 519,200 32,000 551,200 . 515,400 93.5
H13/80 255,960 16,000 271,960 400,680 147.3
H13/80 269,640 16,000 285,640 515,900 180.6
H13/80 407,350 6,400 413,760 504,000 121.8
H16/80 14,260 none 14,260 14,700 103.1
H16/80 18,300 25,600 43,900 67,600 154.0
H16/80 5,400 19,200 24,600 15,000 61.0
H16/80 1,860 12,800 14,660 34,880 237.9
HI6/80 5,320 5,320 11,720 22,560 192.5
H17/80 64,300 6,400 71,600 72,600 101.4
H17/80 61,600 3,200 64,800 "126,040 194.5
H17/80 53,380 3,200 56,580 88,550 136.7
H17/80 97,980 none 97,980 110,400 112.7
HlOl/81 41,150 800 41,950 39,270 93.6Hioi/ai 79,000 400 79,400 99,040 124.7
HlOl/81 73,140 16,000 89,140 93,280 104.7
HlOl/81 5,520 16,000 21,520 22,125 102.8
H104/81 41,180 320,000 361,180 191,700 53.1
HI04/81 70,680 320,000 390,680 232,960 59.6
H104/81 18,530 8,000 26,530 36,850 138.4
H104/81 20,680 800 21,430 23,500 109.4
H104/81 33,520 16,000 49,520 45,100 91.1
H106/81 13,540 6,400 19,940 9,325 45.8
H106/81 12,920 8,000 20,920 27,030 • 129.2
Mean j 82,337 63,244 145,455 140,622
TABLE 7
increase or decrease in the expected insulin content ( tissue 
insulin content of the duplicate sample plus the added insulin ) 
When compared to the spiked sample. This recovexy experiment was 
carried out on 40 duplicate samples ( Table 7 )
The mean insulin content of the non-spiked samples was 
82.337 ng to which was added an average of 63.244 ng of exogenous 
insulin so that the expected recovery of insulin ( assuming no 
insulin loss occurred ) was 145,455 ng.
The measured insulin content of the spiked samples averaged 
140.622 ng which indicates a recovery of tissue insulin of 96.7%.
The variance between individual estimates is illustrated in 
fig 1 . vdiich shows the log insulin content of expected against 
actual recovery. Linear regression analysis confirmed the accu­
racy of the method over the range measured ( K = 0.93 ) with
negligable loss of insulin during the extraction and measuring.
RECOVERY OF IRI ACTIVITY FROM SPIKED SAMPLES 
5.8-
Expected 5.6-Recovery 
Log ng 5 4,
5.2-
5.0- 
4.8-
4.6-
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4.2-
4.0-
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Actual Recovery Log ng
Figure 1
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RECOVERY OF THE INSULIN CONTENT FROM
CHOPPED PANCREATIC TISSUE
Blade Total Insulin Total insulin % Tissue .
Advance Content of Content of Insulin
Setting Chopped Tissue Supernatant Recovered
55,333 37,500 59.6
lOO/tfm • 23,591 7,760 75.25
• 192,120 86,320 69.0
47,325 20,665 69.61
40,000 16,622 70.64
Mean t S.D. 71,574 33,773 67.97 f 5.7
81,330 39,000 67.59
250yum 28,683 8,220 77.73
146,320 40,182 78.46
46,072 3,571 92.81
51,580 14,186 78.43
Mean t S.D. 70,847 21,032 77.11 t 8.99
70,666 24,000 74.65
SOOyvm 34,908 5,560 86.26
156,302 14,315 91.08
68,175 4,052 94.29
87,000 10,152 89.55
Kean t S.D. 83,410 ■11,616 87.78 t 7.59
112,000 20,500 84.53
750 yUm 39,513 5,760 ’ -37.28
160,840 15,820 91.02
60,507 - 1,818 97.08
85,000 8,956 90.47
Mean î S.D. 91,590 10,571 88.78 t 4.71
120,000 25,000 82.76
1 nun 46,312 2,460 94.96
146,940 11,350 92.83
49,612 1,531 97.01
76,000 14,364 84.1
Mean Î S.D. 87,773 10,941 88.92 t 6.49
139,666 7,200 95.05
Control 49,458 4,160 86.65
128,523 8,946 93.49
44,574 1,479 96.79
62,500 12,149 83.73
Mean Î S.D. 84,944 6,787 92.6 Î5.65
TABLE 8
Thus any variability in the amount of insulin measured 
( table 6 ) is due to differences in the insulin content of the 
pancreatic tissue evaluated and not to the methodology used .
MECHANICAL CHOPPING
In order to provide data on the dynamic aspects of insulin 
release from normal pancreatic tissue it was essential to chop 
the tissue into sufficiently small pieces to allow diffusion into 
and secretion of insulin out of the tissue fragments . It is 
clear that any tissue loss during this chopping procedure would 
to some extent invalidate these results.
I am aware of only one commercially available purpose built 
machine which has been used for chopping a variety of tissues 
The result of using this Mcllwain tissue chopper which makes 
parallel cuts transversing the tissue at pre-set intervals was 
investigated. It was found that if a rigid single edged blade was 
substituted foi* the recommended double edged razor blade and the 
blade force was set to maximum the human pancreas could be 
efficiently chopped into small fragments. The effect of using the 
Mcllwain tissue chopper in regard to cellular damage and islet 
tissue loss was estimated on pre-weighed chopped tissue by 
measuring the insulin content of the chopped tissue and the 
insulin which was released during the chopping process i.e. the 
insulin content of the supernatant following washing of the 
chopped tissue. Several blade advance settings were used ,the 
results of which are presented in table 8 .
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The recovery of tissue insulin was calculated from the 
following formula .
Insulin content of chopped tissue
—  ng
Insulin content of chopped tissue supernatant 
In addition histology examination of the chopped tissue was 
carried out ( photographs 1 & 2 , page 92 ).
One interesting and perhaps not unexpected finding (table 8) 
was that there was a small but significant release of IRI from 
the unchopped control tissue following washing with cold balanced 
33^^ solution . Whether this was due to IRI release from cells 
prior to pancreatectomy or during the period of cold storage 
remains unclear .
The results of the recovered tissue insulin content indicate 
that the human pancreas could be chopped into small pieces ngTng 
a blade advance of between 500//m and 1 mm with negligable loss 
of the insulin content from the tissue when compared to the 
unchopped control pancreas .The effect of mechanical chopping at 
lesser blade advance settings resulted in a 13% loss at 250yW m 
which was increased to a 33% loss following chopping at 100/fm .
As can be seen from photographs 1 & 2 , there, was no apparent 
morphological evidence of cellular destruction around the cut 
tissue edges when a blade advance setting between 500^ 6/m and 1 mm 
was used . Thus the blade advance setting of 500^ m was used to 
chop the pancreatic tissue throughout the following studies.
It remained to establish the insulin secretory capacity of 
this chopped tissue to establish the parameters needed against 
which to critically evaluate the islet function remaining 
following disaggregation.
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VChopped Tissue 
Haematoxylin and Eosin Magnification X 25 
PHOTOGRAPH 1
9
Chopped Tissue 
Haematoxylin and Eosin Magnification X 500 
PHOTOGRAPH 2
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PERIPERFUSION OF CHOPPED PANCREATIC FRAGMENTS
A known weight of randomly chosen tissue fragments from the 
chopped pancreas as above was gently introduced into the periper- 
f usion system as described in Appendix III .
It was clear that there were considerable difficulties in 
the interpretation of the dynamic aspects of IRI release from the 
cheeped pancreatic tissue and that certain aspects of this IRI 
release warranted explanation.
The results of those studies using media with a constant 
non-stimulatory ( 2.8 mMol ) level of glucose are presented in 
Table 9 , page 94 ( see also fig 4 , p.100 ). It can be seen
that an initial extraordinary high IRI release during the 
early phase of periperfusion was followed by steadily declining 
rates of IRI release .
Although similar patterns of insulin release have been
described following experimental periperfusion studies using
other species ( Dorming 1981 ) ,these have so far not been satis-
factorally explained . Several suggestions have however been put 
forward.
1. That the apparent high insulin levels may be due to 
zymogen and enzyme release from the non—endocrine tissue leading 
to degradation of released endogenous insulin or the iodinated 
insulin used in the radioimmunoassay . Similarly these enzymes 
could lead to degradation of ,or loss of ,the labelled ligand, 
from the insulin antibody used . These factors would of course 
lead to either false high or low estimates of IRI activity.
2. That the cell membrane integrity may be severely impaired 
and ' leakage ' of insulin may occur and may possibly lead to deple-
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RTrnnVFRY OF IODINATED INSULIN
Time Exueriment 1
{mins) 1 2 3 4 5 Mean
5 ' 53.7 66.9 74.0 52.4 55.3 60.5
10 71.8 79.0 78.9 59.4 62.3 70.3
15 75.0 85.4 84.5 77.4 66.0 77.7
20 85.4 88.4 87.2 75.3 88.0 84.9
25 89.4 85.5 89.2 68.3 90.3 84.5
30 85.1 89.5 90.9 91.8 100.7 91.6
35 80.1 87.6 87.2 85.1 92.3 86.5
40 87.8 83.1 91.5 93.9 88.7 89.0
45 79.3 89.3 94.6 91.9 87.7 88.6
50 89.6 82.5 88.4 79.3 87.0 85.5
55 73.5 84.9 86.3 81.3 93.3 83.9
60 76.6 89.8 91.6 77.3 88.0 84.7
65 89.1 84.3 82.9 77.2 78.3 82.4
70 67.0 90.5 75.4 84.3 101.0 83.7
75 68.3 89.4 82.8 83.5 89.0 82.6
80 84.5 88.4 80.0 93.3 99.7 89.2
85 94.1 86.6 91.2 74.1 82.0 85.6
90 62.3 84.2 76.1 86.9 96.7 81.2
95 85.9 90.8 90.6 78.2 89.0 86.9
100 86.2 87.0 93.3 91.7 90.7 89.8
105 72.7 88.4 93.3 81.6 86.7 84.4
110 79.0 84.7 84.3 84.6 90.3 84.6
115 81.8 89.1 88.4 78.3 86.2 84.8
120 81.1 89.6 88.7 85.9 88.0 86.7
Perfusate 81.1 86.9 87.5 82.2 89.0 85.3
TABLE 10
RECOVERY OF IODINATED INSULIN - ANTIBODY COMPLEX
Time Experiment
Mean( mins ) 1 2 3 4
5 91.9 84.4 92.0 87.8 89.0
10 91.6 85.2 92.0 98.9 91.9
15 93.1 98.4 91.1 84.6 91.8
20 86.5 90.4 109.8 94.1 95.2
25 102.1 89.8 102.9 98.1 98.2
30 100.1 115.8 89.3 96.2 100.4
35 96.8 104.9 96.9 105.1 101.7
40 103.6 ■ 105.1 98.9 114.7 105.5
45 100.7 97.3 103.1 102.2 100.8
50 107.5 102.9 116.0 107.1 108.5
55 112.8 111.0 86.7 91.2 100.4
60 111.8 112.9 93.6 100.3 104.6
65 94.5 116.9 94.0 90.6 99.0
70 109.2 107.2 94.2 86.7 99.5
75 114.3 87.3 97.6 86.7 96.6
80 94.2 90.6 118.1 95.1 99.5
TABLE 11
tion of insulin reserves.
3. A final reason may be that what one is observing is the 
progressive death of insulin containing cells during the period 
of perifusion.
It was possible to check the first assumption by two series 
of experiments. Iodinated insulin equivalent to 1,000/» U ml was 
added to the perfusate throughout the periperfusion . It has been 
shown that this can be absorbed by using a charcoal—dextran 
slurry ( Herbert 1965 ) and more importantly that this absorbant 
is sensitive to damaged tracers ( Hunter 1971 ) . The recovery of 
iodinated insulin would indicate whether insulin degradation 
occurred . The results of these studies are shown in Table 10.
Similarly .factors which may have an adverse effect upon 
the insulin antibody used were investigated by incubating the 
collected perfusate fractions overnight at 4*C with a measured 
amount of the bound iodinated insulin—antibody complex . Because 
of* the nature of the ligand antibody complex , the presence of 
free insulin in the perfusate would to some extent replace the 
labelled ligand frcxn the antibody until equilibrium was reached. 
It was therefore necessary to remove the free insulin from the 
perfusate This was carried out by incubating the perfusate 
fractions at 4^C overnight with an excess of insulin antibody . 
The antibody was removed by precipitation and centrifugation and 
the perfusate was then incubated overnight with the bound 
labelled ligand antibody complex. Once again a reduced recovery 
of the labelled ligand-antibody complex would suggest either 
damage to the antibody or the avidity of the bound ligand . The 
results of these studies are shown in Table 11 .
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It is clear from these figures that the recovery of 
iodinated insulin is reduced during the first 15 minutes of the 
periperfusion ( Table 10 ). A similar effect was demonstrated 
from the initial 20 minute periperfusate on the recovery of the
iodinated ligand-antibody complex ( Table 11 ) .
The effect of this reduced recovery of the labelled 
ligand indicates that less ligand will be available to bind to 
the antibody complex and will therefore result in reduced counts 
in the precipitated antibody complex and falsely high estimates 
of the actual IRI activity during the first 15 minutes of the 
periperfusion. The high recovery of both iodinated and bound 
ligand during the remainder of the periperfusion also indicates 
that the measured IRI activity reflects an accurate estimate of 
the actual IRI activity .
It remains to be seen whether insulin release after the first 
20 minutes of the periperfusion was the result of ' leakage ' as 
Sutherland ( 1981 ) suggests or whether active physiological
secretion was occurring . No experimental model was set up which 
would determine whether •leakage occurred ', although data to be 
presented later does not rule out its occurrence contributing to
the initial high IRI release during the first 20 minutes of the
glucose challenge.
One interesting finding was that the measured IRI release 
after the first 40 minutes of periperfusion could be inhibited to 
in excess of 60% by the addition of 10^  g ml diazoxide (a 
substance known to inhibit insulin release in vivo).This finding 
argues against 'leakage' playing an important .-ole in the
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pattern of IRI release during the period of periperfusion • 
The results of the periperfusion studies using non—stimula­
tory ( 2.8 mMol ) glucose levels (shown in table 9 ,p.l04 )
indicate that the individual values of insulin release exhibit a 
wide distribution ranging from 6.9 to 346 ng/ g tissue, similar 
to the wide range in tissue insulin content ( table 6 ). This
creates considerable problems in data analysis . The 
distribution has proved impossible to present in graph form
without recourse to using logarithms or complex statistical
procedures. In addition we cannot be jure that the few extreme 
values were nv t derived from the pancreas of donors who had 
abnormal pancreatic endocrine function .
For this reason and for the sake of clarity it aippears
sensible to use the arithmetic mean as our measure of central
tendency and the mean deviation to demonstrate the range of 
values ( Moroney 1951 ). It is realized that these rather simple 
statistical procedures are to some extent limited in their abili­
ty to deal with more advanced sampling theories such as are 
appied lo normally distributed data but for the purpose of this 
study they would appear adequate .
The mean and mean deviation of idle values obtained during 
the constant non-stimulatory glucose periperfusion ( shown in 
Table 9 ) are presented in graph form in Figure 2 .
It is thus possible to make the assumption ( although we 
cannot absolutely prove this ) that the steady state of IRI 
release under constant non-stimulatory levels of glucose would 
indicate that nozmal physiological secretion was occurring and 
that islet cells were surviving during this period of
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periperfusion . In terms of confirmation that normal islet cell 
function was occurring it was also necessary to show that this 
tissue responded to elevated levels of glucose with an increase 
in IRI release.
For this reason the glucose challenge was carried out in 
the following manner .
After a 30 minute period of periperftision in which lOyw g/ml 
diazoxide was added to the perfusate to inhibit insulin release, 
a non-stimulatory glucose level of perfusate ( as described in 
the methodology in Appendix III ) tuas introduced . This was 
changed to a 16.8 mMol glucose level of- - perfusate after 30 
minutes and once again 2.8 mMol glucose was re—substituted after 
a further 30 minutes. The perfusate was collected at two minute 
intervals.
The results of these studies shown in Table 12 , and the 
mean IRI release and mean deviation are presented in Figure 3 
p. 99 .
Once again a high initial rate of IRI release was observed 
using 2.8 mMol/1 glucose . This declined after the first 20 
minutes of the glucose challenge to a relatively steady rate of 
IRI release ranging from 8.3 to 145 ng/min/g tissue with a 
mean of 49ng/ min/ g tissue .
In all experiments the rate of IRI release could be shown to 
increase in response to an increased glucose concentration of 
16.8 mMol. The mean IRI release over the 30 minute periperfusion 
using 16.8 mMol glucose concentration was found to increase to 95 
/ g / tissue and more importantly from the point of view of
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this potentiated IRI incz*ease this was shown to be 
sustained over the 30 minute period.
The final 10 minute periperfusion using 2.8 mMol glucose 
resulted in a decrease in IRI release to a mean of 54.2 ng / min 
/g tissue.
It was clear uhat the pattern of IRI release did not ( or as 
is more likely the periperfusion design was insufficiently 
sensitive to ) demonstrate the primary and secondary peaks of IRI 
release reported when rodent isolated islet preparations ( Lacy 
1972 ) and whole organs ( Landgraf 1971 ) have been perfused . It 
is likely that mixing within the periperfusion chamber and the 
time taken for diffusion of glucose into and IRI release out of 
the tissue may have contributed to masking this reported cyclic
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GLUCOSE CHALLENGE ON STORED TISSUE
r Period of storage of whole giaind in ice
6 Hours 8 Hours 24 He)urs
Time n = 4 n = 4* n = 2
.^ 'mins ) Mean Mean
Deviation
Mean Mean
Deviation
Mean Mean
Deviation
r- 2 349.0 132.0 525 - — —
c 6 163,0 67.0 88.3 20.0 —
10 66.5 27.0 41.5 21.0 75.8 42.0
r 14 25.1 5.0 26.5 14.0 1135.2 75.0
• 18 23.5 4.0 22.3 11.0 44.0 11.0
m 22 19.0 13.0 18.0 6.6 17.7 11.7
26 24.2 11.0 16.9 6.0 4.5 3.6 _
C 30 47.2 13.0 13.6 6.7 sTe 0
k» 34 38.8 7.0 12.4 3.7 1.2 1.2J-
38 44.3 10.3 14.2 5.3 0 05> 42 38.9 11.0 13.9 5.0 0 0
t 46 35.3 7.3 14.1 4.0 0 0
50 36.7 13.4 11.3 4.0 0 0
m 54 31.3 6.0 11.8 3.6 0 0
58 34.9 8.0 12.2 4.6 0 0
t-aa 20.4 6.0 9.6 0 G, 0
TABLE 13
pattern of IRI release.
For the purpose of this study, the analysis of primary and 
secondary peaks of IRI release was not considered essential and 
the steady state of IRI release under both basal and stimulatory 
levels of glucose was more amenable to quantitative estimates of 
islet function .
The constant rate of IRI release under basal glucose and the 
increased response to elevated levels of glucose provide two 
important measures of endocrine function . These of course also 
provide the parameters which allow us to critically evaluate the 
effect of the proposed techniques of human pancreatic 
disaggregation both in terms of the quantity and quality of 
remaining islet function.
4.2 TISSUE DISAGGREGATION OF THE HUMAN PANCREAS
Effects of storage:
As previously mentioned ( Appendix I ) it was 
impossible to control the length of storage in ice of the 
pancreas . Nevertheless , it was possible to attempt to evaluate 
the effect of prolonged ice storage on endocrine tissue survival 
using the periperfusion technique .
Cold storage of the whole gland in ice led to the 
progressive loss in the abili*^ of the tissue to produce a 
sustained IRI release during a glucose challenge ( Table 13 ).
Periperfusion of pancreatic tissue fragments following 6 
hrs cold storage showed a decreased level of IRI release both in 
response to low and stimulatory levels of glucose .The tissue
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GLUCOSE CHALLENGE OF STORED CHOPPED TISSUE
24 HOUR STORAGE 
at 4 C ( n = 3 )
I«!ean Mean Deviation
CRYOPRESERVATION 
( n = 7 )
Mean Tiean Deviation
Time 
( mins )
2 817.0 354.0 — —
j 6 289.0 59.0 —
? 10 137.0 27.0 75.9 27.6
c 14 75.0 45.6 45.5 17.6
18 40.6 25.6 26.7 7.5
? 22 23.1 9.3 21.5 7.2
A 26 19.9 9.0 19.5 5.9
#» 30 43.7 23.3 27.0 10.5
4 34 . 40.0 18.3 26.5 14.6)
3 33 46.2 20.3 20.9 13.9* 42 39.3 *14.6 23.8 15.3
46 39.0 15.3 20.0 12.5
50 40.0 22.0 19.9 11.8
54 30.1 7.3 16.6 10.3A 53 29.8 7.0 21.2 14.0
62 19.6 — 16.1 10.6
66 - - 12.8 4.5
TABLE 14
did however respond to stimulatory glucose concentrations with 
increased IRI release indicating that a percentage of islet 
tissue survived for this period of time . Following 8 hours 
storage in ice a further reduction in IRI release was recorded, 
and no increase in IRI release could be shown in response to 
increased glucose levels suggesting that damage to the normal 
physiological response of the endocrine tissue had occurred. In 
the two studies in which the pancreatic tissue was stored in ice 
for 24 hours no IRI release could be demonstrated after • 20 
minutes periperfusion suggesting that the tissue had failed to 
survive .
In contrast in the four studies in which the pancreas was 
chopped into small fragments within three hours of pancreatectomy 
and stored in tissue culture media at 4* C a degree of the IRI 
secreting capacity of the pancreatic fragments could be 
maintained following storage for up to 24 hours ( Table 14 ).
An alternative metiiod of preservation was attempted by the 
storage of pancreatic tissue fragments cryopreserved following 
the procedures outlined in Appendix IV . A markedly reduced 
level of IRI release was however measured following thawing 24 
hours later ( Table 14) .
These combined results are presented in Figure 4
It is clear from these studies that none of the strategies 
used were effective in totally preserving endocrine function and 
the loss of endocrine function was rapid and progressive . If 
processing of the pancreas has to be delayed for any reason then 
the most favourable conditions in terras of the preservation of
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endocrine function would appear to be as chopped fragments 
stored in culture media at 4*C.
Tissue Distention:
In the following studies attempts were made to initially 
disrupt the tissue prior to chopping by injection of cold (4 * C) 
digestion solution ( Appendix III).
Ductal distension was performed by injecting 50 ml of the 
distention solution into the pancreatic duct . Histologic 
examination ( Photograph 3 ) indicared that there was no
apparent damage to the pancreatic islets . The most striking 
finding was the grossly dilated ductal system and it would appear 
that distention was confined to these vessels as no distention or
102
disruption of the tubular or acinar endpieces were observed. 
Ductal distention would therefore seem completely ineffective in 
producing the desired tissue disruption.
The superior mesenteric artery was cannulated and all major 
tributaries of the pancreatic veins were clamped . The gland was 
distended by injecting 50 ml of the cold distention solution.
Histological examination of the tissue was carried out ,
from which it was clear that intra-arterial distention resulted 
in the total disintegration of islet tissue ( Photograph 4 ).
Venous distention of the pancreas was carried out by
injecting 50 ml of distention solution into the superior mesen­
teric vein after all other major blood vessels had been clamped.
Histological examination indicates that excellent disruption of 
the pancreatic tissue strwna both around tiie acini and ductal 
tissue can be achieved . In addition , it can be seen that there 
was complete disruption of the tissue stroma surrounding the 
islets ( Photographs 5 & 6 ).
These findings would indicate that venous distention 
provides considerable advantages in its abilily to initially 
disrupt the tissue stroma and was therefore performed on all 
pancreatic tissue prior to digestion.
Out of interest the reason why venous distention would
appear to be so effective was further studied by adding Indian
ink to the culture media used for distending the gland. 
Histological evidence of a 20^ m unstained section of the 
pancreas ( Photograph 7 ) demonstrates the extensive venous 
network within the pancreas and the m stained section 
( Photograph 8 ) shows that the distention solution can be seen
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reaching what on morphological grounds would appear to be the 
the efferent arterioles of the islets . Thus if sphincters 
separating the endocrine-exocrine components exist in the human 
pancreas then they must be located wiliiin the pancreatic islets.
Following venous distention , the pancreas was carefully 
dissected free of fat , major blood vessels , ductal tissue and 
the pancreatic capsule .
The pancreas was then sliced into 3 to 4 mm slices and 
chopped using the Mcllwain tissue chopper at 500^  m . This hap 
been described in detail in part 4.1 .
These procedures took on average slightly in excess of 30 
®i^ wfccs during which time the tissue was mai ntai at as near 
to 4*0 as possible.
Enzymatic Digestion
Since our primary aim in using enzymatic digestion was to 
achieve islet isolation while preserving islet function , we 
needed to answer the question of vdiich enzymatic ctampnripntg were 
effective in tissue disaggregation and the relative effect of 
these components on islet cell survival.
The detailed methods and results «nployed to fractionate 
and purify these enzymes are presented in Appendix V .
Various fractions of the eluate following ultragel 
fractionation were used to digest chopped tissue for 40 minutes 
at 37 C. The degree of tissue diseiggregation was estimated by 
filtering tiie tissue remaining following digesf" ion through 
a nylon mesh with a 250yU m pore size .
The average percentage of the total tissue which would
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pass through this size mesh is plotted against the of the
column eluate ( Figure 5 ).
It was clear that only two areas of the column eluate were 
effective in achieving tissue disaggregation. The first which
eluted between K„y 0.13 and 0.35 exhibited only collagenolytic 
activity . The second although less effective peak eluted 
between 0.40 and 0.53 and contained collagenolytic, tryptic
and non- specific protease activity.
When the histogram of filtered tissue ( Figure 5 ) is
compared with the enzymatic elution profile following gel 
filtration ( Figure 6 ) it is clear that the degree of tissue 
disaggregation closely follows the presence and concentration of 
collagenolytic activity.
Purified preparations of the amidase-esterase , clostripain 
and the three isolated non-specific proteases ( isolated 
following the procedures outlined in Appendix III ) had no 
significant effect in achieving tissue disaggregation and islet
isolation even when used at high concentrations.
The effect of these enzymes on individual cell release 
were studied further by estimating from aliquots of Oie d-i 
solution the number and viability ( using dye exclusion ) of 
those cells which were released during this period of digestion.
As a further indication of the effect of these individual 
enzymes histological evaluation of the non-disaggregated tissue.,, 
was carried out following 40 minutes digestion .
The cell counts and viability measures of the cells 
released following 40 minutes digestion are presented in Table 15
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nr!T.T. CQUTJTS ON ALIQUOTS OF DIGESTED TISSUE.
K#* Cells X 10*,
Viability
Ex d ..1 Exp.2 Exp. 3 Exp.4 Exp.l Exp. 2 Exp.3. Exp. 4
0.1-0.15 4 — - 1 95 - 95
0.15-0.2 32 12 — 3 95 95 — 95
0.21-0.25 46 21 42 15 95 80 95 95
0.26-0.3 57 16 29 22 95 . 95 .. 95 95
0.31-0.35 18 8 8 21 95 60 90 95
0.36-0.4 7 10 11 10 95 60 90 90
0.41-0.45 4 5 14 7 95 80 50 95
0.46—0.5 5 15 4 28 95 80 90 95
0.51-0.55 4 14 10 10 95 80 90 95
0.56-0.6 14 25 35 16 20 90 90 95
0.61-0.65 12 20 16 16 20 80 50 50
0.66-0.7 5 20 10 11 20 60 50 80
0.71-0.75 5 - 9 11 70 — 50 95
TABLE 15
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and the mean cell recovery and viability is presented in Figure 
7.
It is clear that each of the column fractions was capable of 
releasing individual cells and acini from the tissue during the 
digestion period . The greatest release of cells occurred when 
fractions eluating between K^y ^.2 and 0.3 were used . Although 
considerable numbers of cells were released using column 
fractions eluting between 0.55 and 0.65 it would appear from 
the dye exclusion results that considerable cell death had 
occurred .
Histological evidence suggests that the digestion solution 
was capable of maintaining normeüL tissue morphology throughout 
the period of digestion ( Photograph 9 ) . The use of 100 units 
per ml of a purified collagenase preparation ( Photograph 10 ) 
suggests that this enzyme was capable of achieving islet 
isolation and that no gross signs of tissue dsunage were 
observed. In contrast histological evidence of tissue fragments 
partially digested with purified preparations of clotripain , or 
the three non-specific proteases ( Photographs 11,12,13 and 14 ) 
all show evidence of massive areas of non—disciminatory tissue 
damage .
Taken together these findings indicated that the use of a 
purified clostridial collagenase preparation was sufficient to 
effect tissue disaggregation and provided considerable advantages 
over the use of the crude collagenase enzyme complex.
The digestion procedure which evolved using this pure enzyme 
preparation was as follows.
The chopped tissue was washed with two changes of the
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digestion solution ( Appendix III ). It was then incubated in 
ten times the tissue volume with digestion solution in a conical 
flask containing between 400 and 600 Units per ml purified 
collagenase.During digestion the tissue was maintained at 37* C 
and constantly mixed using a rotary shaker oscillating at 60 
cycles per second.
The digestion was carried out in two stages . The first 
stage was limited to 30 minutes at which time the tissue could be 
seen to be breaking up. At the end of this period the tissue was 
allowed to settle for two minutes and the suspended tissue 
fragments were removed by decanting the digestion solution .The 
tissue fragments were harvested and washed using RPMI 1640 to 
remove the digestion solution by centrifugation at 500 g for 5 
minute periods .
A second digestion was carried out using a fresh enzyme 
solution . The second digestion was allowed to continue until 
it was considered that complete tissue disaggregation had 
occurred i.e. only a minimal amount of tissue fragments was not 
in suspension . The time taken to achieve this degree of 
disaggregation varied considerably . In some cases disaggregation 
was complete after 15 minutes of the second digestion however 
occasionally pancreatic tissue proved resistant to complete 
^^®P®^sal even after 30 minutes in which case recourse was made 
to gentle pipetting to disaggregate the remaining tissue using a 
wide bore movette pipette ( Flow Laboratories).This disaggregated 
tissue was again harvested and washed with RPMI 1640 using 
centrifugation at 500g for 5 minutes .
One point relating to the digestion process is of note.In
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early studies there was a propensity for the disaggregating 
pancreatic tissue to form clumps due to the formation of a mucoid 
substance during the digestion period. A similar type of mucoid 
formation is a well recognized consequence of tryptic digestion 
( Waymouth 1974 ) and is thought to be caused by spindle
extrusion from cells damaged during 1±ie digestion. It has been 
reported that the formation of this mucoid substance can be 
prevented by adding DNAase during the digestion. It was found 
that soya bean tzypsin inhibitor had a similar effect but that 
at -1- antitrypsin ( a more general protease inhibitor extracted 
from human serum ) was notably more effective and was added 
during both stages of digestion at a concentration of 100
g / ml . We are aware of the reported inhibitory effect of
X  -1-antitrypsin on collagenolytic activity but in control studies 
no prolongation of the time needed to achieve tissue
disaggregation was noted .
Examination of the unfixed tissue using incidental 
illumination of the disaggregate against a black background 
( Photograph 15 ) showed what would appear to be islets .
Histology of these presumed islets confirmed the endocrine 
type nature of the cells within these structures ( Photograph 16).
For completeness Photographs 17 and 18 are presented to
show the histological appearance of the dispersed pancreatic 
tissue at the end of enzymatic disaggregation and harvesting . >,
It now remains to evaluate the recovery and viability of 
this disaggregated tissue using the criteria developed on normal 
human adult pancreatic tissue developed in Chapter 4 .1 .
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Pancreatic disaggregate - incidental light 
Magnification X 10 
PHOTOGRAPH 15
Isolated Islets 
Haemotoxylin & Eosin Magnification X 250
PHOTOGRAPH 16
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Disaggregated human pancreas 
Haematoxylin & Eosin Magnification X 20 
PHOTOGRAPH 17
&
Disaggregated human pancreas 
Haematoxylin & Eosin Magnification X 200 
PHOTOGRAPH 18
4.3 RECOVERY OF HUMAN PANCREATIC TISSUE AND ENDOCRINE FUNCTION 
In twelve experiments weighed random aliquots of the chopped 
pancreatic tissue were subjected to enzymatic disaggregation 
exactly as described above .
Complete disaggregation occured in each case and the 
harvested tissue was washed , weighed and the tissue insulin 
content was estimated as described ( Appendix II ).
These results are presented below in Table 16.
RECOVERY OF PANCREATIC TISSUE AND INSULIN CONTENT
Exper­
iment
No.
Original wt. 
of tissue 
gm.
Wt. of 
Disaggregate 
gm.
% Tissue 
Recovery
Insulin content 
of disaggregate 
ng/g/tissue
1 5.156 3.916 75.9% 204,602
2 4.927 3.947 79.9% 30,000
3 1.731 1.123 64.9% 90,000
4 1.436 0.995 69.4% 107,388
5 1.848 1.442 76.9% 76,000
6 1.662 0.988 59.4% 98,604
7 2.814 1.557 55.3% 184,000
8 2.499 1.660 66.5% 31,000
9 2.637 1.854 70.0% 640,000
10 7.635 5.865 76.8% 18,500
11 4.085 3.212 78.6% 26,480
12 4.162 2.448 59.8% 135,530
Mean 3.383 2.416 69.4% 136,842
TABLE 16
Thus on average we recovered 69.4% of the tissue by weight 
with a range of 55.3 % to 79.9 % recovery over the 12 samples 
used . The mean recovery of the insulin content of this 
disaggregated tissue was found to average 136,842 ng/g/tissue 
which was not significantly different T = 23 using the Whitney 
Mann rank order correlation coefficient ) from the value obtained
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with fresh normal tissue •
It was then necessary to evaluate the remaining endocrine 
function of this pancreatic disaggregate using the periperfusion 
design presented in chapter 4.1 .
In a further 12 experiments randomly sampled aliquots of 
chopped pancreatic tissue averaging 2 g in weight were digested 
as above . The recovered tissue was washed , weighed and then 
gently introduced into the periperfusion system . Glucose 
challenges were carried out exactly as described for the chopped 
tissue fragments ( chapter 4.1 ). The results of these 
periperfusions are presented in Table 17 and Figue 8 .
GLUCOSE CHALLENGE ON ENZYMATICALLY DISAGGREGATED PANCREAS
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These results clearly indicate that a sustained IRI release 
occurred during the periperfusion and that this was potentiated 
in response to elevated glucose levels. In terms of the rate of 
IRI release this was comparable to chopped but non-digested 
tissue.
The conclusion must be that on average 69% of the IRI 
content of the pancreas was recovered following disaggregation 
and that following the criteria developed during periperfusion 
studies the endocrine function would appear to have been 
preserved.
SUMMARY and CONCLUSIONS ,
In the studies on normal human pancreatic tissue the most 
striking finding was the extreme variation in the IRI content 
between individusü. whole pancreas (table 6).
This finding is not confined to this study . The reported 
mean and standard deviation of the insulin content of the normal 
human pancreas ( 140,000 - 120,000 , Sutherland 1975 ) and the 
mean and standard error of the rat pancreas ( 84,000 — 24,000 ,
Lazarow 1973 ) would suggest similar between sample variations. 
The findings of Maitland (1980) of a similar between sample 
variation in age matched foetal pancreas may even indicate that a 
genetic predisposition towards this varied distribution exists.
This extreme variation ( although previously ignored ) may 
have important implications. It would suggest that some ( perhaps 
10—20 % ) of individuals may have an enormous insulin reserve or 
that conversely a larger percentage may be predisposed towards 
certain types of diabetes i.e. NIDDM .
The within assay precision of estimating IRI content has
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been shown (Appendix IV) to be accurate to within - 3% to which 
should be added possible errors in dilution.. The constancy in 
tissue and amylase content of the whole pancreas ( table 6 )
suggests that errors in dilution did not introduce significant 
errors in the estimation of tissue IRI levels
The recovery experiment carried out using adjacent portions 
of the pancreas (Table 7) indicates that the methodology used to 
extract IRI content was reasonably accurate with an overall 
recovery of 96.7% . The individual recoveries however veuried 
considerably . It therefore follows that the sometimes large 
discrepancies in individual IRI levels in Table 7 could only have 
arisen from within tissue variations in the IRI content.
In view of this large between and within tissue variation it 
is perhaps not surprising that the periperfusion studies should 
also exhibit a wide variation in non-stimulatory IRI release .
It was established using constant non-stimulatory levels of 
glucose that criteria needed to be established in order to
provide a reproducible and reliable estimate of the released IRI 
activity .
It was important to establish criteria in deciding which 
parameters would be indicative of 'viable' islet tissue . Perhaps 
the only valid criteria which could be argued to apply was that 
the tissue had retained its normal secretory potential in
response to its main secretagogue glucose. This means that as in 
vivo the tissue being periperfused should show a constant IRI
release in response to non stimulatory glucose and a potentiated 
and sustained increase in response to stimulatory levels of
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glucose .
As can be seen from the constant non-stimulatory glucose 
periperfusion of chopped normal human pancreas ( Table 9 ) there 
was (as in reported periperfusions using rodent pancreas ) an 
initial surge in IRI release over the first 30 to 40 minutes 
lodinated insulin degradation and damage to or loss of avidity 
within the antibody-label complex ( Tables 10 &.11 ) during the 
first 30 to 40 minutes suggested that measurements during this 
period were inaccurate and should be disregarded.
In 9 out of 11 pancreas periperfused with non-stimulatory 
levels of glucose (Table 9) the IRI release remained reasonably 
constant between 40 and 100 minutes . Glucose challenges carried 
out during this period using alternate low and h i ^  glucose 
concentrations ( Table 12 ) showed that in 9 out of 12
experiments the dynamic aspects of IRI release paralleled the 
known in vito response of islet tissue and therefore satisfied 
the criteria for viability above.
It remains unknown why in 75 % of periperfusions the tissue 
failed to satisfy the criteria for viability . It may be that 
these tissue preparations may have differed in their endogenous 
zymogen or enzyme components or that even the relatively short 
ischaemic times may have damaged the tissue .
What is clear from Figure 4 is that diminuition of IRI 
release could be shown with all tissue with cold ischaemic times 
of 6 hours or more , and that no totally successful way was found 
to fully preserve islet function after this time.
The consequence of these findings is that one has to exercise 
extreme care in the evaluation and selection of human pancreatic
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tissue for both experimental and possible transplantation 
studies. Pancreatic tissue has been shown to differ in IRI 
content by as much as 2,000 % in its initial IRI content . In 
addition the failure to demonstate the viability of 25% of these 
pancreas even under the controlled conditions of this study must 
raise grounds for concern . These findings serve to reinforce the 
aims of this thesis in trying to establish criteria predictive of 
successful islet isolation .
The development of a periperfusion system measuring the 
dynamic aspects of IRI release in response to alterations in 
glucose concentration allowed us to define the parameters against 
which to test the remaining endocrine function following the 
disaggregation procedures proposed.
Several areas of the digestion procedures have been 
critically examined . From these findings it was concluded that 
the use of the Mcllwain tissue chopper ,intra-venous distention 
and digestion with a fairly high level of the enzyme or enzymes 
exhibiting only collagenolytic activity ( K^^0.13 to K^^O.35 ,
Figure 6 ) together with a trypsin inhibitor appeared to offer 
considerable advantages both in terms of the degree of tissue 
disaggregation and the apparent viability of the cells and cell 
aggregates released .
We are aware of the report by Traverso (1978) that a 
commercially available collagenase preparation ( purified by 
affinity chromatography ) was totally ineffective in digesting 
canine pancreatic fragments . I find it difficult to understand 
or explain this discrepancy . In this study the collagenolytic
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components of clostridial collagenase was the sole factor 
necessary in achieving disaggregation of the human and as Chapter 
5 shows was equally effective in dealing with the canine 
pancreas. It may be that our use of a more concentrated enzyme 
preparation could partly explain this difference in results or 
that their use of a different separation technique resulted in a 
less effective enzyme preparation. One further explanation may be 
that as Traverso (1978) demonstrates ,the use of purified 
collagenase fails to activate endogenous enzyme activity which 
suggests that a measure of 'controlled* autolysis may be a 
necessary factor in their disaggregation procedure.
Following disaggregation with pure collagenase an average of 
69 % of the pancreatic tissue weight was recovered . Islet tissue 
would appear to have been preserved for no significant difference 
was found in the IRI content of the disaggregated tissue ( Table 
16 ).
Finally periperfusion procedures were used to establish the 
viability of islet tissue following disaggregation .
A total of 12 periperfusions on disaggregated pancreas were 
carried out ( Table 17 ). One periperfusion failed to exhibit any 
potentiated IRI release ' in response to elevated glucose 
suggesting that the tissue was or had become non-viable. In the 
remaining 11 periperfusions sustained potentiated IRI release was 
demonstrable in 7 periperfusions ( 67% ) compared to 75% of 
periperfusions of chopped pancreas ( Table 12 ).
The conclusion must be therefore that the disaggregation 
procedures outlined are capable of providing a tissue preparation 
which has been shown to be viablity at least in the short term.
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Provided that criteria for assessing islet function are met 
the disaggregation procedures described are capable of providing 
viable islet tissue enabling its ^plication in transplantation 
studies to be carried out.
It remains to be established however whether this type of 
unseparated pancreatic disaggregate can be safely implanted or 
whether further islet separation techniques are needed to produce 
a 'safe' islet preparation.
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CHAPTER FIVE
CANINE AUTO-IMPLANTATION OF UNSEPARATED DISAGGREGATE 
5.1 Introduction
It was decided to use the canine model to investigate
whether the disaggregation technique ( chapter 4 ) was equally
effective when desJ.ing with the dog pancresis .
If this was so then it was also intended to use the dog
model to investigate whether this type of unseparated pancreatic
preparation could be safely infused and to evaluate its effect in 
restoring carbohydrate control.
It can also be argued that the outcome of attempts to 
implant this type of preparation in the canine model may be 
predictive of outcome following human implantation.
5.2 Experimental Procedures .
Three groups of outbred mongrels were used of between 10 
and 20 kg in weight .
Group I
Seventeen dogs were used to establish normal fasting levels 
of plasma glucose , insulin and glucagon. In addition fasting 
IVGTT's were carried out under sodium pentobarbitone anaethesia 
following cannu 1 at ion of tiie jugular vein and injection ( as a 
50% dextrose solution ) of a bolus, of 500 mg glucose per kg body 
weight ( Bewick 1976 ). Blood samples were collected into sodium 
flouride tubes for glucose and lildiium heparin tubes containing 
10,000 KI units aprotinin for insulin and glucagon estimations. 
The supernatant was separated by centrifugation and stored at 
— 20*0 sus collected ,
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Group II
Ei^t dogs underwent total pancreatectomy . Post-operative
daily fasting plasma insulin and glucose levels were raeaiured and
the dogs weight was closely monitored. All pancreatectomized
dogs were given 6 Pancrex V forte tablets ( Pabiyn Ltd, ) before 
meals.
Group III
Nine dogs were subjected to total pancreatectomy . The 
excised pancreas was disrupted by intra-venous distention , 
chopped using the Me Ilwain tissue chopper and digested following 
the procedures outlined in chapter 4 . The dispersed pancreatic 
tissue was harvested and washed three times ( to avoid 
introducing free insulin and enzymes contained in the supernatant ) 
by centifugation at 500 g for 5 minutes intervals. The disaggre­
gate was resuspended in between 100 and 150 ml of RPMI 1640 
culture media . This mass was then infüsed over a ten minute 
period into a branch of the superior mesenteric vein of one dog 
and into the splenic artery in the remaining eight dogs between 
90 and 120 minutes following pancreatectomy . No attempt was made 
to interupt the venous effluent from the spleen and therefore 
prevent the passage of cells into the portal circulation .
Portal vein pressure was measured using an intra-portal 
catheter connected by a manometer line to a high fidelity 
pressure transducer ( Model SE 4.82) and monitored using arir' 
multichannel recorder ( Model SF 4001 ) , both supplied by 
Electro — Medical Instruments Ltd.•
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Pancreatic disaggregate - incidental light 
Magnification X 10 
PHOTOGRAPH 15
Isolated Islets 
Haemotoxylin & Eosin Magnification X 250 
PHOTOGRAPH 16
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Disaggregated human pancreas 
Haematoxylin & Eosin Magnification X 20 
PHOTOGRAPH 17
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Disaggregated human pancreas 
Haematoxylin & Eosin Magnification X 200 
PHOTOGRAPH 18
4.3 RECOVERY OF HUMAN PANCREATIC TISSUE AND ENDOCRINE FUNCTION 
In twelve experiments weighed random aliquots of the chopped 
pancreatic tissue were subjected to enzymatic disaggregation 
exactly as described above .
Complete disaggregation occured in each case and the 
harvested tissue was washed , weighed and the tissue insulin 
content was estimated as described ( Appendix II ).
These results are presented below in Table 16.
RECOVERY OF PANCREATIC TISSUE AND INSULIN CONTENT
Exper­
iment
No.
Original wt. 
of tissue 
gm.
Wt. of 
Disaggregate 
gm.
% Tissue 
Recovery
Insulin content 
of disaggregate 
ng/g/tissue
1 5.156 3.916 75.9% 204,602
2 4.927 3.947 79.9% 30,000
3 1.731 1.123 64.9% 90,000
4 1.436 0.995 69.4% 107,388
5 1.848 1.442 76.9% 76,000
6 1.662 0.988 59.4% 98,604
7 2.814 1.557 55.3% 184,000
8 2.499 1.660 66.5% 31,000
9 2.637 1.854 70.0% 640,000
10 7.635 5.865 76.8% 18,500
11 4.085 3.212 78.6% 26,480
12 4.162 2.448 59.8% 135,530
Mean 3.383 2.416 69.4% 136,842
TABLE 16
Thus on average we recovered 69.4% of the tissue by weight 
with a range of 55.3 % to 79.9 % recovery over the 12 samples 
used . The mean recovery of the insulin content of this 
disaggregated tissue was found to average 136,842 ng/g/tissue 
which was not significantly different T = 23 using the Whitney 
Mann rank order correlation coefficient ) from the value obtained
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with fresh normal tissue •
It was then necessary to evaluate the remaining endocrine 
function of this pancreatic disaggregate using the periperfusion 
design presented in chapter 4.1 .
In a further 12 experiments randomly sampled aliquots of 
chopped pancreatic tissue averaging 2 g in weight were digested 
as above . The recovered tissue was washed , weighed and then 
gently introduced into the periperfusion system . Glucose 
challenges were carried out exactly as described for the chopped 
tissue fragments ( chapter 4.1 ). The results of these 
periperfusions are presented in Table 17 and Figue 8 .
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These results clearly indicate that a sustained IRI release 
occurred during the periperfusion and that this was potentiated 
in response to elevated glucose levels. In terras of the rate of 
IRI release this was comparable to chopped but non-digested 
tissue.
The conclusion must be that on average 69% of the IRI 
content of the pancreas was recovered following disaggregation 
and that following the criteria developed during periperfusion 
studies the endocrine function would appear to have been 
preserved.
SUMMARY and CONCLUSIONS ,
In the studies on normal human pancreatic tissue the most 
striking finding was the extreme variation in the IRI content 
between individual whole pancreas (table 6).
This finding is not confined to this study . The reported 
mean and standard deviation of the insulin content of the normal 
human pancreas ( 140,000 ± 120,000 , Sutherland 1975 ) and the 
mean and standard error of the rat pancreas ( 84,000 — 24,000 ,
Lazarow 1973 ) would suggest similar between sample variations. 
The findings of Maitland (1980) of a similar between sample 
variation in age matched foetal pancreas may even indicate that a 
genetic predisposition towards this varied distribution exists.
This extreme variation ( although previously ignored ) may 
have important implications. It would suggest that some ( perhaps 
10—20 % ) of individuals may have an enormous insulin reserve or 
that conversely a larger percentage may be predisposed towards 
certain types of diabetes i.e. NIDDM .
The within assay precision of estimating IRI content has
116
been shown (Appendix IV) to be accurate to within - 3% to which 
should be added possible errors in dilution.. The constancy in 
tissue and amylase content of the whole pancreas ( table 6 )
suggests that errors in dilution did not introduce significant 
errors in the estimation of tissue IRI levels
The recovery experiment carried out using adjacent portions 
of the pancreas (Table 7) indicates that the methodology used to 
extract IRI content wais reasonably accurate with an overall 
recovery of 96.7% . The individual recoveries however varied 
considerably . It therefore follows that.the sometimes large 
discrepancies in individual IRI levels in Table 7 could only have 
arisen from within tissue variations in the IRI content.
In view of this large between and within tissue variation it 
is perhaps not surprising that the periperfusion studies should 
also exhibit a wide variation in non-stimulatory IRI release .
It was established using constant non-stimulatory levels of 
glucose that criteria needed to be established in order to
provide a reproducible and reliable estimate of the released IRI 
activity .
It was important to establish criteria in deciding which 
parameters would be indicative of 'viable' islet tissue . Perhaps 
the only valid criteria which could be argued to apply was that 
the tissue had retained its normal secretory potential in
response to its main secretagogue glucose. This means that as in 
vivo the tissue being periperfused should show a constant IRI
release in response to non stimulatory glucose and a potentiated 
and sustained increase in response to stimulatory levels of
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glucose .
As can be seen from the constant non-stimulatory glucose 
periperfusion of chopped normal human pancreas ( Table 9 ) there 
was (as in reported periperfusions using rodent pancreas ) an 
initial surge in IRI release over the first 30 to 40 minutes 
lodinated insulin degradation and damage to or loss of avidity 
within the antibody-label complex ( Tables 10 &,11 ) during the 
first 30 to 40 minutes suggested that measurements during this 
period were inaccurate and should be disregarded.
In 9 out of 11 pancreas periperfused with non-stimulatory 
levels of glucose (Table 9) the IRI release remained reasonably 
constant between 40 and 100 minutes . Glucose challenges carried 
out during this period using alternate low and h i ^  glucose 
concentrations ( Table 12 ) showed that in 9 out of 12
experiments the dynamic aspects of IRI release paralleled the 
known in vito response of islet tissue and therefore satisfied 
the criteria for viability above.
It remains unknown why in 75 % of periperfusions the tissue 
failed to satisfy the criteria for viability . It may be that 
these tissue preparations may have differed in their endogenous 
zymogen or enzyme components or that even the relatively short 
ischaemic times may have damaged the tissue .
What is clear from Figure 4 is that diminuition of IRI 
release could be shown with all tissue with cold ischaemic times 
of 6 hours or more , and that no totally successful way was found 
to fully preserve islet function after this time.
The consequence of these findings is that one has to exercise 
extreme care in the evaluation and selection of human pancreatic
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tissue for both experimental and possible transplantation 
studies. Pancreatic tissue has been shown to differ in IRI 
content by as much as 2,000 % in its initial IRI content . In 
addition the failure to demonstate the viability of 25% of these 
pancreas even under the controlled conditions of this study must 
raise grounds for concern . These findings serve to reinforce the 
aims of this thesis in trying to establish criteria predictive of 
successful islet isolation .
The development of a periperfusion system measuring the 
dynamic aspects of IRI release in response to alterations in 
glucose concentration allowed us to define the parameters against 
which to test the remaining endocrine function following the 
disaggregation procedures proposed.
Several areas of the digestion procedures have been 
critically examined . From these findings it was concluded that 
the use of the Mcllwain tissue chopper ,intra-venous distention 
and digestion with a fairly high level of the enzyme or enzymes 
exhibiting only collagenolytic activity ( K^^O.13 to K^^O.35 ,
Figure 6 ) together with a trypsin inhibitor appeared to offer 
considerable advantages both in terms of the degree of tissue 
disaggregation and the apparent viability of the cells and cell 
aggregates released .
We are aware of the report by Traverso (1978) that a 
commercially available collagenase preparation ( purified by 
affinity chromatography ) was totally ineffective in digesting 
canine pancreatic fragments . I find it difficult to understand 
or explain this discrepancy . In this study the collagenolytic
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components of clostridial collagenase was the sole factor 
necessary in achieving disaggregation of the human and as Chapter 
5 shows was equally effective in dealing with the canine 
pancreas. It may be that our use of a more concentrated enzyme 
preparation could partly explain this difference in results or 
that their use of a different separation technique resulted in a 
less effective enzyme preparation. One further explanation may be 
that as Traverso (1978) demonstrates ,the use of purified 
collagenase fails to activate endogenous enzyme activity which 
suggests that a measure of 'controlled' autolysis may be a 
necessary factor in their disaggregation procedure.
Following disaggregation with pure collagenase an average of 
69 % of the pancreatic tissue weight was recovered . Islet tissue 
would appear to have been preserved for no significant difference 
was found in the IRI content of the disaggregated tissue ( Table 
16 ).
Finally periperfusion procedures were used to establish the 
viability of islet tissue following disaggregation .
A total of 12 periperfusions on disaggregated pancreas were 
carried out ( Table 17 ). One periperfusion failed to exhibit any 
potentiated IRI release ' in response to elevated glucose 
suggesting that the tissue was or had become non-viable. In the 
remaining 11 periperfusions sustained potentiated IRI release was 
demonstrable in 7 periperfusions ( 67% ) compared to 75% of 
periperfusions of chopped pancreas ( Table 12 ).
The conclusion must be therefore that the disaggregation 
procedures outlined are capable of providing a tissue preparation 
which has been shown to be viablity at least in the short term.
120
Provided that criteria for assessing islet function are met 
the disaggregation procedures described are capable of providing 
viable islet tissue enabling its application in transplantation 
studies to be carried out.
remains to be established however whether this type of 
unseparated pancreatic disaggregate can be safely implanted or 
whether further islet separation techniques are needed to produce 
a 'safe' islet preparation.
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CHAPTER FIVE
CANINE AUTO-IMPLANTATION OF UNSEPARATED DISAGGREGATE
5.1 Introduction
It was decided to use the canine model to investigate 
whether the disaggregation technique ( chapter 4 ) was equally 
effective when dealing with the dog pancreas •
If this was so then it was also intended to use the dog 
model to investigate whether this type of unseparated pancreatic 
preparation could be safely infused and to evaluate its effect in 
restoring carbohydrate control.
It can also be argued that the outcome of attempts ta 
implant this type of preparation in the canine model may be 
predictive of outcome following human implantation.
5.2 Experimental Procedures .
Three groups of outbred mongrels were used of between 10 
and 20 kg in weight .
^aroupJL
Seventeen dogs were used to establish normal fasting levels 
of plasma glucose , insulin and ^ucagon. In addition fasting 
IVGTT's were carried out under sodium pentobarbitone anaethesia 
following cannulation of ttie jugular vein and injection ( as a 
50% dextrose solution ) of a bolus of 500 mg glucose per kg body 
weight ( Bewick 1976 ). Blood samples were collected into sodium 
flouride tubes for glucose and litiiium heparin tubes containing 
10,000 KI units aprotinin for insulin and glucagon estimations. 
The supernatant was separated by centrifugation and stored at 
— 20*C as collected .
122
GLUCOSE CHALLENGE ON DISAGGREGATED CANINE PANCREAS
240-
-  200 
3
(D
3IQ
>
160
120-
80-
40-
LOW_
GLUCOSE ■ X
H IG H
GLüCOSc - X
LOW
GLUCOSE
mean 
±. mean déviai ton
■r r r r ' r T r r - i - i g i  i . , '^^1 1 I i i i i
MINUTES
FIGURE 10
Group II
Eight dogs underwent total pancreatectomy . Post-operative
daily fasting plasma insulin and glucose levels were m e a ^ d  and
the dogs weight was closely monitored. All pancreatectomized
dogs were given 6 Pancrex V forte tablets ( Pabryn Ltd. ) before 
meals.
Group III
Nine dogs were subjected to total pancreatectomy . The 
excised pancreas was disrupted by intra-venous distention 
chopped using the Me Ilwain tissue chopper and digested following 
the procedures outlined in chapter 4 . The dispersed pancreatic 
tissue was harvested and washed three times ( to avoid 
introducing free insulin and enzymes contained in the supernatant ) 
by centifugation at 500 g for 5 minutes intervals. The disaggre­
gate was resuspended in between 100 and 150 ml of RPMI 1640 
culture media . This mass was then infused over a ten minute 
period into a branch of the superior mesenteric vein of one dog 
and into the splenic artery in the remaining eight dogs between 
90 and 120 minutes following pancreatectomy . No attempt was made 
to interupt the venous effluent from the spleen and therefore 
prevent the passage of cells into the portal circulation .
Portal vein pressure was measured using an intra-portal 
catheter connected by a manometer line to a high fidelity 
pressure transducer ( Model SE 4.82) and monitored using air* 
multichannel recorder ( Model SF 4001 ) , both supplied by 
Electro — Medical Instruments Ltd..
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DAILY PLASMA GLUCOSE LEVELS M MOL / L
Days following implantation
DOG 1 2 3 4 5 6 7 8 9 10 12
AAl 21.3 24.8 28.0 *
AA2 21.8 - - 26.3 27.4 25.6 30.2 31.4 . - 35.6 ♦
AA4 23.5 23.5 21.8 — — 40.3 *
AA21 17.9 - — 23.5 25.8 ♦
AA22 21.3 - — 21.8 23.5 — 24.6 »
AA26 20.2 22.4 23.5 — — 33.6 35.8 24.9 ♦
AA27 17.4 22.4 20.2 35.8 *•
AA28 16.0 20.7 21.3 — — 28.0 42.0 ♦
' 'AEMl 19.9 22.8 21.3 26.9 25.6 31.9 32.5 _ 28.1 - 35.6
. 3.D. 2.6 1.5 3.8 6.3 2.0 6.6 6.6 - -
( * = died )
TABLE 18
SURVIVAL Arm '.VEIGIiT LOSS OF DEPANCREATISED DOIS
DOG
Plasma Glucose 
Before Death
Survival
Days
Pre-Op 
’Vt. (Eg)
v;t. at 
Death (Eg)
Daily V/t. 
Loss(Eg)
, \A1 28.0 3 - 13.0 10.3 0.73
AA2 35.62 12 12.0 8.5 0.29
AA4 40.32 6 10.0 7.8 0.37
AA21 25.76 7 20.0 15.5 0.54
AA22 24.62 7 15.0 10.5 0.64
AA26 24.62 9 16.0 13.0 0.33
AA27 35.84 4 15.0 10.5 1.13
AA28 42.0 7 9.5 7.0 0.36
MEAN 32.09 6.9 13.3 10.5 0.55
TABLE 19
%'.o.
Venous Distention of the Canine Pancreas 
Aldehyde - Fuchsin Magnification X 250
PHOTOGRAPH 19
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never recovered.
In the eight dogs which underwent implantation through the 
splenic artery the portal vein pressure was measured on four 
occasions ( Table 20 ) .
Dog
Pre—infusion Maximum pressure Post—inAision
pressure recorded ( 20 mins )
AA 25 6 12 7
AA 41 6 15 8
AA 42 11 31 9
AA 43 7 17 8
Mean 7.5 18.8 8S .D . 2.4 8.4 0.8
TABLE 20
All four dogs exhibited a transient and relatively mild 
degree of portal hypertension . It was considered unlikely that 
this level and duration of increased portal pressure would affect 
the subsequent recovery of tbeae dogs and portal pressure 
monitoring was discontinued in the rest of this series.
The post-operative course in iiiese eight dogs was 
complicated in that treatment was needed to correct the tendency
towards severe hjpoglycaemia and hypokalaemia .These values 
together with the estimated IRI activity are presented in table 
21 .
The most obvious feature of these results are the initial 
high IRI activit)^ measured in the first hour following- 
implantation .It may be that as in liie periperfusion studies
( chapter 4 ) these cc'uld be false high estimates due to factors
released from the tissue but this was not investigated . What is
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PLASr.?A GLUCOSE AND IRI ACTIVITY FOLLOVmC D-TLArrrATTHM
Pre—Operative 
Pre—Infusion 
Pos t-Infusion
(
0
30
60
90
120
150
ISO
210
240
270
330
mins ) 
30 
— 60 
90 
-  120
- 150
- 180 
-  210
- 240
- 270
- 300
- 360
Plasma Glucose 
Levels ( m Mol/ L )
Mean S.D n
5.03
10.27
0.35
3.3
7
8
3.89 3.98 4
9.46 5.29 5
7.32 3.32 5
5.88 2.16 5
5.66 3.84 4
3.16 1.3 5
1.25 0.16 4
— —
All animals receiving 
parenteral dextrose 
( see text )
TABLE 21
Plasma Insulin
Mean S.D
/ m 
n
12.3 8.2 7
3.0 2.6 4
484.0 326.0 4
162.7 36.3 5
41.7. 16.3 4
39.8 11.3 5
35.9 12.7 4
16.2 6.2 4
15.0 6.6 4
11.3 9.6 3
10.5 7.1 5
3.5 10.6 3
7.9 4.4 6
TTRSITR TT.IPT.AWTtTTnM
DOG Survival
(days)
Outcome Cause of
Death
3B1
BB2
AA42
AA43
AA45
AA46
3B3
334
0
0
10
12
0
1
5
0
Died
Died
Despatched
Despatched
Died
Died
Despatched
Died
No obvious cause
Massive internal 
Haemorrhage 
Severely jaundiced
Weight loss ,infected, 
generally unwell 
No obvious cause
Massive internal 
Haemorrhage 
J aundiced,gener­
ally unwell 
Massive internal 
Haemorrhage
table 22
clear is that this apparent high IRI activity although 
immunologically active in the radio-immunoassay would appear to 
be in a biologically inactive form i.e. pro-insulin or one of its 
derivatives . In the normal animal levels of insiil -in such as this 
would initiate an extremely rapid fall in the blood glucose 
levels which clearly did not occur .
This was clearly not the case two to three hours later . In 
the presence of falling IRI levels of activity the plasma glucose 
level fell precipitatously . In the case of three dogs ,to below 
the level which is known to produce hypoglycaemic ccxna. In two 
dogs the rate of decline in plasma glucose was estimated at 
three hours following implantation to be 9.13 and 11.17 m Mol / L 
over a 30 minute period , equivalent to a loss of between 325 and 
400 mg of glucose per kg body weight per hour.
In an attempt to prevent these events over the immediate 
post-operative period , between between 100 and 250 g of a 20% 
dextrose solution and between 1.5 and 4.2 g of potassium
chloride was slowly infused between three and six hours following 
implantation .
The recovery and survival of these eight dogs proved 
disappointing ( Table 22 ).
Four dogs died during the first night, one died during the 
second night and the remaining three were depatched for humane 
reasons at 5 , 10 and 12 days , each with grossly elevated olasma 
Sl^cose levels although each had evidence of insulin secretion 
( Table 23 ).
Necropsy was can'ied out on all animals. Of the five dogs 
which died within 24 hours the spleen in all cases was contracted
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POST-OPERATIVE DAILY BLOOD SUGAR AND INSULIN LEVELS
Plasma
Levels
Glucose 
M Mol/L
Plasma Insulin 
Levels U/ml
Days post­
implantation AA42 AA43 AA46 BB3 AA42 AA43 AA46 BB3
1 18.8 12.9 6.3 5.0 4 10.5 11 1
2 - 15.7 ♦ 16.2 4 » —
3 - - - . 5 23
4 18.6 — — 6
5 20.2 - — 5 5 36
6 21.3 24.1 * 7 4 ♦
7 22.2 24.6 12.5 5.5
3 22.0 26.9 21 9.5
9 20.8 22.0 12 8
10 - 22.0 42
11 24.0 * 21 *
12 24.3 26
( * = died )
TABLE 23
POST-OPERATIVE BLOOD COAGULATION FACTORS
Prothrombin Time 
n=4
i
Kaolin-cephsü-in 
Time n=4
Platelet 
Count X 10
Time
Mean S.D Mean S.D. Mean S.D.
Pre-
Implantation 9
(range
1.2
8-10)
20.5
(range
2:1
18-23)
232 68 
(range 179-329)
Post-implan­
tation (mins) 
60 15
(range
2.6
12-18)
37.3
(range
7.7
30-48)
55 13 
(range 37-67)
120 16.5
(range
3.7
12-20)
36.3 
(range
7.8
29-46)
94 40 
(range 54-147)
180 17
(range
4.2
14-20)
42.0
(range
5.7
38-46)
84 44 
(range 53-115)
240 18 5.7 
(range 14-22)
42.5
(range
10.5
28-57)
93 59 
(range 51-134)
300 20.5 3.5 
(range 18-23)
34.5
(range
13.4
25-44)
65 16 
(range 54-77)
TABLE 24
to between 1/2 and 3/4 of its pre-operative size but this is a 
well recognized consequence of the agonal state.
There was no macroscopic evidence of occlusion to either 
large or small arteries of the spleen . Histological examination 
of the spleen revealed a relatively normal tissue morphology 
( Photograph 21 ). The one surprising finding was the almost 
complete absence of pancreatic fragments and only 3 out of 20 
histological sections provided evidence of pancreatic tissue 
remaining within the vasculature of the spleen ( Photograph 22 ). 
The conclusion must be drawn that either these pancreatic 
fragments failed to lodge within the arterial and sinusoidal 
network or failed to survive in this site.
No abnormalily was noted in any other organ with the 
exception of the liver which in all cases was cream coloured and 
friable. Microscopic examination revealed that severe cellular 
necrosis had occurred ( Photogrsq)hs 23 & 24 ) the cause of which 
remains unknown .
Of more serious concern was the finding that despite care in 
ensuring haemeostasis following pancreatectomy three dogs died as 
a result of massive haemorrhage arising from the site of the 
excised pancreas.
The death of the first dog and the protracted bleeding from 
the site of wound closure led us to suspect that a clotting 
disorder similar to intravascular coagulation had occurred.
This problem was investigated in four subsequent dogs by 
measuring the prothrombin (PT) time , kaolin-cephalin (KCT) time 
and the platelet count both before and following implantation. 
These results are presented in Table 24 .
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Haemostasis can be considered as an ongoing process which is 
dependent upon vascular integrity, platelet count and the 
coagulation plasma proteins as well as the inhibitors and 
thrombolytic factors which maintain the balance of this system. 
The process of coagulation can be accelerated by either vascular 
damage or by thrombogenic substances within the bloodstream which 
over-ride the ability of inhibitors to maintain haemeostasis.
When intravascular coagulation is accelerated there is a 
decline in some of these clotting factors ( notably platelets and 
factors I , II and XII ) which can lead to severe and 
uncontrolled bleeding.
As can be seen ( Table 24 ) the implantation of pancreatic 
tissue was followed by an increase in PT from 9 to in excess of 
15 seconds an increase of KCT from 20.5 to betweeen 34.5 and 42.5 
secs, and a fsü.1 in platelet counts from 232 X 10^ to between 55 
and 94 X 10^ platelets / ml , which were sustained over at least 
six hours. This coagulatdon pattern is diagnostic of disseminated 
intravascular coagulation ( DIG ) having occurred although these 
studies do not of course elucidate the cause.
Further studies of this severe haematological dysfunction 
were carried out in conjunction with two associates and with the 
clinical haematology department of Guy's Hospital. This 
experimental evidence showing that components of the implanted 
pancreatic tissue was directly responsible for the onset of 
D.I.C. and suggestive evidence as to the cause of this 
dysfunction have been published ( Miller 1983) .
Of the four dogs which survived in excess of one day two had 
blood sugar levels within the normal range on the first post­
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operative day . One of these dogs died during the second postope­
rative night. Subsequently all dogs had elevated levels of plasma 
glucose not significantly different from the pancreatectomized 
animals ( Table 18 , page 121 ).
In each of these dogs increasing levels of fasting IRI 
activity were noted to in excess of normal fasting levels. What 
this means in terms of the level of restored pancreatic endocrine 
function remains unclear as we have no figures for IRI activity 
in control animals with a corresponding level of hyperglycaemia. 
Nevertheless it does indicate that some islets must have 
survived. Confirmation of this was provided by the histological 
demonstration of a few islet like structures and islet cells 
which stained with aldehyde fuchsin ( photographs 24 & 25 ) .
Summary and Conclusions
Attempts have been made to evaluate the quantitative and 
qualitative endocrine function contained within the ( non­
separated ) pancreatic disaggregate. In excess of 60% of the 
pancreatic tissue volume and 50% of the insulin secreting 
capacity was recovered following disaggregation .
Implantation of this volume of tissue into the portal vein 
was followed by a severe and fatal portal hypertension.
Of the other sites available the spleen would appear to 
offer certain advantages in that as in the normal anima.', insulin 
is secreted directly into the portal circulation . In addition 
splenic implantation following subcapsular ( Kretshmer 1977 ) and 
interstitial ( Mirkovitch 1976 ) implantation have proved
successful in the canine model. Reported instances of
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subcapsulai* haematomas, intrasplenic necrosis ,intraspleric 
cavitation and subcapsular perforations ( DuToit 1982 ) suggest 
that this approach could not be applied in attempts at clinical 
implantation . Even without these reported complications there is 
a certain reluctance on the part of the regional transplant team 
to even consider splenic capsular rupture ( personal 
communication ).
For this reason implantation in the canine model was carried 
out by infusion into the splenic artery . There were no s^pare’^t 
signs of damage to the splenic parenchyma . Considerable signs of 
cellular trauma were however shown to have occurred within the 
liver .It is possible that this trauma could have resulted from 
the limited degree of portal hypertension or the severe 
fluctuations in blood glucose during the first 20 hours following 
implantation. A more likely explanation is that cellular 
components of the implanted tissue may have produced this effect. 
The total splenic outflow drains directly into the liver and the 
effect of certain enzymes e.g. pronase ( Mills 1969 ) have 
been shown to exert a marked selective cytotoxic effect upon 
hepatocytes.
Implantation of the dispersed pancreatic disaggregate 
resulted in a marked increase in plasma IRI activity which was 
by the rapid disappearance of plasma glucose from the 
systemic circulation . Parenteral glucose was used in an attempt 
to prevent critically low levels of blood sugar but it is thought 
that hypoglycaemic coma may still have occurred and may have 
caused the death of the two dogs in which no other cause of death 
could be found.
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Implantation was also shown to be followed by severe intra­
vascular coagulation which is thought to have caused the massive 
bleeding diathesis which resulted in the death of three dogs.This 
problem has been reported and considered by two other groups who 
suggest that prophylactic treatment using aprotinin ( a trypsin / 
kallikrein inhibitor ) and systematic heparination can abrogate 
this haematological disorder . This was not investigated as 
evidence suggests that although the risk may be diminished it is 
not removed . Indeed , uncontrolled bleeding which eventually 
proved fatal has been reported in two patients who received 
aprotinin and anticoagulation therapy ( Mehigan 1980 and Toledo- 
Pereyra 1983 ).
Despite infusion of in excess of 60% of the original 
pancreatic tissue volume there was an apparent paucity of 
pancreatic tissue fragments within the spleen suggesting that 
very little tissue had survived in this site. In the three dogs 
which survived more than two days ,elevated levels of plasma 
glucose only slightly less than those of the pancreatectomized 
control group were recorded until death. In each dog however 
increasing plasma IRI activity to between 26 and 42^ U/ml were 
recorded . This would be in agreement with the studies of 
Mirkovitch (1976) which first indicated that endocrine function 
may take many days to recover sufficiently to restore 
normoglycaemic control .
In this study there is another possible explanation. In the 
normal animal the liver plays a major role both in carbohydrate 
control and insulin degradation by enzymes conveniently labelled
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as 'insulinases '. It is not known whether the observed hepatic 
damage and the probable loss of these enzymes may have affected 
these results.
It may be that the site of implantation was inappropriate. 
Kretschmer (1977) found implantation into the splenic artery to 
be ineffective in restoring normoglycaemia in three dogs with a 
mean survival of 13 days and a fasting level of hyperglycaeraia at 
death of 24.6 ra Mol / L . It is possible that as Kretschmer 
(1977) reported sub capsular implantation would have been more 
effective but the aim of this study was to eventually attempt to 
apply this technique in man and rupture of the splenic capsule 
could provide considerably risk.
In conclusion our experience indicates that implantation of 
this type of dispersed pancreatic tissue into the splenic 
vascularture was ineffective in influencing the diabetic state. 
In addition it represented an extremely hazardous procedure with 
serious life threatening consequences .
If islet cell implantation is to become a reality then it is 
our opinion that as in the rat model ,purified islets represent 
the only safe preparation and this must therefore be a 
prerequisite before attempts at clinical implantation can be 
justified.
Further results to be presented and continuing research into 
islet cell implantation have been carried out in the belief chat 
a relatively pure islets cell preparation is essential if the 
aims of a ’safe and effective ’ cure for the disease is to become 
a reality.
13.6
CHAPTER SIX 
TECHNIQUES OF ISLET ISOLATION
6.1 Introduction
From the results presented in the preceding chapter on 
auto—implantation in dogs it is obvious that implantation of 
unseparated disagregate is ill advised . There is no evidence to 
suggest that isolated islet implantation in man may be less safe 
than the experimental studies in rodents would indicate.
We therefore need to look at methods of isolating and 
implanting pure islet preparations . Experimental evidence in 
rodents suggests that pure islet preparations invoke no 
significant degree of hepatic damage or exert any thrombogenic 
influence upon the blood clotting mechanism following 
implantation .
In order to arrive at any measure of islet cell enrichment 
it is necessary to exploit factors which lead to either selective 
survival or selective harvesting of the cells of interest. 
As in animal studies several approaches are possible .Selective 
survival of islets and death of exocrine tissue in culture either 
with ( Matas 1976 ) or without ( Reemtsma 1980 ) non-endocrine 
tissue toxins are a possibility . Alternative approaches relate 
to differences in the physical properties of the desired cell 
population i.e. differences in density or cell size { Scharp 
1974 ), electrical membrane potential ( Matthews 1969 ) and
surface properties such as membrane adhesive factors ( Chick 
1977 ).
Alternatively some investigators have further fractionated
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islets into individual cells. Velocity sedimentation ,density 
centrifugation ( Piperleers 1981 ) and flourescent activated cell
f
sorting techniques ( Nielsen 1982 ) have been used to purify 
these individual cell lines and even reaggregation of the 
individual cells into islet like structures has been reported 
( Downing 1979 ). The yield of islet cells, fallowing disaggrega­
tion into single cell suspensions has however been extremely low 
which does not suggest that this approach could be applied to 
providing sufficient cells for transplantation studies. In 
addition there may be valid physiological reasons { i.e. the 
paracrine relationship between islet cells , page 13 ) why an
intact islet preparation is to be preferred.
Thus many techniques of cell separation have been used. 
Of the more obvious and readily available methods it is intended 
to investigate whether culture techniques or differences in 
density or size , or adhesive properties can be applied to arrive 
at a viable purified islet preparation.
6.2 Separation Techniques
6.2.1 Culture of dispersed pancreatic tissue
Standard tissue culture techniques were used to exsmiine the 
survival of non-separated pancreatic disaggregate.
Between 100 and 200^ 1 of the washed dispersate was placed 
in Multiwell tissue culture dishes ( Flow Laboratories ) and 4 ml 
of RPMI 1640 containing 10% foetal calf serum and 1% antibiotic— 
antimycotic solution was added. The wells were kept within a 
modular incubator ( Flow Laboratories ) which was gassed with 5% 
CO 2 in air under maximum humidity. The cultures were nourished by
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miT.TURES NON-SEPARATED PANCREATIC TISSUE,
IRI Content of the Culture Media m  U / ml
1 2
Days in culture
4 6 8
1.830 970 228 101 31
2.000 460 112 34 8
127 78 90 30 3
,225 76 57 15 5
610 115 81 16 3
360 125 46 9 3
1,700 410 107 42 11
1,700 1,290 360 42 9
410 95 53 11 5
610 200 10 2 0
Mean 947 382 114 30 8
S.D. 757 424 104 28 8
TABLE 25
exchanging two thirds of the culture media on the first and every 
subsequent 2 days of culture.
Culture of unseparated tissue was carried out on 10 separate 
occasions and in each case the B cell function would seem to be 
lost after a few days ( Table 25 ).
The amylase level of the culture media was 9.45-3.6 on day 
1 and fell to 4.372 2.1 and 1.152 0.85 on days 2 and 4 
respectively indicating the failure of exocrine components to 
survive.
Before discussing the measured IRI activity it is perhaps 
appropriate to briefly consider the criteria we are using to 
assess the survival of endocrine tissue under culture conditions.
In Chapter 4 it was argued that the only valid indicator of 
islet viability was a continuous IRI release under low glucose 
stimulation and a potentiated and sustained IRI release in 
response to elevated glucose levels under controlled conditions 
as in the periperfusion studies .
Several factors may combine to make this type of study 
inappropriate when dealing with cultured tissue . Islet tissue 
may attach to the surfaces of culture vessels and may be 
difficult to recover intact . Of more serious concern is the 
evidence that suggests that islet cells become degranulated 
during culture ( to be discussed more fully in Chapter 7 ) and
consequently the normal pattern of primary and secondary IRI 
secretion may not correlate directly with the volume or the 
viability of the cultured endocrine tissue.
In view of these problems in assessing the viability of 
islet tissue in culture it was considered that for the purpose of
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ADDITION OF APROTININ TO NON-SEPARATED DIGEST
Aprotinin IRI Concentration Of Culture Media
Conc.K.I.U. Day 1 Day 2 Day 4 Day 6 Day 8
0 743t 435 365 t 194 89 t 58 37 t 14 lit 2
1,000 1193 t 633 247 t 145 106 t 60 40 t 19 161 6
2,500 . 1307 t 531 517 t 180 299 t 133 1561 72 57 t 39
5,000 1243 Î 421 515 t 269 224 t 88 123 t 66 35 t 15
10,000 1405 t 615 385 Î 91 166 t 93 111 t 49 48 1 41
20,000 1227 Î 393 422 Î 101 303 t 273 88 t 89 421 35
( meant S.D., n=5 )
TABLE 26
the following experiments , continuing release of IRI into the 
tissue culture media would provide a direct indication that the 
islet tissue was surviving . In terms of the viability of islet 
tissue or its normal responsiveness to secretagogues it is of 
course necessary to investigate the dynamics of IRI release in 
response to high and low glucose levels. For this reason the
only valid assumption we can make at this time is that the rapid 
disapearance of IRI activity indicates that the tissue has become 
non-viable. Conversely as we are replacing 2/3 of the culture 
media every two days an increase in IRI levels to in excess of 
1/3 of the previous measurement indicates continued secretion and 
therefore continued cell viability .
Following culture of the non—separated disaggregate ( Table 
25 ) there was a 60% loss in IRI activity on day two followed
by a 70%, 73.7% and 74.2% decline on days 4,6 and 8 .This failure 
to demonstrate any de novo IRI secretion suggests that islets 
were failing to survive under these culture conditions. The 
addition of aprotinin to the culture media resulted in an 
increased measurement of IRI activity over the period of culture 
( Table 26 ) which appeared maximum at a concentration of above 
2,500 KlU/ml . It therefore seems likely that the rapid loss of 
IRI activity is due to released proteolytic activity in the 
culture media , the effect of which could be only partially 
prevented by the use of this proteolytic inhibitor.
These results suggested that culture of non—separated 
pancreatic disaggregate cannot be of use in arriving at 
sufficient islets to reverse diabetes following implantation.
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SEDIMENTATION VELOCITY OF DISAGGREGATED PANCREAS
30 % Percoll
figure 11
DENSITY CENTRIFUGATION OF DISAGGREGATED PANCREAS
PERCOLL
CONC.
30%
40%
50%
60%
75%
1.044
1.056
1.068
1.08
1.097
DENSITY
FIGURE 12
6.2.2 Density Centrifugation and Velocity Sedimentation
Many variations exist in the techniques available to 
separate cells on the grounds of either differences in size or 
density ( for a comprehensive review see Pretlow 1974 ) . All
however are dependent upon an aproximation to Stokes Law ;
d ( P, - Pi)
V= -------------  X g
18 n
where V= sedimentation rate d= diameter of the particle
Ç= particle density P= density of the liquid
n= viscosity of liquid g= gravitational force
On purely theoretical grounds velocity sedimentation and 
density separation are not entirely independent procedures. 
Although from the above equation it can be seen that sedimentation 
separates cells on the basis of both cell density and cell 
size. For most cell lines , size has been shown to be inversely 
proportional to cell density ( Cavalier-Smith 1978 ). Thus , 
sedimentation velocity separates cells mostly on the basis of 
particle size.
In the case of density centrifugation the sedimentation rate 
will tend towards zero as the particle density approaches the 
density of the media . Therefore density centrifugation ( or more 
accurately in the case of this study , isopycnic sedimentation ) 
separates cells on the basis of cell density .
Velocity sedimentation ( sü.though more usually performed on 
single cell preparations ) was carried out by layering 2ml 
aliquots of dispersed pancreatic tissue over 25 ml of an iso- 
osmotic Percoll solution ( see below ) with a density of 1.045 
( Buitrago 1977 ) and a surface area of 40 sq. cm ( Figure 11 ). 
At the end of 15 minutes the upper tissue layer and sedimented
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PERCOLL CENTRIFUGATION
Percol % Tissue Weight at each Interface Mean
Interface Exp.l Exp. 2 Exp. 3 Exp. 4 Exp. 5 Exp.6
100-75% 7.8 2.7 0 2.8 2.7 0 2.70
60-75% 20.4 8.9 14.5 17.7 8.9 1.4 11.97
50-60% 15.4 9.5 5.2 15.4 9.5 1.7 9.45
40-50% 34.1 54.1 11.2 14.9 54.1 22.6 31.83
30-40% 9.1 11.9 16.4 16.8 11.9 26.6 15.45
0-30% 13.2 12.9 52.3 32.5 12.9 48.7 28.75
TABLE 27
PERCOLL CENTRIFUGATION
Percol % Insulin Content at each Interface Mean
Interface Exp.l Exp. 2 Exp. 3 Exp.4 Exp. 5 Exp.6
100-75% 11.0 1.4 0 0 0.5 0 2.15
60-75% 21.4 10.6 0.4 16.7 8.1 8.6 10.97
50-60% 11.8 14.3 1.8 24.2 11.0 12.6 12.62
40-50% • 28.0 45.9 22.6 28.2 64.2 41.7 38.40
30-40% 9.3 12.6 26.6 10.1 8.9 14.6 13.68
0-30% 18.5 15.2 48.8 20.9 7.8 22.5 22.30
TABLE 28
PERCOLL CENTRIFUGATION
Percol Insulin Content at each Interface (ns/ff/tissue) MeanInterface Exp.l Exp.2 Exp.3 Exp.4 Exp.5 Exp.6
100-75%
60-75%
50-60%
40-50%
30-40%
0-30%
70,805
93,084
126,871
326,255
264,057
201,067
11,344
47,590
118,387
148,778
122,226
74,198
2,533
26,670
167,587
134,589
76,642
91,340
155,133
185,600
58,000
61,418
7,976
39,200
53,234
51,112
32,212
26,043
t1,429 
74,118 
184,513 
54,884 
/8,201
30,042
55,879
92,407
177,307
110,996
80,928
TABLE 29
tissue was removed , weighed and assayed for insulin content .
Measurement of the insulin content of the sedimented and 
non- sedimented tissue showed that while a fairly pure islet 
preparation was obtained , the yield of insulin containing tissue 
recovered in the sedimented tissue was extremely low , being
3.8 i 2.14 % of the total tissue insulin content . This low yield 
suggests that this technique would be unable to yield sufficient 
islets to warrant attempts at transplantation and therefore no 
further: studies were carried out .
Density Centrifugation ,
After adjustment of the Percoll with XIO concentrated Hanks 
solution to achieve an osmolality of 300 raOsm/kg , further 
dilutions using iso-osmotic Hanks solution were made to produce 
computed densities of between 1.044 and 1.097 . A discontinuous 
gradient was constructed by layering 3mls of each density within 
a 20 ml conical tube ( figure 12) . Following the preparation of 
the gradients 2 mis of washed digest was added and the tubes were 
centrifuged at 2,000 g for 20 minutes . Following centrifuga­
tion the tissue was seen to have separated at each interface into 
6 discrete bands .These layers were carefully collected , weighed 
and either assayed for insulin content or placed into culture
The tissue weight and insulin content ( expressed as a 
percentage ) of the tissue from each of these fractions are 
presented in Tables 27 and 28 .
The tissue fragments can be seen to have settled over the 
total range of densities used , with the greatest tissue volume 
( 75% ) being concentrated in the less dense layers . This of
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CULTURE OF PERCOLL SEPARATED TISSUE
Percoll IRI Concentration Of Culture Media
Interface 1 Day 2 Daya 4Daya 6 Days 8 Days
0 - 30 % 
30 - 40 % 
40 - 50 % 
50 - 60 % 
60 - 75 % 
75 - 100 %
782t 706 
576t 240 
718 t 329 
693 i 234 
79 ? 80 
8 t 9
196 t 94 
^02 t 65 
314^212 
271 t 38 
16 t 19 
4 t 6
501 21 
711 32 
193 t 111 
186 Î 39 
11 1 15 
3 + 3
20'! 18 
311 25 
137 t 109 
130 t 20 
2 1 2  
2 1 3
at 3 
131 6 
68 156 
113133 
2 1 3  
0 1 0
( Néant S.D. ; n = 6 )
TABLE 30
course means that ( unlike density centrifugation of rodent 
islets ) these human islet preparations will be grossly 
contaminated by non-endocrine components .
The total insulin content at each density ( Table 29 ) 
showed that IRI containing tissue could be recovered at each of 
the interfaces used and that whichever layer was selected a 
marked loss in endocrine tissue was inevitable.
The insulin content of the tissue sedimenting at each 
interface shows however that a degree of islet enrichment had 
occurred in some fractions.
The most IRI enriched tissue content ( 177,307 ng/g/tissue ) 
was shown to sediment at a density of between 1.056 and 1.068 . 
This layer contained 38.4% of the total insulin containing tissue 
and 31.83 % of the total tissue volume .
The tissue at each interface was cultured using the 
procedures outlined above . IRI release into the culture media 
is shown in Table 30 .
The rapid fall in IRI activity of tissue settling at 
densities of below 1.056 and above 1.08 suggests that it was or 
became non-viable during the period of culture . In contrast it 
can be seen that although a decrease in IRI activity in the
culture media was measured ,culture of the tissue at the
1.056/1.068 and 1.068/1.08 interfaces resulted in a level of IRI
release in excess of 30% of the previous measurement . The
conclusion must therefore be that continued IRI secretion 
occurred and therefore at least a proportion of the endocrine 
tissue was and remained viable during the period of culture . 
It is tempting to speculate that the components present in non—
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Insulin Content prier to and following filtration
Insulin content 
prior to 
filtration 
ng/g/tissue
Insulin content 
following 
filtration 
ng/g/tissue
Percentage
reduction
Exp.l 300,800 195,230 35.1
Exp.2 422,990 307,640 27.3
Exp.3 89,000 42,000 52.8
Exp.4 243,170 77,360 68.4
Exp.5 328,000 130,960 39.9
Exp.6 63,120 44,240 29.9
TABLE 31
STATIC GLUCOSE CHALLENGE 
( ng per initial gm tissue )
Low glucose High glucose Low glucose
Exp.l 350 226 225
Exp.2 116 607 235
Exp.3 112 110 25
Exp.4 200 260 120
Exp.5 225 244 116
Exp.6 133 310 125
Mean 189 293 141
S.D. 91 167 78
TABLE 32
separated dispersed pancreatic tissue responsible for the rapid 
cell death of endocrine tissue during culture ( Table 25 , page
135 ) may have been retained within the less or more dense
Percoll layers . This raises the possibility that this type of 
preparation might be safely implanted .
4.2.3 Cell adhesion
Although the mechanisms involved remain unclear it is known 
that certain cells will adhere to certain chemo-attractants such 
as collagen ( Postlethwaite 1978 ) , and fibrcnectin ( Gauss- 
Muller 1980 ).
The ability of human islets to preferentially adhere to such 
a surface was tested by filtering the washed pancreatic 
disaggregate through a collagen coated 1,000^# ™ nylon mesh ( as 
described in Appendix IV ) supported within a Sartorius filter 
vessel ( model SM—16-510 ). It was considered that a reliable 
estimate of the percentage of insulin containing tissue which 
adhered to the collagen filters could be obtained indirectly by 
measuring the insulin content of the disaggregated tissue prior 
to and following filtering . This showed that on average the 
filtered tissue insulin content was reduced frcxn a mean of 
241,163 to 132,905 ng/g/tissue following filtration ( Table 31 ) 
indicating that on average 42.2% of the endocrine tissue had 
been retained upon the filters .
Ethanol extraction of two of these filters confirmed that 
the insulin containing tissue had been retained on the nylon mesh 
with comparable IRI content to that of the loss from the filtered 
tissue .
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Examination of the coated nylon mesh ( Photographs 26 & 27 ) 
indicated that an almost pure preparation of islet tissue could 
be isolated .
The ability of these freshly isolated islet preparation to 
respond to alterations in glucose concentrations was tested by 3 
consecutive 30 minute incubations in the periperfusion solution 
containing 2.8 , 16.8 and 2.8 mMol/1 glucose .
The mean rate of IRI release during each 30 minute 
incubation was found to increase from 189 to 293 ng per 
initial g of tissue in response to a stimulatory level of glucose 
( Table 32 ) . In only 50% of the purified preparations was there 
unequivocal evidence of a sustained IRI release which increased 
in response to high glucose levels . As in the periperfusion 
studies ( Chapter 4 ) it would seem tiiat not all tissue
preparations had retained their normal physiological secretory 
potentisd .
In a further series of experiments islets have been removed 
from the filters by exposure to collagenase and med-ntained under 
culture conditions as described previously .Continued IRI release 
during 8 days of culture ( Table 33 ) suggests that the islets
, isolated, in this manner were capable of surviving under tissue
culture conditions .
In summary we have investigated four techniques for
harvesting islet preparations . The results suggest that while 
density centrifugation of dispersed human tissue would appear 
to have only a marginal effect upon islet cell enrichment ,the 
continued IRI release into culture of the endocrine tissue
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ICollagen Coated Filter 
Magnification X 20 
PHOTOGRAPH 26
Collagen Coated Filters 
Magnification X 10 
PHOTOGRAPH 27
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CULTURE OF COLLAGEN ISOLATED ISLETS
IRI Concentration of Culture Media U / ml
Day 1 Day 2 Day 4 Day 6 day 8
993 353 308 92 152
857 327 218 133 187
940 315 169 93 168
820 255 315 124 208
1475 480 300 448 178
700 435 550 296 390
490 340 310 465 250
710 750 408 356 292
425 535 270 238 245
398 205 126 155 114
430 510 215 265 295
Mean 749 409 290 242 223
SJl. j 323 154 116 137 79
TABLE 33
sedimenting at a density between 1.056 and 1.08 indicates that it
was viable and at least a percentage of the islet tissue remained
so during the 8 days of culture . Whether this type of cultured
preparation could be safely implanted remains unknown however.
In contrast collagen coated nylon mesh filtration allowed
the recovery of an almost pure islet preparation . Both direct
and indirect measurements of the adherent tissue indicates that
approximately 40% of the insulin containing tissue can be
»
recovered from the pancreatic disaggregate using collagen coated 
filters
This figure suggests that approximately 25% of the original 
islet mass remained after the procedures outlined to disaggre^te 
the "tissue and arrive at a purified islet preparation.
In terms of islet survival ,static glucose challenges have 
been used to identify and select those islet preparations
147
isolated by chemotaxis which were shown to be viable •
Whether the implantation of only 25 % of the islet tissue 
would be sufficient to fully restore normoglycaemia following 
implantation remains unknown . Evidence from both segmental whole 
organ and experimental islet implantation suggests that 
implantation of a reduced islet volume results in a return to the 
diabetic state • Thus it would seem likely that we have to 
consider the possibility of using islet material from more than 
one donor .
The introduction of culture techniques enabling preservation 
of the endocrine tissue would appear to hold certain advantages •
It would provide time so that islet function could be 
assessed-and sterility ensured • It may offer advantages in that 
a short period in culture has been suggested as a prerequisite 
for successful engraftment in some models ( Payne 1979 , Selawny 
1978 ) .
Perhaps the greatest potential benefit of in vitro culture 
may be in dealing with the allograft tissue phenomena .
The final chapter of this thesis is therefore concerned with 
briefly considering techniques and attempts to preserve islet 
morphology and function in vitro and in reporting preliminary 
experiments at implanting long term cultured islets across a 
xenogeneic histocompatability barrier ,
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CHAPTER SEVEN
CULTURE AND XENOGENEIC IMPLANTATION OF HUMAN ISLETS
7.1 Introduction .
Most early investigators attempting in vitro cultivation of 
pancreas used classical explant tecniques with foetal or neonat^ 
tissue as their starting material.
The first indication that foetal derived islet tissue would 
survive in vitro was provided by Chen (1954) following watchglass 
culture of 13—15 day rat foetal tissue. Electron microscopy 
studies and tinctorial staining of the explanted tissue revealed 
typical endocrine cytoplasmic granules throu^out the 9 days of 
culture.
Coalscm ( 1956 ) used the rat diaphragpi assay and Dieterge— 
Lievre ( 1960 ) measured the loss of PAS positive granules from 
co-cultured liver cells to show that the functional activity i.e. 
insulin and glucagon secretion of the pancreatic explants could 
be preserved in vitro .
Similar results were obtained with foetal or neonatal 
pancreatic endocrine tissue from other species. Chick (Black 
1954) , neonatal mouse ( Wells 1963 ) and embryonic rat (Zagury 
1959) were reported to survive and in some cases continue gro%rth 
and functional differentiation during culture .
Trowell ( 1959 ) was the first to demonstrate that the
naturally occurring media used in these cultures could in the 
most part be replaced by a defined culture media. A wide variety 
of these often very complex media have subsequently been used , 
although the addition of a small amount of serum hsis in all cases
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except one ( Buiti-ago 1975 ) been shown to be necessai? for
cell survival ( Andersson 1977 , Nielsen 1979 ).
Foetal tissue has since been successfully cultured as
explants at the air/gas interface of the media ( Hegre 1977 )
attached to artificial capilliaries ( Knazek 1977 ) and
submerged in media in petri dishes ( Chick 1975 ) where under
appropriate experimental conditions the endocrine tissue has been
encouraged to form monolayers of replicating B cells ( Fisher 
1977 ) .
Early studies suggested that islets had 
requirements for survival in vitro . An in vitro dependency upon 
adrenal secretion in maintaining pancreatic tissue integrity was 
shown by the work of Zagury ( 1959 ). It is interesting that a 
similar although sex specific dependency upon adrenal secretion 
was shown to occur in vivo ( Grossman 1969 ) ,
Moskalewski (1965) first showed the importa.ce of Oie 
glucose concentration of the medium used . It is now generally 
agr^d that culture in low glucose ( below 5.6 mMol ) results in 
a depression of IRI synthesis and release ,and to impaired 
response of the islet tissue to increased glucose levels. Culture 
in 15 to 20 mMol glucose leads to extensive degranulation of B 
cells but may result in nuclear hypertrophy , DNA synthesis and 
cell division ( Lacy 1977 ) . Andersson has suggested that high 
stimulatory levels of leucine may substitute in some part for 
glucose .
Since then many other factors have been suggested to play 
a supportive role in maintaining islet cell viability in vitro .
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These include ions such as calcium ( Schatz 1982 ), vitamins such 
as nicotinamide (Andersson 1980 ) and inositol ( Clemens 1979 ) , 
adenosine ( Fussganger 1976 ) ,branched amino acids e.g. leucine 
but not valine ( Nakhooda 1977 ) , hormones such as somatotrophin 
( Larsson 1978 ) , somatostatin ( Williams 1980 ) and
glucocorticoids ( Andersson 1977 ) as well as homologous serum 
( Goldman 1976 ) and perhaps surprisingly the serum from newly 
diagnosed diabetics ( Nielsen 1977 ) •
To this must be added the possible efi^ ect on islet tissue of 
one of a number of recently discovered factors shown to be potent 
stimulators of cell proliferation ( for a recent review of these 
growth factors see Sato 1982 ).
Thus it can be seen that a bewildering array of techniques 
and additives have been reported to maintain the morphological 
and functional integrity and to support the growth of endocrine 
tissue during culture .
Under appropriate culture conditions , the continued gro^ /th 
and development of human foetal derived endocrine tissue has been 
reported ( Leach 1973 ) , ( Agren 1980 ) and ( Maitland 1980 ).
In contrast botii in vivo and in vitro growth of adult 
derived islet tissue has been the exception rather than the rule 
( King 1977) .
Althou^ rare in vivo ( LeCompte 1962 ) , an increased rate 
of islet cell mitosis has been reported following conditions 
where chronic elevations of blood glucose occur ( Brosky 1975 ), 
concommitant with regeneration of hepatic tissue ( LeCompte 
196b ) and in the presence of certain insulinotrophic compounds
i.e.following the administration of ACTH and cortisone ( Kinash
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1954 ) .
There is general agreement that a degree of adult islet cell 
replication can be stimulated by increased glucose levels in 
vitro ( Moskalewski 1977 ) however the mitotic index would
appear to be low and we are aware of no cases where a non­
transformed permanently dividing ( primary ) B cell line has 
occurred .
This means that although growth of adult islets in culture 
remains an exciting possibility the culture of adult islets must 
be viewed at present as simply a means of preservation of islet 
tissue prior to other studies i.e. transplantation.
Survival of adult derived islets in culture have been 
reported by many investigators ( see Sutherland 1981 )
Cultured isolated islets have been shown to maintain their 
ability to both synthesize and secrete insulin ( Schatz 1982 ).
The effect of culture techniques in preserving islet function has 
been tested further by implantating cultured rat islets into 
streptozotocin diabetic rats. Scharp ( 1974 ) reported a delayed 
return to normoglycaemia. Nakagawara ( 1978 ) and Bretzel ( 1982 ) 
however noted no difference between cultured or fresh islets in 
the time needed for the restoration of normoglycaemia while 
Selawry ( 1978 ) reported a beneficial effect of short term
culture on islets from older rats. This suggests that any changes 
in endocrine tissue function which may occur during short term 
culture would appear to be reversible following implantation.
We must remain aware however that in vitro culture 
introduces a totally artificial environment and that the culture
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conditions may induce differences "In the physiological response 
of the cultured islet tissue . For instance many investigators 
have shown that daily IRI release into the culture media
decreases over the first 7 to .10 days of culture although insulin 
biosythesis remains unaffected (Schatz 1982 ) .
From this it follows that IRI release may be considerably 
reduced during the period of culture .This has been reported even 
in the presence of a rapidly increasing islet mass ( Maitland 
1980 ) . In addition it has been suggested that degradation of
IRI activity ( Andersson 1977 ) , adaptation of the cells to h i ^  
glucose levels ( Moskalewski 1977 ) and feedback inhibition by 
accumulation of hormones i.e. somatostatin ( Turcot—Lemay 1975 ) 
may combine in underestimating the remaining endocrine viability 
and function .
It is recognized that more sensitive techniques (i.e. the 
incorporation of radio—labelled metabolites into insulin and pro- 
insulin or periperfusion techniques ) are necessary to quantify 
islet survival . As yet no studies have however been carried out 
along these lines.
In this study our primary aim at this time was to investigate 
the possibility of culture as a means of preserving islet tissue 
and if successful to evaluate the effect of long term culture in 
reducing the immune tissue rejection phenomena .
7.2 Culture of Human Islets.
Human islets were purified and recovered from the collagen 
coated filters . Between 50 and 100 islets were introduced as 
free floating cultures into non-coated multiwell dishes
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IRI RELEASE INTO CULTURE
^ U  / ml of culture media
Days Mean S.D n Days Mean S.D n
3 1720 848 30 30 ' 335 214 10
6 1000 212 30 33 215 75 10
9 935 272 29 36 135 92 10
12 865 238 14 39 210 95 9
15 684 640 14 42 165 80 10
18 515 316 10 45 158 48 10
21 395 280 10 51 175 78 15
24 578 430 10 54 128 64 10
27 375 230 10 60 168 58 9
n = 30
TABLE 34
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FIGURE 13
containing 4 ml of culture media , The culture media was RPMI 
1640 with the addition of 10 % foetal calf serum ( Flow 
Laboratories type 29-101 ) and 1% antibiotic-antimycotic solution 
( Gibco-Biocult ) . The cultures were maintained in a humidified 
atmosphere of 95% air and 5% CO . Two thirds of the culture media 
was exchanged every 3 days by centrifugation of the dishes using 
plate holders ( type M18F , Dynatech ) at SOOg for 5 mins.
Th© IRl content of the culture media over a 60 day period is 
shown in Table 34 and Figure 13 .
Examination of the cultured islets using an inverted 
microscope provided evidence that islet and cell morphology had 
been preserved during the period of culture . IRI production 
rates ( IRI released into the media during 3 days culture ) 
decreased progressively over the first 21 days of culture from 
1 1720 to 395yW U / ml , decreased to 33^*U / ml between day 21 and 
30 and remained fairly constant from 30 days onwards at a level 
of 170^U / ml .
Although the reasons for the decline in IRI release remain 
unexamined these results clearly show that a degree of IRI 
release can be preserved in free floating islet cultures for a 
period of up to 60 days which demonstrates continuing islet 
survival .
This allowed us to carry out a pilot study to see whether 
the immunogenicity of these cultured islets could have been 
altered by the period of in vitro culture .
7.3 Xeno—implantation of long term cultured islets
With the exception of such procedures as skin sensitization
154
tests in man there would appear to be no obvious model in which 
to test the Summerlin hypothesis upon human cultured islets .
Three lines of evidence however are of note and suggested 
that any loss of immunogenicity of human islets following long 
term culture could perhaps ba investigated even across a 
discordent xenogeneic barrier •
The long term growth and survival of human islet tissue in 
athymic immunodeficient nude mice and rats ( Usadel 1980 )
suggests that the only barrier to xenoimp"* antation is of an 
immunological nature .
Xenogeneic implants into immunocompetant hosts are usually 
rejected within a few hours ( Shons 1974 ). Two theories of the 
pathogenesis of the hyperacute xenograft rejection have been
proposed ( see Kemp 1978 ), both of which involve rapid cellular 
destruction following activation of the complement cascade.
Bretzel ( 1982 ) reported that there was no evidence
of this hyperacute xenogeneic tissue rejection mechanism
following islet implantation even when discordant species were 
used i.e. pig islets implanted into rats. Both the time of onseic 
of rejection ( 3 days ) and the morphological evidence was
apparently similar to the assumed jell mediated rejection 
phenomena seen when implantation has been carried out across 
allogeneic barriers. In addition Shumakov ( 1980 ) has reported 
one month survival of cultured human fOetal pancreas in
immunocompetant rats.
If this is so ,then the rat model could be used to evaluate 
the effect of long tern culture on altering the immungenicity of 
human islet tissue.
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It was decided to follow the protocol initiated by Lafferty 
( 1975 ) who successfully transplanted thyroid tissue following a 
period of 26 days in culture .
An experimental study was therefore carried out using a 
limited number of AC2 rats of between 150 and 200 g in weight. 
Freshly isolated human islets were implanted into the peri-renal 
space in four rats . Two rats received human islets which had 
been maintained in culture for 28 days and which still showed 
continued IRI release into the culture media. In addition two 
rats served as controls for normal blood sugar and ingni -in 
levels.
No attempt was made to induce diabetes neither were any 
immunostqppressive regimes used.
Results
Of the 4 rats which received fresh islets two were 
sacrificed at 2 days and the remEuning two at 4 days • The two 
rats which received 28 day cultured islets were sacrificed at one 
and three months.
In the rats which received fresh islets macroscopic evidence 
of graft survival was seen at day 2 but not at day 4 . Histology 
of the grafts revealed evidence of lymphocyte infiltration and 
cellular destruction at day 2 ( Photograph 28 ) • No evidence
of remaining pancreatic tissue was seen by day 4 although areas 
of massive lymphocyte infiltration were noted and provided 
suggestive evidence that the tissue had been destroyed by an 
immune reaction ( Photograph 29).
In the 2 rats which received long term cultured islets the
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Implant of Non-cultured Islets 
After 2 days 
Haematoxylin & Eosin Magnification X 100 
PHOTOGRAPH 28
a .:
Implant of Non-cultured Islets 
After 4 days 
Haematoxylin & Eosin Magnification X 100 
PHOTOGRAPH 29
157
most remarkable finding was the vast amount of adipose tissue 
which had developed around the site of implantation. Histological 
examination of the tissue at the site of implantation of both the 
1 & 3 month xenografts showed islet like structures surrounded by 
but not infiltrated by a large number of lymphocytic cells 
( photographs 30 & 31 ). Similar findings i.e. lymphocyte
accumulation around surviving islets have been reported following 
other zenograft studies ( Lacy 1982 ) . Staining with Ivic ' s 
Victoria Blue B ( appendix II ) provided proof that these 
structures were indeed islets and showed the presence of B cell 
intracellular granules within these islets ( photograph 32 ).
One finding euLthough not relevant to the purpose of this 
thesis is of interest . Following implantation of human islets 
all rats exhibited a significant level of hyperglycaemia .with a 
mean non-fasting blood sugar of 11.9 mMol/1 against a pre­
operative ( fasting ) glucose level of 4.8 mMol/1 and a non­
fasting level of 5.7 mMol/ 1 in the two control animals. This 
level of hyperglycaemia would in many studies be indicative of 
the existence of the diabetic state and are of course in direct 
opposition to the aims of this project which are of course to 
cure and not cause diabetes . Suppressed islet function of host 
animals following implantation of an insulinoma has been 
previously reported ( Like 1977 ) however the reasons why diabetes 
should occur are puzzling.
This to my knowledge is the first report of successful 
implantation of adult islets across a major histocompatability 
barrier and although it does not prove that allogeneic human 
islet immunogenicity can be abrogated following culture ( for
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Implant of 28 Day Cultured Islets 
After 30 days 
Haematoxylin & Eosin Magnification X 100 
PHOTOGRAPH 30
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Implant of 28 Day Cultured Islets 
After 90 days 
Haematoxylin & Eosin Magnification X 100 
PHOTOGRAPH 31
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Demonstration of B Cell Granulation 
Implant of 28 Day Cultured Islet 
After 90 days 
Ivic Stain Magnification X 500
PHOTOGRAPH 32
other histocompatability barriers may exist ) it does clearly 
demonstrate that the immunogenicity of human adult islets can be 
altered during culture .
These findings indicate that the culture of human purified 
islets may provide considerable advantage in dealing with the 
rejection phenomena .
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CHAPTER EIŒiT 
SUMMARY AND DISCUSSION
The history of diabetes is fascinating and in many ways 
parallels the history of our knowledge of physiology .
It is clear that in antiquity the physical signs of the 
disease were known and described . The massive diuresis and 
wasting away of both muscle and fat ( i.e. the exagerated effect 
of starvation despite a voracious appetite )were well known .
It is now nearly 100 years since the association between 
diabetes and the pancreas was finally accepted and the essential 
role of insulin in maintaining glucose hoeostasis was proposed . 
The expertise from many academic roots have combined to explain 
many of the physiological mechanisms involved .
Many of the cardinal symptoms of the disease i.e. 
hyperglycaemia , glycosuria , polyuria and weight loss may be 
explained by a lack of glucose transportation from the blood into 
the cells of insulin sensitive tissues i.e . skeletal muscle and 
adipose tissue . This diminution in intracellular glucose 
transport , if uncorrected , results in alternative metabolic 
energy pathways such that fatty acid formation and protein 
catabolism occur .The net result of this is to release end 
products into the circulation which explains the resultant 
negative nitrogen balance , keto—acidosis , leading to coma and 
death .
The repercussions of the lack , or alterations in the 
effect , of insulin are manifest in the development of the 
heterogenous disease which we know as diabetes .
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other histocompatability barriers may exist ) it does clearly 
demonstrate that the immunogenicity of human adult islets can be 
altered during culture .
These findings indicate that the culture of human purified 
islets may provide considerable advantage in dealing with the 
rejection phenomena .
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For the severely diabetic individual the discovery of the 
therapeutic use of insulin proved a major breakthrough in the 
treatment of the disease .
Innovations in the chemical stnructure and alterations in 
the time and mode of insulin therapy have ccxnbined to improve 
metabolic control • However , the quality of life for many 
diabetics , particularly those who develop the disease early in 
life , remains depressingly bleak.
More than 60% of juvenile diabetics will experience the 
serious secondary complications of the disease , the cause and 
prevention of which remsdn the outstanding problem in diabetic 
treatment and management .
It has been suggested that greater control of blood sugar 
levels may influence the onset and development of these secondary 
complications of the disease . The role of insulin treatment 
regimes designed to improve control of glucose metabolism 
remains contentious and both opponents and proponents of greater 
control continue to argue their respective cases . Whether the 
therapeutic use of insulin can ever achieve the sensitive 
control of glucose metabolism exhibited by normal individuals 
must remain questionable . Even if this is achieved we cannot be 
sure that other metabolic aspects of the disease ( some 
perhaps as yet unknown ) may influence the onset or severity of 
these dreadful sequalae to the disease.
In contrast there is now little doubt that total pancrea­
tic endocrine replacement following transplantation is capable of 
correcting the physiological abberaticns of the disease . In
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addition one of the most exciting aspects of experimental 
pancreas and islet tr.msplantation has been the demonstration 
that similar diabetic lesions in experimental animals have been 
reported to stabilise or in some cases even regress following 
successful implantation . Thus the potential of islet and 
pancreas transplantation ( provided that it can be made safe ) is 
one of enormous benefit as an alternative and more important an 
effective treatment for the disease .
For several reasons whole organ grafting has been the most 
commonly carried out in man . Surgical procedures are . fairly 
straightforward and excellent glucose homeostasis has been 
achieved. Problems remain however in dealing with pancreatic 
exocrine drainage , fibrotic reactions within the gland following 
atrophy of the exocrine tissue and of course in dealing with «le 
immune tissue rejection phenomena . Despite improvements in 
technique the results of whole organ transplantation have 
continued to be extremely disappointing ( Caine 1983 )
Experimental studies in rodents have shown that transplanta­
tion of collagenase isolated islets from multiple donors into 
syngeneic recipients is now a reliable technique for correcting 
experimentally induced diabetes with excellent animal survival 
and glucose homeostasis .
other approaches ( at least in animal models ) have been 
shown to be possible ,
The continued growth and development of foetal derived 
tissue both in vitro and in vivo may provide exciting 
possibilities for the future .
An alternative strategy developed in the canine model is
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that of preparing and implanting partially digested pancreatic 
microfragments
Thus considerable innovation and invention have been used 
to design and improve strategies of tissue disaggregation , islet 
isolation and implantation • It would be erroneous however to 
suggest that all of the problems of experimental islet 
implantation have been resolved .
The disaggregation procedures used to prepare both isolated 
islet and partially digested microfragments preparations remain 
limited in the quantity of islets that can be recovered .
In the extensive review of attempts at human islet 
implantation it can be seen that the effectiveness of these
procedures which have been developed in other species have been 
far less successful when dealing with the separation and 
implantation of islet cells or microfragments in the clinical 
field.
It is perhaps prudent to ask the question of why this
success has not been repeated in the clinical model , and more
importantly to consider approaches to improve the success of this 
technique in the clinical field .
It is my belief that improvements can only arise following 
the careful appraisal of techniques designed to specifically 
investigate and evaluate procedures developed in and shown to
apply to the human gland. Perhaps surprisingly when considering- 
the importance of this topic there is a dearth of studies which 
have dealt with islet isolation from and preparation of the more 
compact and fibrous human pancreas. The need to critically
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investigate problems associated with islet preparation of the 
human pancreas was therefore obvious .
In the few studies where this has been attempted , 
evaluation of the recovered islet function have been based upon 
crude and possibly unreliable measures of assumed islet numbers 
or islet mass. The development of an in vitro method to assess 
endocrine function following disaggregation is considered 
essential for valid evaluation of the disaggregation techniques .
The emphasis of this study was therefore in developing 
techniques of assessing islet function prior to and following 
disaggregation . Only then would we be able to critically 
evaluate and perhaps improve methods of disaggregating the human 
pancreas .In particular it was decided to pay particular 
attention to steps in the disaggregation procedure where the loss 
of endocrine tissue has been reported to be most marked , i.e. 
following mechanical chopping and enzymatic digestion.
Our first concern however was to define the parameters ( the 
normal values ) against which assessment of tho effectiveness of 
^^^^8S^®8^tion procedures could be made . Considerable between 
sample variation was meeusured which presented problems in both 
data handling and analysis . However , the range of tissue 
insulin content and the dynamic aspects of IRI release in 
response to alterations in glucose content were defined . In 
addition measures were taken to verify the accuracy of the 
methodologies used to arrive at these figures.
Periperfusion techniques enabled us to measure the loss of 
endocrine function and to define the most advantageous storage 
conditions and the time limits within which this loss of function
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occurred during the period of storage .
We have also shown that intra-venous distention of the gland 
resulted in the anatomical separation of the endocrine-exocrine 
tissue ( a reported pre-requisite of rodent islet isolation ),and 
that the use of the Mcllwain tissue chopped was extremely 
effective in providing regular size fragments with no significant 
degree of cellular damage .
Whether rightly or wrongly we considered that the greatest 
improvement in endocrine tissue survival could be achieved by 
judicious use of the enzymes used to effect tissue 
disaggregation.
In theory there are two approaches to enzymatic 
disaggregation . The first is to use enzymes which only digest 
the extracellular tissue stroma , while the alternative is to use 
less specific enzymes and hope that the cell membranes are more 
resistant than the extracellular matrix to proteolytic attack.
The primary problem with commercial collagenase is that it 
is an enzyme complex . The consequence of this is that it was 
necessary to fractionate commercial collagenase into its 
individual enzyme components and to evaluate each in its effect 
in tissue breakup . The presence of at least 6 separate enzyme 
components were identified . The effect of these components on 
tissue morphology , tissue disaggregation and cell release 
clearly showed that only the enzyme exhibiting collagenolytiC 
activity was essential in achieving tissue disaggregation and 
islet separation. In addition it was found that enzyme 
contaminants of crude collagenase could result in a marked degree
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of cellular damage ,
It is our belief thau the use of a pure collagenase
preparation together with a protease inhibitor provided
considerable advantages in its ability to provide a viable islet 
preparation from the human pancreas . For this reason a
disaggregation procedure was developed using this highly purified
énzyrae preparation .
The only real test however of a disaggregation procedure is 
in the total insulin producing capacity of "the recovered tissue .
Periperf usions were carried out and demonstrated that. baseJ. 
IRI release during the period of periperfusion approximated to 
a mean of 1.5 Units per hour per pancreas . This was on average
increased to 4.5 Units per hour under 16.8 ra Mol / 1 glucose
stimulation . This figure indicated that in excess of 60 % of the
endocrine function of the pancreas could be recovered.
It weus therefore considered that the endocrine components
contained within the unseparated disaggregate should be 
sufficient to significantly alter the diabetic scate following 
implantation.
The disaggregation technique developed using the human 
pancreas was shown to be equally effective when dealing with the 
canine gland. It was argued that its possible effect upon 
altering the diabetic state or possible noxious effects of 
implanting the unseparated disaggregate in dogs , would be 
predictive of its possible future application in man.
In a series of nine experiments in dogs the non—separated 
disaggregate was implanted as autografts into either the liver or 
spleen
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In each of these dogs early there were extreme fluctuations 
in blood glucose levels following implantation and blood sugar 
levels were difficult to control . In none of these animals was 
there a sustained beneficial effect upon blood sugar control .
Intra-hepatic implantation resulted in the development of a 
fatal portal hypertension . Following implantation into the 
splsnic vasculature the resultant morphological evidence 
suggested that severe hepatic trauma had occurred . In addition 
in all dogs severe hematological disorders resembling DIG 
occurred and 3 dogs died as a result of massive reactive 
haemorrhage .
It is at first difficult to reconcile this finding with 
other studies . Many investigators have used this technique in 
both experimental animals and man wiidiout reporting the 
development of serious complications , although others have been 
less successful . We can only suggest that two factors may have 
played an important role . In this study the large volume of 
disaggregated tissue ( 15 to 30 g ) which was implanted may have 
produced a more pronounced effect upon the liver and blood 
homeostasis • In addition it is known that enzyme contaminants of 
collagenase have been shown to induce cytotoxic changes within 
exocrine cells and it may be that the exocrine components of the 
implanted tissue were more viable and exerted a greater degree of 
pancreatic exocrine release resulting in increased cell damage 
and activation of the blood coagulation cascade . Whatever the 
validity of this this the extremely disappointing results 
indicate that the risks involved in implanting this type of
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unseparated digest were considerable .
As mentioned previously the rationale behind pancreatic
transplantation suggests that its greatest potential may be in 
the prevention of the sequalae of secondary complication of the 
disease . In order to meet this aim it must be shown to be safe 
and effective .
It was clear that steps were needed to eliminate the
toxicity of this type of pancreatic disaggregate before this aim
can be met.
Techniques of harvesting isolated islets developed in animal 
models were shown to be inadequate in dealing with the human 
pancreas . An alternative techniques which exploits differences in 
the chemotaxis of islet tissue was shown to be extremely
in arriving at a pure endocrine preparation •
Recovery of islet tissue showed that 75 % of the endocrine 
tissue was lost during the disaggregation and isolation procedure 
and it remains unknown whether this volume of endocrine tissue 
would be sufficient to fully restore normal carbohydrate control 
or whether improvements in harvesting or the possible use of 
islet tissue fi*om multiple donors are needed before any 
s^©^i^*icant effect on carboh'/drate control can be predicted .
The long terra culture studies have shown that culture as a 
means of human islet preservation is a possibility and perhaps 
more importantly has allowed us to carry out preliminary studies 
into whether long term culture of islet tissue may sufficiently 
alter the immunogenicity of islet tissue so that its possible 
future application in non— immunosuppressed diabetics may 
ethically be considered . The results of these xenogeneic studies
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are encouraging in that they clearly demonstate that the 
Summerlin hypothesis may also apply to the transplantation of 
human endocrine tissue .
In conclusion , the experimental aims of this thesis have 
in part been achieved • A satisfactory method of human pancreatic 
disaggregation has been described allowing recovery of in excess 
of two thirds of the endocrine function. A method of harvesting 
a pure endocrine tissue preparation has been shown .however time 
has not as yet allowed its evaluation following implantation 
Evidence from in vitro culture suggests continued function and 
survival of the endocrine tissue . Although studies into the 
optimal conditions of in vitro culture have only just begun 
evidence suggests that long term vitro culture may also abbrogate 
the immune tissue rejection phenomena of human tissue 
sufficiently for implantation to eventually be possible in non- 
immunosuppressed recipients.
The implications of these studies for the possible eventual 
treatment of diabetes by islet implantation are clear. As
mentioned previously its greatest potential must be in the 
treatment of young diabetics in whom the secondary complications 
of the disease are only beccxning manifest and in whom a 
reasonable chance exists that these sequalae may be avoided .
The risks of implantation together with the risks involved 
in measures taken to avoid the immune tissue rejection phenomena 
must be carefully weighed against the projected life expectancy
using alternative forms of treatment .
It is clear that progress in this field is being made and
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that a safe and effective cure for the disease will one day be 
possible . In the words of Victor Hugo it is ray belief that ,
' nothing is as powerful as an idea whose time has come '.
The work contained in this thesis and by other workers in 
this field show that although improvements are still necessary to 
improve the yield and effectiveness of islet implantation the 
promise of this technique as a complete cure for this distressing 
disease is as great as ever •
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APPENDIX I 
MATERIALS
Source of Tissue ,
Rats and do^ were obtained through and experiments carried 
out at the Royal College of Surgeons Research Centre or the 
animal house at Guys Hospital.
Adult and infant human pancreatic tissue was obtained 
following nephrectomy of brain dead kidney donors. The donor age 
ranged fron 3 to 70 years. In all cases the pancreas was stored 
in ice until processing could be carried out. The period of warm 
ischaemic time was limited to less than 5 minutes.There was 
however a considerable and largely unavoidable variation in the 
of cold ischaemia due to the time taken to transport donor 
tissue etc. This ranged from 30 minutes to in excess of 8 hours.
Apparatus
An orbital shaker (type TM—1) was purchased frcxn Braun .The 
Mcllwain tissue chopper was supplied by Mickle Laboratories , 
Gomshall , Surrey . The modular incubator and multidish culture 
dishes were obtained from Flow Laboratories. All other apparatus 
WEIS standeurd laboratory equipment .
Chemicals
Insoluble collagen type I , azocasein , collagenase type lA 
and 5 , N -Benzoyl-dl-arginine p-nitroanilide .bovine albumen 
fraction V (RIA grade) , %  —1—antitrypsin, PGO enzymes , o—diani— 
sidine , 3—isobutyl—l—methyl—xanthine and dl—dithiothreitol were
obtained from Sigma . Ultragel AcA 54,44,34 and 202 and 
ampholines pH 3.5-10 were supplied by LKB and Sephadex 200
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superfine, Percoll and Ficoll were purchased from Pharmacia. Flow 
Laboratories supplied collagenase type IV , foetal bovine serum 
and RPMI 1640 culture media . Gibco-Biocult prepared RPMI 1640 
without glucose , arginine, leucine , glutamine and cysteine as a 
specisü. order. Antibiotic-antimycotic soln. and L-leucine, L- 
arginine, L-cysteine and L-glutamine were also supplied by Gibco- 
biocult. Anti-insulin serum and insulin binding reagent were 
purchased from Wellcome Reagents , and glucagon antisera was 
kindly donated by Surrey University. Human insulin and glucagon 
was given by the National Institute for Biological Standards and 
Control . lodinated insulin was purchased from Amersham 
International and iodinated glucagon from New England Nuclear. 
Diazoxide was supplied by Allen and Banbury's .
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APPENDIX II
Methods
II. a LABORATORY TESTS
Insulin
Insulin or more accurately immunologically reactive insulin 
activity ( IRI ) was assayed according to the double antibody 
method developed by Hales (1963) . The assay was carried out 
using the pre-precipitated double antibody (binding) reagent and 
following the method recommended by Wellcome Reagents Ltd. .All 
samples standards and blanks were assayed in dulplicate .IRI 
activity was estimated from the mean of two standard curves (at 
the beginning and end of the assay )prepared using the interna­
tional standard for human insulin supplied by the World health 
Organization .
The diluent used to prepare standards and tissue extracts is 
given in Appendix III . Non-specific binding effects ( 200ywl of 
plus 100^1 label ) were less than 1% in all assays .It is 
possible that non-specific factors (i.e.plasma effects ) could be 
present when assaying IRI in plasma samples but the pre­
precipitated double anibody method was chosen in part for its 
known insensitivity to these artifacts.
Figure A1 shows a typical standard curve . Per cent counts 
precipitated are shown on the ordinate and Log microunits of 
insulin standard are on the abscissa.
The IRI content of the unknowns (mean percentage bound of 
the two duplicates ) were read directly from the steepest and 
therefore most sensitive part of the standard curve (between 2 
and 128^U/ml).
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. The reliability of estimation was initially confirmed by 
the quality control scheme organized through the Dept, of 
Biochemisty at the University of Surrey . In addition aliquots of 
three pooled and frozen serum samples with known IRI 
concentrations were included in each RIA assay to enable between 
assay variation to be quantified.
The standard error of the means of the percentage binding of 
individual values (Figure 1 ) range from 0.22 to 1.8 
over the range 2 to 128 U ml which indicates that the precision 
of within test accuracy of IRI provides a 95% confidence level of 
between — 0.83% at high IRI and — 3.6% at low IRI concentrations. 
Similarly the standard error of between test variation ( as 
determined from quality control samples ) was - 4.2% (n=12).
Because of the convention used in the literature of using 
metric quantitation for insulin content and international units "
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to report physiological levels , both have been used . These 
figures may be converted using the following formula.
1 Unit ( 4th International Standard ) =  41.67 g
Total Protein
This was measured using Peterson's (1977) modification of the 
Lowry reaction ;
Amylase
Amylase was assayed according to the method of Gomieson 
(1969). The assay was carried out at 25 C using hog pancreatic 
amylase as the standard .
Glucagon
This was measured using ihe radioimmunoassay method
developed and supplied by A1 Tagar at the radioimmunoassay
department of the University of Surrey .
Plasma Glucose
Glucose was assayed using the glucose oxidase - peroxidase 
reaction and o-dianisidine as the oxygen receptor using kits 
supplied and following the procedure recommended by Sigma .
Potassium
Plasma potassium levels were measured using an Eel flame 
photometer calibrated using a 5 m Mol KCl / 130 m Mol Na Cl 
standard solution.
II.b Haematological Tests
Blood samples of 2.5 ml were collected into tubes containing
0.25 ml of 3% sodium citrate , mixed gently and stored in ice.The 
tubes were centrifuged at 2,000 g for 10 minutes and the plasma
withdrawn using a plastic pipette. All tests were performed in
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duplicate.
Prothrombin time ( PT )
This was measured according to the method of Quick ( 1935 ).
Kaolin-Cephalin time ( KCT )
100 1 of plasma was mixed with 100 1 of a 5mg/ml kaolin
solution pH 7 . This was incubated for exactly 9 minutes 45
seconds at which point 100 1 of 10 mg/ml platelet extract was
added . At exactly 10 minutes 100 1 of 0.025 Molar calcium
chloride was added and the time taken for clot formation was
timed using a stopwatch.
Platelet counts 
These were estimated using sequested whole blood and were 
counted using a model S-Plus Coulter counter ( Coulter 
Electronics Ltd. ) .
II.c Histological Procedures
The tissue was fixed in buffered formal saline ( pH 7 ),
followed by routine processing using par afin wax. Sections were 
stained using haemotoxilyn and eosin, aldehyde fuchsin ( Gommori 
1940 ) or victoria blue 4R ( Ivic 1959 ) .
II.d Tissue components
Insulin
Acid ethanol extraction of tissue insulin was carried 
out according to the method of Dickson (1977) with the following 
modification. Because degradation of insulin was found to be 
rapid in aqueous extractions the tissue was processed throughout 
in 80% ethanol titrated to pH3 with orthophosphoric acid. The 
method used is presented below .
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1. The tissue was weighed and then collected into at 
least 4 times its volume of acid ethanol ( 80% Ethanol titrated 
to pH 3 with orthophosphoric acid and stored at 4* C ) .
2. The tissue was homogenized at 4*0 using an Ultra-Turax 
tissue homogenizer sifter which 0.1 Molar orthophosphoric was used 
to reajust to pH3 .
3. The homogenate wsis shaken overnight at 4* C , 
centrifuged at 2,000 g for 20 minutes and the supernatant saved .
4. The deposit was re-extracted using a similar quantity 
of fresh acid ethanol at 4 C for 6 hours . Following centrifuga­
tion the two supernatants were pooled . Two initial 1 in 100 
dilutions were made using insulin diluent (Appendix III) followed 
by serisü. 1:1 dilutions . This enabled the mean of two 
measurements on the most sensitive part of the IHI curve to be 
computed».
The tissue IRI content ( ng / gm / tissue ) was calculated 
using the following formula ;
_ (/4Ü/ ml ) X Volume of supernatant ( mis )
25 X Weight of Tissue 
Tissue protein and amvlase 
Total protein and amylase was measured on aqueous tissue 
extracts following homogenization at 4* C using an Ultra-Turax 
and sonification using a MSE sonicator.
II.e Rat Tail Collagen
Acid soluble rat tail collagen was extracted following the 
procedures recommended by Paul ( 1972 ) . Briefly the tendons 
from three rat tails were carefully dissected and submerged in 
150 ml of 1% acetic acid for 48 hours . Prolonged centrifugation
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( 1 hour at 2,500 g ) was used to separate the residue from the
acid solution of collagen . Before use it was dialyzed several 
times against distilled water .Care was taken to ensure sterility 
throughout .
The filters were prepared by coating with the extracted 
collagen following dialysis at 4*C for 36 hours and denatured by 
exposure to ammonia vapour . The filters were then washed in 3 
changes of sterile buffered salt solution before use.
Crvooreservation 
This was carried out following the procedure of Kratzsch 
( 1982 ) . An equal volume of RPMI 1640 containing 20% dimethyl 
sulfoxide was added • The vials were closed and cooled at 
-2* C per minute and stored in liquid nitrogen at -196*C .
The cryopreserved tissue was rapidly thawed to room 
temperature using a shaking water bath .
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APPENDIX III
Solutions Used
III.a Preparation of media
The choice of media to be used during storage and subsequent 
procedures was considered important. It was decided to use a 
defined culture media of which RPMI 1640 was the one of choice 
mainly because histological studies on pancreatic tissue 
incubated in either various balanced salt solutions or culture 
media clearly demonstrated the superiority of this defined media 
in terms of supporting tissue survival.
Two considerations however prompted us to prepare two 
different solutions by modifying the basic recipe of RPMI 1640 to 
suit the purpose for which this culture media was intended.
Soln 1 , Periperfusion media
Differences have been reported ( Lacy 1981 ) in the pattern 
of insulin release obtained using different perfusates . This is 
to some extent due to the presence of insulin secretagogues when 
more complex media are used. For this reason the level of the two 
amino acids known to increase insulin secretion i.e. leucine and 
arginine , were reduced to near physiological levels ( 10 and 15 
m Mol / L respectively. Bovine serum albumin ( RIA grade ) was 
added to a final concentration of 500 g / ml and the glucose 
concentration was adjusted to either 2.8 or 16.8 m Mol/L . 
Antibiotic-antimycotic solution ( Gibco-Biocult ) was added at 
the recommended level ( 1ml / dl ) to prevent microbial 
contamination . All other ingredients were sis recommended by 
Moore.( 1967 ).
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Soin»2 . Digestion solution.
The active conformation of bacterial collagenase depends 
upon both the availability of calcium ions and the presence of 
zinc within the molecule ( Nordwig 1971 ). Collagenolytic
activity has been shown to be reversibly inhibited by chelating 
agents such as EDTA ( Gallop 1957 ) and irreversibly inhibited , 
{ presumably by sequestion of the zinc atom ) by amino acids 
containing SH groups of which cysteine and cystine have been
shown to be the most effective ( Harper 1970 ) «
For this reason cystine was ommitted from the digestion
solution. Leucine ( 10 mg/L ) and arginine ( 15 mg/L )were added. 
Glucose was added to a final concentration of 2.8 ra Mol/L 
together with Irai/dl antibiotic-antimycotic solution .All other
ingredients were as described by Moore (1967).
Ill.b Insulin Diluent
This was made up from the following formula using double 
distilled water ;
1. 4.6 g Naj HPO+
2. 1.9 g NaH, PO», .2H 0
3. 9.0 g NaCl
4. 1.0 g Sodium Azide
5. 5.0 g Bovine Serum Albumin ( R.I.A. Grade )
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APPENDIX IV
IV.a Periperfusions .
Basically the periperfusion system consisted of a 20 m 
nylon mesh filter ( R.Cadish , London ) enclosed within a 
polycarbonate filter holder ( type 165 , Sartorius ) through 
which the periperfusion solution ( page 175 ) was drawn at a 
constant rate using a multichannel Serva elution pump ,
( Figure A.2 ) .
Care was taken to avoid the introduction of air into the 
perif usion system as this was noted to reult in surges in insulin 
release. For this reason a 3 way tap was used so that chopped 
tissue or tissue disaggregate could be introduced , and the 
perfusate changed without introducing air bubbles.Glucose was 
added to a final concentration of 2.8 or 16.8 m Mol. The perfu­
sate was constantly gassed with a 95% air 5% CO gas mixture and 
the perifusion was carried out within a 37* C incubator , thereby 
ensuring adequate temperature control.
The perfusate was collected at room temperature using a LKB 
Ultrarac fraction collector and stored at -20 * C until it could 
be assayed for insulin.
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APPENDIX V 
Enzyme Preparation
Methods used
Although many separation techniques have been employed in 
isolating the various enzymes from the filtrate of clostridia 
hystolyticum ( Yoshida 1965 , Kono 1968 , Kesselring 1971 ) it 
was decided to apply gel filtration both for its ease of appli­
cation and because the reported recovery of enzyme activity has 
been extremely high ( Mandl 1961 ).
Gel Filtration .
Collagenase from various suppliers was chromatographed at 
room temperature on either a 2.5 X 100 cm column using sephadex 
G200 or on three 2.5 X 70 cm columns connected in series 
These columns contained Ultragel AcA34 , AcA44 , and Ac A 44 .
The elution buffer used was 0.75 M tris HCl, ph 7.3 , containing
0.4 mg / ml sodium azide to prevent microbial contamination. The 
flow rate was 40 ml per hour . Ultra violet absorption was 
measured at 278 nm .
The elution buffer and sodium azide was removed prior to use 
by eluting fractions through Ultragel AcA 202 equilibrated with 
the media to be used to digest the tissue .
Electrofocusing .
This was performed using a LKB 8100-1 preparative column 
and a glycerol gradient containing ampholines covering a pH 
range of between 3.5 and 10.
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Enzyme analysis ,
Collagenolytic enzymes have been defined as those enzymes 
which specifically degrade soluble and non-soluble collagen and 
model peptides of the ( Gly - Pro - r ) type , under 
physiological conditions.
This definition is complicated in that enzymes have been 
described which attack native and denatured collagen but which 
are unable to cleave model peptides ( Straub 1966 ) . Similarly 
( Mitchell 1968 ) has described a 'pseudocollagenase' from
Clostridia histolyticum which cleaves synthetic gly-pro-n 
peptides but is inactive against native collagen. In addition it 
is known that a hererogeneity exists among collagenolytic enzymes 
derived from clostridia histolyticum in terms of the number of 
collagen peptide bonds hydrolyzed and in their enzyme kinetics 
against differing substrates (Nordwig 1971).
The choice of substrate for measuring collagenase activity 
is therefore very important and to some extent is dictated by the 
use for which the purified enzyme is intended . It was considered 
that in attempting to effect tissue disaggregation the enzyme 
presumable acts upon native collagen and for this reason bovine 
insoluble collagen was chosen as the substrate .
Collagenase activity was measured using the method of 
MacLennan (1953) at 37*0 , except that the reaction time was 
reduced to three hours . The extent of native collagen breakdown 
was estimated by measuring free amino acids liberated according 
to the colorimetric assay described by Rosan (1957) and 
quantified against a standard curve prepared from L-leucine.
The method used is presented below.
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OPTICAL DENSITY OF L-LEUCINE STANDARD CURVE
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Reagents:
1. Substrate; Insoluble bovine tendon collagen (Type I , Sigma)
2» Substrate Buffer; 0.05 M Tris—HCl with 0.36 M calcium chloride
pH 7.6.
3. Inactivator; 0.1 M Ethylenediamine Tetraacetic Acid
4. Chromagen; 3% Ninhydrin in 2-Ethoxyethanol
5. Chromagen Buffer; 3.5 M Acetate-cynanide buffer , pH 5.2
( 360g CH .C00Na.3H 0 , 67ml CH .COOH to which is added NaCN to 
a final concentration of 0.0002M immediately before use ) .
6. Diluent; n-Propanol diluted 1:1 with water.
Method,
Weigh 25 mg substrate into test tubes for each unknown 
plus two tubes for blanks (no enzyme). Add five mis of soln.2 and 
incubate in a shaking water bath for 15 mins at 37*C. Start the
reaction by adding 100/w 1 of enzyme solution . After 3 hours stop
the reaction by adding 500^1 of soln.3 . Centrifuge at 2,500g for 
20 minutes .
To 250/41 of supernatant, blanks and a 0 to 4 M ml L-Leucine 
standard curve add 600/41 of soln. 5 and 400/«l of soln 4. Boil 
for 20 minutes to enable full colour development , cool and add 
10 ml of soln.6 . Read optical density at 570 nm.
Figure A 3 relatesMoles of leucine per ml to optical 
density at several dilutions of leucine. Beer's law can be seen 
to hold at all of these dilutions.
The reaction rate was estimated by measuring product forma­
tion at several dilutions of enzyme with constant substrate
concentration against time. These results are presented in 
(Figure A 4)
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As can be seen the rate of enzyme reaction tends to be . non­
linear with time . Several factors may combine to produce this 
lack of linearity i.e. enzyme inactivation , depletion of 
substrate and accumulation of products etc. or it may be that the 
plot relects the additive effects of more than one collagenolytic 
enzyme .
Figure A 5 shows the product formation at 3 hours for 
differing concentrations of a column fraction with high collage­
nolytic activity . As can be seen the shape of the curve
reflecting the time course of product formation is similar at 
each concentration of enzyme used and more importantly , the 
product formation is linear with respect to enzyme concentration 
( Figure A 6 ). The amount of product formed is therefore 
proportional and can be used to provide a measure of enzyme
activity against this specific substrate .
Results are expressed as 1 unit = 1 yW mole leucine
equivalent liberated per ml enzyme solution in three hours 
at 37 ' C .
Tryptic activity was measured according to the method of 
Erlanger ( 1961 ) . The hydrolysis of N-Benzoyl-DL-Arginine-p- 
nitroanilide HCl was carried out at 25 C and at pH 7.4 . Results 
are expressed as moles hydrolyzed per ml per minute.
Caseinolytic activity (non- specific proteolytic activity )
was measured using a modification of the method of Charney 
(1947), . The coupling of a protein with a diazotized aryl amide
produces an azoprotein ( in this case azocasein ) . This may be 
precipitated with Trichloracetic acid ( TCA ) to produce a 
colourless filtrate . If the azoprotein is subjected to
187
PROTEINS USED TO CALIBRATE ULTRAGEL COLUMNS
Protein
Loaded
Molecular
Weight
Log Mol. 
Weight
Elution
Volume
K*v
Dextran 476,000 5.67 270 0
2,000,000
Glucose 150,000 5.176 376 0.15
oxidase
Uricase 110,000 5.041 430 0.21
Bovine *. 66,000 4.819 584 0.37
albumin
Pepsin 36,000 4.556 768 0.59
Chymo- 25,000 4.398 860 0.68
trypsin
Papain 21,000 4.322 900 " 0.73
Ribo- 13,700 4.137 990 0.85
nuclease
TABLE A.l
proteolytic digestion coloured products are formed the intensity 
of which are a function of the activity of the enzyme solution. 
The assay used was as follows .
500/f1 of the enzyme solution was added to 4 ml of 5 %
azocasein in 0.15 M Tris / HCl buffered to pH 7.4 and pre-warraed 
to 37* C. After 1 hour the reaction was stopped by adding 1 ml
TCA and centrifuged at 2,500 g for 10 minutes .1 ml of the
supernatant was diluted to 5 mis with 0.8 M NaOH and the Optical
density was read at 470 nm . Results are expressed as 1 Unit = 1
/4 mole hydrolyzed azocasien per hour at 37 C.
Total protein was assayed using the modified lowry reaction 
of Peterson ( 1977 ) . Bovine albumin fraction V was used as the 
standard.
Results.
Column Chromatograohv.
The log molecular weight of globular proteins besu* a linear 
relationship to the elution volume . The columns were calibrated 
using proteins of known molecular weight ( Table A1 ) .
values were calculated from the following formula ,
Vg - V,
Vj. -  V
( where V ^ = the elution volume , V ^ = the total column 
volume and V » = the column void volume. )
The calibration curve is shown in Figure A.7 .
Between 500 mg and 1 g of commercial collagenase from 
various suppliers was dissolved in 10 ml of elution buffer and 
introduced onto the columns .
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The UV absorption spectra Figure A.8 shows two fairly 
narrow absorption maxima with a K^v of 0.11 and 0.82 . These
correspond to molecular weight proteins of approximately 170,000 
and 95,000. The remainder of the eluate comprised a less well 
defined absorption maxima between K^^O.4 and 0.95 .
This UV absorption spectra was essentially the same with 
all batches of commercial preparations of collagenase tested.
From Figure A.8 it is also clear that in comparison to the 
UV absorption the protein spectrum showed a marked increase in 
those fractions at the K value of 0.28 .
This discrepancy can perhaps be explained.
It has been shown that the UV absorption characteristics 
depend mainly upon peptide bonds and the presence and the degree 
of ionization of the three aromatic amino acid residues tyrosine, 
tryptophan and phenylalanine. Of these three amino acids only 
tyrosine and phenylalanine have been demonstrated in acid 
hydrolysates of collagenase and phenylalanine is known to absorb 
less strongly at this wavelength.
In the Lowry reaction the colour yield is considered to 
arise from the same three aromatic amino acid residues but also 
to some extent sequences of certain amino acids bearing 
functional side groups such as arginine, histidine and glutamic 
acid .
It therefore appears likely that collagenase may absorb UV 
light less stongly than most proteins and for this reason the 
Lowry reaction may provide a more accurate estimate of the 
protein spectra obtained following gel filtration of collagenase.
The column fractions were assayed for collagenolytic ,
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tryptic and non-specific protease activity. These results are 
shown if Figure A.9 .
The first enzyme to elute was shown to coincide with the 
first protein peak . This enzyme exhibited only a slight non­
specific activity and its characteristics i.e. high molecular 
weight and low K suggest that it may be the amino-peptidase 
first described by Kessler ( 1973 ) .
As can be seen the main peak exhibiting collagenolytic 
activity appeared in the range 0.12 to 0.3 . This corresponds 
to a molecular weight of approximately 95,00 to 110,000 which is 
in close aggreement to published figures ( Yoshida 1965 ) . It is 
interesting that two distinct peaks were obtained and may 
correpond to the type I and type II forms of the enzyme reported 
by Kono ( 1968 ) . Both of these peaks eluted well before the 
contaminating proteases so that a pure collagenolytic enzyme 
preparation was obtained for use in tissue disaggregation.
The enzyme spectrum shows the presence of the tryptic like 
enzyme clostripain eluting between K 0.3 and 0.5 and a broad 
band of non-specific protease activity eluting between K 0.32 
and 0.68 .
The tryptic and non-specific enzyme fraction were 
fractionated further following electofocusing . It was found that 
clostripain produced a single band exhibiting a Pj of 4.8 . In
contrast the non-specific protease activity could be shown to be 
comprised of three separate enzymes with values of 3.7 , 4.8
and 7.5 ( Figure A.10 ).
The methods presented above have enabled us to isolate
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enzymes preparations with defined activities The purity of each 
of the fractions obtained following gel filtration in terras of 
the number of proteins or enzymes they contained would require 
further separation techniques (i.e. electropheresis or*affinity 
chromatography ) or extensive experimentation into the enzyme 
kinetics or immunological properties contained within these 
fractions . These were not carried out .
The above procedures have enabled the separation of enzyme 
preparations classified according to their ability to react with 
one or each of three substrates known to be specific for 
collagenolytic, tryptic and non-specific enzyme activities.
This allows us to critically examine the role of these 
individual enzyme preparations in terms of the type of bonds they 
attack and their effectiveness in tissue disaggregation and in 
preserving cell viability .
191
APPENDIX VI
NORMAL CANINE VALUES
Tissue Components
TISSUE COMPONENTS OF THE NORMAL CANINE PANCREAS
INSULIN TOTAL PROTEIN AMYLASE
ng g wet wt. mg g wet wt. mg g wet wt.
144,640 126 16.3
276,970 110 27.3
91,082 154 13.8
74,162 161 18.9
41,163 179 7.9
109,966 129 11.2
214,978 168 14.8
91,082 142 15.9
MEAN 130,505 144 15.8
S.D 78,807 . 23 5.7
TABLE A.2
REGIONAL DISTRIBUTION OF PANCREATIC INSULIN CONTENT
INSULIN CONTENT OF TISSUE SAMPLES 
( ng per gm wet weight )
TAIL OF BODY OF HEAD OF
PANCREAS PANCREAS PANCREAS
( Splenic Lobe ) ( Uncinate Process )
27,853 26,927 29,052
236,152 121,335 95,380
192,500 107,230 38,169
178,200 57,800 65,311
240,361 73,905 91,538
62,430 131,389 95,363
102,174 312,200 247,092
346,387 166,857 67,326
63,330 113,414 126,141
240,361 73,905 65,311
MSAN 1 168,975 118,496 92,062
S.D.' 102,040 79,045 61,586
TABLE A.3
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PERIPERFUSION OF ENZYMATICALLY DISPERSED CANINE 
PANCREAS DURING A GLUCOSE CHALLENGE
IRI RELEASE ig g tissue -
Collection Glucose Mean Mean n
Time (mins) Conc.mMol IRI ng Deviation ng
2 2.8 162.0 104.2 8
4 2.8 157.5 107.6 8
6 2.8 124.1 74.7 7
8 2.8 128.6 92.0 6
10 2.8 116.4 92.4 8
12 2.8 108.2 98.0 8
14 2.8 86.8 83.1 8
16 2.8 76.5 70.5 6
18 2.8 64.6 51.8 8
20 2.8 53.1 38.6 8
22 2.8 48.7 30.8 7
24 2.8 43.3 33.2 6
26 2.8 48.5 37.7 8
28 2.8 43.6 30.4 7
30 16.8 134.3 124.5 8
32 16.8 108.6 100.3 8
34 16.8 84.1 64.8 8
36 16.8 72.7 54.3 8
38 16.8 75.0 59.6 6
40 16.8 60.8 46.3 6
42 16.8 60.2 50.5 8
44 16.8 54.3 46.8 8
46 16.8 58.6 46.5 8
48 16.8 60.0 32.1 7
50 16.8 63.2 31.1 8
52 16.8 59.4 39.7 8
54 16.8 63.8 33.0 7
56 16.8 74.2 50.6 8
58 16.8 73.8 45.6 7
60 16.8 70.6 46.2 7
62 5.6 39.8 29.5 7
64 5.6 37.0 22.7 7
66 5.6 30.8 27.0 6
68 ë.6 32.5 17.4 7
70 5.6 30.1 27.3 6
TABLE A.7
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NORMAL BLOOD COAGULATION FACTO#
Prothrombin 
Time (secs)
Kaolin-Cephalic | 
Time (secs)
Platelets 
X 10 ml
8.4 20.2 235
0.3 3.5 43
20 20 20
MEAN
TABLE A.8
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